About Me

Name: Doctorwascher
Biography
Loading...

Create Your Own Blog Find Other Townhall Blogs

Comments

  • Robert
    Exercise Reverses...
    Gar Swaffar
  • Yikes!
    Exercise Reverses...
    Robert
  • Dr W
    Exercise Reverses...
    Gar Swaffar
  • Dr W
    Exercise Reverses...
    Gar Swaffar

Blog Roll

 

Red Yeast Rice, Statins & Cholesterol

 
Health Report:



Red Yeast Rice, Statins & Cholesterol

 

"A critical weekly review of important new research findings for health-conscious readers..."


By, Robert A. Wascher, MD, FACS


Photo of Dr. Wascher

Last Updated:  06/21/2009


The information in this column is intended for informational purposes only, and does not constitute medical advice or recommendations by the author.  Please consult with your physician before making any lifestyle or medication changes, or if you have any other concerns regarding your health.

RED YEAST RICE, STATINS & CHOLESTEROL

According to the American Heart Association, more than 50 million Americans require some sort of intervention to prevent or treat coronary artery disease, and another 15 million, or more, require medication in order to lower their cholesterol levels to a safer range.  

 
Today, the statin class of drugs plays a dominant role in the management of elevated cholesterol (hyperlipidemia), and these drugs are widely used to both prevent and treat coronary artery disease when diet and exercise prove inadequate by themselves. While the full spectrum and extent of the health benefits of statin drugs continues to be the subject of debate, there is ample high-level clinical research evidence that statins significantly reduce the risk of clinically significant coronary artery disease, heart attack (myocardial infarction), and death in patients with elevated blood levels of “bad cholesterol” (LDL), and even in patients who have normal LDL levels, but who also have elevated C-reactive protein (CRP) levels.  (CRP is a protein that becomes elevated in the blood in the presence of inflammation.) 

 
Unfortunately, as with all medications, the statins are associated with potentially significant side effect. The most serious side effects that have been associated with statin drugs are muscle injury (rhabdomyolysis) and liver injury. Based upon recent research data, approximately 5 percent of patients taking statin drugs will experience significant muscle pain and weakness, requiring that they discontinue their statin medication. In severe cases, rhabdomyolysis can lead to permanent muscle injury and kidney failure. An additional 2 percent of patients may have to stop taking statins due to significant liver toxicity. Joint pain, peripheral nerve injury, and memory loss have also been associated with the use of some statin drugs, although the link between statins and these more uncommon side effects is less clear than for rhabdomyolysis and liver injury.

 
When diet and exercise alone fail to reduce elevated LDL levels, particularly when there is a personal or family history of cardiovascular disease, statins are generally the first line of treatment (in addition to aspirin, if there are no contraindications to taking aspirin). However, patients who do not tolerate statins have limited choices in terms of effective alternative lipid-lowering therapy.  

 
Niacin, which is one of the oldest forms of therapy for hyperlipidemia, is one alternative option , and although not as effective as statins, this vitamin supplement, when given in high enough doses, can not only reduce LDL cholesterol, but also triglycerides (the predominant form of fat in the blood) as well. Additionally, niacin therapy can also raise the “good cholesterol” (HDL) level in the blood.  (By comparison, statins have only small effects on triglyceride levels, and minimal effects on HDL levels in the blood.) The biggest disadvantage of niacin therapy, however, is its tendency to cause severe flushing in about half of patients who take the standard form of this drug, as well as the abdominal pain, nausea and vomiting that occurs in another 8 to 10 percent of patients. However, newer extended-release preparations of niacin are much better tolerated, with an incidence of adverse side effects of approximately 6 to 8 percent. (Fortunately, in most cases, flushing and the other adverse side effects associated with niacin therapy will improve over time if patients continue to take this medication.) As with statin drugs, however, there is a 1 or 2 percent risk of liver toxicity associated with niacin therapy for hyperlipidemia, and most patients who take either statin drugs or niacin for elevated LDL levels should be periodically monitored for elevations of liver enzymes in their blood. Long-term niacin therapy may also increase blood sugar (glucose) levels in patients with pre-diabetes or diabetes, and may also raise blood levels of uric acid, which may, in turn, lead to the development of gout in susceptible individuals. Therefore, fasting blood glucose levels and the level of uric acid in the blood should be monitored, as well, in patients who are taking niacin for hyperlipidemia (these two latter complications of niacin therapy also appear to be less common when taking the newer extended-release niacin preparations.)

 
Other non-statin therapies are also available for the treatment of elevated LDL and triglyceride levels, but they are seldom used, as they are not only less effective than statins and niacin, but their side effects profiles are so significant that very few patients remain compliant with these alternative lipid-lowering therapies.

 
Red yeast rice (
Monascus purpureus, for you botanists out there), has been used in China for at least 1,200 years. The yeast spores are typically grown on rice, from which this product gains its name. In addition to its use, for centuries, as an herbal medication (mostly in East Asia) for stomach complaints and poor circulation, Chinese food lovers will recognize the brick-red color of red yeast rice whenever they eat Peking duck or char siu.

 
A handful of small previous research studies have suggested that red yeast rice may be as effective as some statins in reducing LDL and triglyceride levels when taken as a dietary supplement. This is not surprising, as most pure preparations of red yeast rice actually contain naturally-occurring lovastatin, one of the early statin drugs (and which, by the way, was first isolated from aspergillus, which is another form of fungus). However, other compounds contained within red yeast rice are also thought to additively contribute to the claimed LDL-lowering effects of this dietary supplement, above and beyond the contribution of the small amount of lovastatin contained within many of these preparations.

 
A new prospective, randomized, placebo-controlled clinical research study of red yeast rice strongly suggests that at least some forms of red yeast rice supplements may, indeed, be highly effective in reducing elevated blood levels of LDL in patients who have been unable to tolerate standard statin medications. This study, which appears in the current volume of the Annals of Internal Medicine, randomized 31 patients to receive 1,800 milligrams of red yeast rice twice per day, while the other 31 patients in this study received placebo (sugar) pills that looked identical to the red yeast rice supplement pills. Neither the patients nor the researchers knew which patients were receiving the red yeast rice and which patients were receiving the placebo pills until after the study was completed. All 62 patients were also enrolled in a 12-week lifestyle and dietary modification program for patients with hyperlipidemia.

 
This study was continued for 24 weeks, and blood levels of LDL, HDL, triglycerides, and liver enzymes were measured at the beginning of the study, as well as 12 weeks and 24 weeks into the study. Additionally, blood levels of creatinine phosphokinase (CPK), a muscle enzyme that is released when statin-induced rhabdomyolysis occurs, were also measured at these same time points. (All of these 62 patients had previously discontinued statin therapy due to muscle pain.)

 
At the 12-week point, the average LDL levels of the patients in the red yeast rice group had declined by a very significant 43 milligrams per deciliter (mg/dl), compared to the 11 mg/dl reduction obtained in the placebo group with lifestyle and diet modification alone. At the 24-week point, a 35 mg/dl reduction in LDL levels was observed in the red yeast rice group versus a 15 mg/dl average decrease in LDL levels at 24 weeks in the placebo pill group. (It is very important to note, by the way, that even the “placebo group” of hyperlipidemia patients were able to reduce their elevated LDL levels with diet and exercise alone!)

 
While LDL and total cholesterol levels were significantly reduced in the red yeast rice group, when compared to the patients in the placebo group, blood levels of HDL, triglycerides, liver enzymes, and CPK did not differ between the two groups of patients. Moreover, there were also no significant differences in weight loss or the incidence of muscle pain between the two patient groups following 24 weeks of red yeast rice supplementation. 

 
In summary, this was a small prospective, randomized, placebo-controlled clinical research study involving patients who had previously discontinued statin therapy due to muscle toxicity. In this study, which lasted for a relatively short duration of about 6 months, red yeast rice supplementation (in addition to lifestyle and dietary modifications) significantly reduced blood levels of LDL and total cholesterol. Throughout this research study, there was no clinical or laboratory evidence of liver or muscle toxicity associated with the use of red yeast rice supplements.

 
The results of this study are highly intriguing, although it does leave some important questions unanswered. In particular, it is not clear to what extent that naturally-occurring lovastatin, contained within in the red yeast rice supplement used in this study, is responsible for the LDL-lowering effects of red yeast rice that were observed in this study (a small previous research study has suggested, but not proven, that the degree of LDL reduction observed with red yeast rice supplementation is greater than what would be predicted by the actual lovastatin content of red yeast rice).

 
Despite the very intriguing results of this small pilot study, all readers should be reminded of some very important caveats regarding the purchase and use of red yeast rice supplements.  Because of the variable but significant lovastatin content of many red yeast rice dietary supplements, the Food and Drug Administration (FDA) has recently sent warning letters to several dietary supplement manufacturers, indicating the Government’s concern that red yeast rice contains a known prescription-only drug and, therefore, that the FDA’s position is that such supplements should probably not be sold as over-the-counter dietary supplements. The variability of lovastatin content in various forms of red yeast rice also makes it difficult for consumers to know how much lovastatin is contained within these supplements, which may be a problem for patients who are predisposed to liver, muscle, or kidney toxicity associated with statin use. Also, because lovastatin, and other potentially active compounds in red yeast rice, can pass into both the placenta and breast milk, women who are pregnant (or who may be pregnant), and women who are breastfeeding, should not be exposed to any supplement or foods that contain red yeast rice. Finally, other compounds that may be toxic to the liver and kidneys have previously been detected in some red yeast rice preparations.

Because of these various health-related concerns, I want to make it very clear that I am not, at this time, advocating the routine use of red yeast rice for medicinal purposes.  However, if you have failed all other forms of lifestyle, dietary, and medical therapy for significant hyperlipidemia, then you may wish to forward a link to this column to your Internist or Cardiologist. If they are open to the possibility of incorporating red yeast rice into your lipid-lowering regimen, and they are willing to closely monitor you for signs of toxicity (as well as unexpected pregnancy, for fertile female patients), then this approach may be something that you and your doctor may wish to consider. However, I absolutely do not recommend that you begin taking red yeast rice supplements without the involvement and approval of your physician, because of the health-related safety concerns that I have already discussed.

Finally, I will close out this week’s column by wishing all of you other hard-working dads out there a very happy and warm Fathers Day. Among all of the blessings and fortunes that we might be lucky enough to acquire during our busy and often stressful lives (and especially during these trying times), being a dad, and having the privilege of making such a tremendous difference in the lives of our children, is surely one of the greatest gifts that we can receive. Please remember to try to carve out some special time, everyday, to spend with your children. 




Disclaimer:  As always, my advice to readers is to seek the advice of your physician before making any significant changes in medications, diet, or level of physical activity


 

Dr. Wascher is an oncologic surgeon, a professor of surgery, a widely published author, and the Physician-in-Chief for Surgical Oncology at the Kaiser Permanente healthcare system in Orange County, California

  


 

"A Cancer Prevention Guide for the Human Race"

(Anticipated Publication Date:  March 2010)

Link to TV36 Interview with Dr. Wascher

(Click above image for TV36 interview of Dr. Wascher)



Share:






Send your feedback to Dr. Wascher at:  rwascher@doctorwascher.net
 

                                                             

 


Links to Other Health & Wellness Sites


Copyright 2009.  

Robert A. Wascher, MD, FACS.  

All rights reserved.



Dr. Wascher's Archives:

6-14-2009:  Bone Marrow Stem Cell Transplant & Congestive Heart Failure (CHF)

6-7-2009:    Diet, Soy & Breast Cancer Risk

5-31-2009:  Diet and Prostate Cancer Risk

5-24-2009:   Diabetes, Glucose Control & Death

5-17-2009:  Drug Company Marketing & Physician Prescribing Bias

5-10-2009:   Hemorrhoids & Surgery

5-03-2009:   Statin Drugs & Blood Clots (Thromboembolism)

4-26-2009:   Are We Really Losing the War on Cancer?

4-19-2009:  Exercise in Middle Age & Risk of Death

4-12-2009:   Can Chronic Stress Harm Your Heart?

4-05-2009:  Does PSA Testing for Prostate Cancer Save Lives?

3-22-2009:  CABG Surgery vs. PCI in Diabetics with Coronary Artery Disease; Sweetened Beverages and Coronary Artery Disease

3-15-2009:   Depression, Stress, Anger & Heart Disease

3-8-2009:   Coronary Artery Disease: CABG vs. Stents?; Swimming Lessons & Drowning Risk in Children

3-1-2009:   Aspirin & Colorectal Cancer Prevention; Fish Oil & Respiratory Infections in Children

2-22-2009:   Health Differences Between Americans & Europeans; Lycopene & Prostate Cancer

2-15-2009:  Statin Drugs & Death Rates; Physical Activity, Breast Cancer & Sex Hormones 

2-8-2009:   Hormone Replacement Therapy (HRT) & Breast Cancer; Stool DNA Testing & Cancer of the Colon & Rectum

2-1-2009:   Obesity and the Complications of Diverticulosis (Diverticulitis & Bleeding); Obesity, Weight Loss & Urinary Incontinence 

1-25-2009:  Prostate Cancer, Fatigue & Exercise; Does your Surgeon “Warm-up” Before Surgery?

1-18-2009:  Cancer & Vitamins; Teenagers, MySpace and Risky Behaviors

1-11-2009: Exercise Reverses Some Effects of Fatty Meals; Vitamin C and Blood Pressure

1-4-2009:     Secondhand Smoke & Heart Attack Risk; Poor Physical Fitness During Childhood & Heart Disease Risk During Adulthood


12-28-2008: Stress & Your Risk of Heart Attack; Vitamin D & the Prevention of Colon & Rectal Polyps

12-21-2008:  Breast Cancer Incidence & Hormone Replacement Therapy; Circumcision & the Risk of HPV & HIV Infection

12-14-2008:  Vitamin E, Vitamin C and Selenium Do Not Prevent Cancer;  Postscript: A Possible Cure for Down’s Syndrome

12-7-2008:    Generic vs. Brand-Name Drugs; Stress & Breast Cancer Survival

11-30-2008:   A Possible Cure for Down’s Syndrome?; Smoking & Cognitive Decline; Calcium & Vitamin D & Breast Cancer Risk

11-23-2008:  Breast Cancer & Fish Oil; Lymphedema after Breast Cancer Treatment; Vasectomy & Prostate Cancer Risk

11-16-2008:  Vitamin E & Vitamin C: No Impact on Cardiovascular Disease Risk; Does Lack of Sleep Increase Stroke & Heart Attack Risk in Hypertensive Patients?

11-9-2008:   Statins Cut Heart Attack Risk Even with Normal Cholesterol Levels; Statins & PSA Level

11-2-2008:   Radiation Treatment of Prostate Cancer & Second Cancers; Sexual Content on TV & Teen Pregnancy Risk

10-26-2008:  Smoking & Quality of Life

10-19-2008:  Agent Orange & Prostate Cancer

10-12-2008:  Pomegranate Juice & Prostate Cancer

10-5-2008:   Central Obesity & Dementia; Diet, Vitamin D, Calcium, & Colon Cancer

9-28-2008:   Publication & Citation Bias in Favor of Industry-Funded Research?

9-21-2008:   Does Tylenol® (Acetaminophen) Cause Asthma?

9-14-2008:   Arthroscopic Knee Surgery- No Better than Placebo?; A Healthy Lifestyle Prevents Stroke

8-23-2008:   Alcohol Abuse Before & After Military Deployment; Running & Age; Running & Your Testicles

8-12-2008:   Green Tea & Diabetes; Breastfeeding & Adult Cholesterol Levels; Fish Oil & Senile Macular Degeneration

8-3-2008:    Exercise & Weight Loss; Green Tea, Folic Acid & Breast Cancer Risk; Foreign Language Interpreters & ICU Patients

7-26-2008:   Viagra & Sexual Function in Women; Patient-Reported Adverse Hospital Events; Curcumin & Pancreatic Cancer

7-13-2008:  Erectile Dysfunction & Frequency of Sex; Muscle Strength & Mortality in Men; Cryoablation for Prostate Cancer

7-6-2008:   Sleep, Melatonin & Breast Cancer Risk; Mediterranean Diet & Cancer Risk; New Treatment for Varicose Veins

6-29-2008:  Bone Marrow Stem Cells & Liver Failure; Vitamin D & Colorectal Cancer Survival; Green Tea & Colorectal Cancer

6-22-2008:  Obesity, Lifestyle & Heart Disease; Effects of Lifestyle & Nutrition on Prostate Cancer; Ginkgo Biloba, Ulcerative Colitis & Colorectal Cancer

6-15-2008:  Preventable Deaths after Coronary Artery Bypass Graft (CABG) Surgery; Green Tea & Colorectal Cancer; Attention-Deficit/Hyperactivity Disorder (ADHD) & St. John’s Wort

6-8-2008:  Vitamin D & Prostate Cancer Risk; Radiofrequency Ablation (RFA) of Kidney (Renal) Cancer; Antisense Telomerase & Cancer

6-2-2008:  Acute Coronary Syndrome- Do You Know the Symptoms?; Green Tea & Lung Cancer; Episiotomy & Subsequent Deliveries- An Unkind Cut

5-25-2008:  Early Childhood Screening Predicts Later Behavioral Problems; Psychiatric Disorders Among Parents of Autistic Children; Social & Psychiatric Profiles of Young Adults Born Prematurely

5-18-2008:  Can Statins Reverse Coronary Artery Disease?; Does Breast Ultrasound Improve Breast Cancer Detection?; Preventive Care Services at Veterans Administration (VA) Medical Centers

5-11-2008:  Smoking Cessation & Risk of Death; Childhood Traumas & Adult Suicide Risk; “White Coat Hypertension” & Risk of Cardiovascular Disease

5-4-2008:  Super-Size Me: Fast Food’s Effects on Your Liver; Exercise, Weight & Coronary Artery Disease; Contamination of Surgical Instruments in the Operating Room

4-27-2008:  Stents vs. Bypass Surgery for Coronary Artery Disease; The “DASH” Hypertension Diet & Cardiovascular Disease Prevention; Testosterone Therapy for Women with Decreased Sexual Desire & Function

4-20-2008:  BRCA Breast Cancer Mutations & MRI Scans; Bladder Cancer Prevention with Broccoli?; Diabetes: Risk of Death Due to Heart Attack & Stroke

4-13-2008:  Breast Cancer Recurrence & Hormone Replacement Therapy (HRT); Carotid Artery Disease: Surgery vs. Stents?; Statin Drugs & Cancer Prevention

4-6-2008:  Human Papilloma Virus (HPV), Pap Smear Results & Cervical Cancer; Human Papilloma Virus (HPV) Infection & Oral Cancer; Hormone Replacement Therapy (HRT) & the Risk of Gastroesophageal Reflux Disorder (GERD)

3-30-2008:  Abdominal Obesity & the Risk of Death in Women; Folic Acid Pretreatment & Heart Attacks; Pancreatic Cancer Regression after Injections of Bacteria

3-23-2008:  Age of Transfused Blood & Risk of Complications after Surgery; Obesity, Blood Pressure & Heart Size in Children

3-16-2008:  Benefits of a Full Drug Coverage Plan for Medicare Patients?; Parent-Teen Conversations about Sex; Soy (Genistein) & Prostate Cancer

3-9-2008:  Flat Colorectal Adenomas & Cancer; Health Risks after Stopping Hormone Replacement Therapy (HRT); Television, Children & Obesity 

3-2-2008:  Medication & Risk of Death After Heart Attack; Hormone Replacement Therapy (HRT) & Mammogram Results; Selenium: Cancer, Heart Disease & Death

2-23-2008:  Universal Healthcare Insurance Study; Glucosamine & Arthritis

2-17-2008:  Exceptional Longevity in Men; Testosterone & Risk of Prostate Cancer; Smoking & Pre-malignant Colorectal Polyps

2-10-2008:  Thrombus Aspiration from Coronary Arteries; Intensive Management of Diabetes & Death; Possible Cure for  Down's Syndrome?

2-3-2008:  Vitamin D & Cardiovascular Health; Vitamin D & Breast Cancer; Green Tea & Colorectal Cancer

1-27-2008:  Colorectal Cancer, Esophageal Cancer & Pancreatic Cancer: Update from the 2008 American Society of Clinical Oncology's Gastrointestinal Cancers Symposium

1-20-2008:  Testosterone Levels & Risk of Fractures in Elderly Men; Air Pollution & DNA Damage in Sperm; Statins & Trauma Survival in the Elderly

1-12-2008:  Statins, Diabetes & Stroke and Obesity; GERD & Esophageal Cancer

1-7-2008:  Testosterone Supplements in Elderly Men; Colorectal Cancer-- Reasons for Poor Compliance with Screening Recommendations

12-31-2007:  Minority Women, Hormone Replacement Therapy & Breast Cancer; Does Health Insurance Improve Health?

12-23-2007: Is Coffee Safe After a Heart Attack?; Impact of Divorce on the Environment; Hypertension & the Risk of Dementia; Emotional Vitality & the Risk of Heart Disease

12-16-2007:  Honey vs. Dextromethorphan vs. No Treatment for Kids with Night-Time Cough, Acupuncture & Hot Flashes in Women with Breast Cancer, Physical Activity & the Risk of Death, Mediterranean Diet & Mortality 

12-11-2007:  Bias in Medical Research; Carbon Nanotubes & Radiofrequency: A New Weapon Against Cancer?; Childhood Obesity & Risk of Adult Heart Disease

12-2-2007:  Obesity & Risk of Cancer; Testosterone Level & Risk of Death; Drug Company Funding of Research & Results; Smoking & the Risk of Colon & Rectal Cancer 

Home


 

Email ItEmail It | Print ItPrint It | CommentsComments (0) | TrackbacksTrackbacks (0) | Flag as offensiveFlag as Offensive

Bone Marrow Stem Cell Transplant & Congestive Heart Failure (CHF)

 

Health Report:

 

Bone Marrow Stem Cell Transplant & Congestive Heart Failure (CHF)

 



"A critical weekly review of important new research findings for health-conscious readers..."

 

By, Robert A. Wascher, MD, FACS

 

 

Updated:  06/14/2009


The information in this column is intended for informational purposes only, and does not constitute medical advice or recommendations by the author.  Please consult with your physician before making any lifestyle or medication changes, or if you have any other concerns regarding your health.


 

 

 

Bone Marrow Stem Cell Transplant & Congestive Heart Failure (CHF)

  

 

Congestive heart failure (CHF) is a serious and life-threatening illness that is associated with premature death.  If one thinks of the heart as a pump, progressive damage to this pump’s muscle fibers results in decreased “pump efficiency,” which causes blood to, essentially, back-up within the vascular system under increased pressure.  This increased back-pressure causes swelling of the entire body (edema), and particularly the lower extremities, the lungs, the liver, as well as within the heart itself.  In more severe cases, CHF is associated with generalized weakness and profound shortness of breath. 

 

 

The American Heart Association estimates that there are already more than 5 million Americans living with CHF, and that more than 550,000 new cases of CHF are diagnosed each year.  Although mortality rates associated with CHF have improved dramatically over the past 30 years, the 5-year death rate associated with clinically significant CHF still approaches 50 percent. 

 

 

As our population continues to grow older, on average, the incidence of CHF is expected to continue to rise.  Although precise estimates are difficult to arrive at, the cost of caring for CHF is thought to be at least $33 billion per year in the United States alone.

 

 

There are several known major risk factors for CHF, including coronary artery disease and heart attack (myocardial infarction), uncontrolled high blood pressure (hypertension), diabetes, obesity, diseased heart valves, elevated cholesterol, and smoking.  In most countries, coronary artery disease and myocardial infarction are the leading causes of CHF, and these two related risk factors account for approximately two-thirds of all CHF cases in the United States.

 

 

In adults, heart muscle fibers (cardiac myocytes) that have become damaged by chronic oxygen deprivation (myocardial ischemia) or oxygen loss (myocardial infarction) are essentially unable to regenerate themselves, and are gradually replaced by scar tissue that interferes with the heart’s pumping action.  At the present time, the standard clinical management of heart injury due to ischemia or infarction includes the use of medications such as aspirin, ACE inhibitors, aldosterone antagonists, beta-blockers and nitrates.  So-called “reperfusion strategies,” including coronary artery stent placement and coronary artery bypass graft (CABG) surgery may also be required in some patients.  However, once the heart’s blood-pumping muscle fibers have become extensively replaced with non-contractile scar tissue (fibrosis), irreversible CHF develops, and only symptomatic management is possible at this point.

 

 

Recent animal studies, and limited clinical research studies in humans, have looked at the use of stem cell auto-transplantation into damaged hearts afflicted with CHF.  Although mature cardiac myocytes cannot regenerate or reproduce following severe ischemia or infarction, primitive “pluropotential” stem cells in the bone marrow are thought to be potentially capable, under certain conditions, of metamorphosing, or differentiating, themselves into almost any type of specialized cell of the body, including cardiac myocytes.  However, this transformation, from undifferentiated bone marrow stem cell into a highly differentiated and specialized cardiac muscle cell, does not occur naturally in the human body, at least not to any clinically significant degree.  Therefore, as is also the case in other areas of stem cell research, the greatest challenge in this type of clinical research is in coaxing undifferentiated stem cells to morph into functional cardiac myocytes and to find a way to incorporate these new heart muscle cells into the damaged heart in such a way that they actually improve the damaged heart’s compromised pumping function.  (These two challenges continue to vex clinical research into stem cell therapy, and particularly research into the use of adult patients’ own stem cells.)

 

 

Now, newly published clinical research in the Journal of the American College of Cardiology appears to have pushed the existing boundaries of so-called autologous stem cell transplantation in the treatment of CHF, and may represent a major advancement towards finding an enduring treatment, if not an eventual cure, for this increasingly common and disabling disease.   

 

 

In this prospective interventional clinical study, 124 patients who had just experienced an acute myocardial infarction were evaluated with coronary angiograms, treadmill EKGs, 24-hour EKGs, and echocardiograms, among other cardiac studies.  Half of this cohort of patient volunteers also underwent collection of their own (autologous) bone marrow cells, and injection of these bone marrow cells into the blocked coronary arteries that had caused these patients’ heart attacks.  Both groups of patients were matched with each other in terms of baseline cardiac function and the extent of their myocardial infarctions.  All 124 patients were then closely followed, at regular intervals, for 5 years.  The results of this study were rather dramatic.

 

 

Within 3 months of bone marrow cell injection, significant improvement was noted in cardiac pumping efficiency (ejection fraction) of the bone marrow cell transplant patients, when compared to the patients who did not receive autologous intracardiac bone marrow cell transfusions.  Moreover, on average, the total area of heart muscle death (infarction) following heart attack was 8 percent smaller in the patients who received the bone marrow cell transplants, when compared to the “control group” patients. 

 

 

In the area of the “infarction zone” of the heart, a very significant 31 percent increase in cardiac contractility was observed in the patients who had undergone bone marrow cell transplant, suggesting that the infused bone marrow stem cells had actually incorporated themselves into the infarcted heart muscle, and had successfully transformed themselves into functional cardiac myocytes.  When compared to the control group patients, the patients who had undergone autologous intracardiac bone marrow cell transplantation also experienced significantly improved exercise tolerance and a decreased risk of death throughout the 5-year observation period within this study.  Furthermore, these highly significant improvements in cardiac function continued to remain stable and durable throughout the 5-year period of post-transplant observation of these patients.  As the “treatment group” patients were infused with their own bone marrow cells, there were no episodes of rejection, and no major complications were reported with this novel treatment.

 

 

This small prospective pilot study strongly suggests that autotransplantation with stem cells contained in the bone marrow can significantly reduce the risk and extent of CHF following acute myocardial infarction.   Not only does this therapy appear to be clinically effective, but it appears to be associated with a very low risk of complications, and it also side-steps the ongoing ethical debate that surrounds the use of more versatile, but more controversial, fetal stem cells.

 

 

Based upon the rather remarkable findings of this small clinical study, much larger multi-institution, prospective, randomized, controlled studies of autologous intracardiac bone marrow cell transplantation, following acute myocardial infarction, need to be performed.  Fortunately, several such studies are already underway in the United States and Europe.  I look forward to the long-term results of such studies, as I believe that they may have the potential to radically transform the management of coronary artery disease and acute myocardial infarction, and offer the best and most practical hope of reducing both the incidence of CHF and the mortality rate associated with CHF.

 

 




Disclaimer:  As always, my advice to readers is to seek the advice of your physician before making any significant changes in medications, diet, or level of physical activity


 

Dr. Wascher is an oncologic surgeon, a professor of surgery, a widely published author, and a Surgical Oncologist at the Kaiser Permanente healthcare system in Orange County, California

 


 

"A Cancer Prevention Guide for the Human Race"

(Anticipated Publication Date:  March 2010)

Link to TV36 Interview with Dr. Wascher

(Click above image for interview of Dr. Wascher)

 

 




Send your feedback to Dr. Wascher at:
 

 

rwascher@doctorwascher.net


 

Dr. Wascher's Biography

 


Links to Other Health & Wellness Sites


http://doctorwascher.com


 

 

Copyright 2009

  

Robert A. Wascher, MD, FACS

  

All rights reserved

 


 

Dr. Wascher's Archives:

 

6-7-2009:   Diet, Soy & Breast Cancer Risk

5-31-2009:  Diet and Prostate Cancer Risk

5-24-2009:  Diabetes, Glucose Control & Death

5-17-2009:  Drug Company Marketing & Physician Prescribing Bias

5-10-2009:  Hemorrhoids & Surgery

5-3-2009:  Statin Drugs & Blood Clots (Thromboembolism)

4-26-2009:  Are We Really Losing the War on Cancer?

4-19-2009:   Exercise in Middle Age & Risk of Death

4-12-2009:  Can Chronic Stress Harm Your Heart?

4-5-2009:  Does PSA Testing for Prostate Cancer Save Lives?

3-22-2009:  CABG Surgery vs. PCI in Diabetics with Coronary Artery Disease; Sweetened Beverages and Coronary Artery Disease

3-15-2009:  Depression, Stress, Anger & Heart Disease

3-8-2009:  Coronary Artery Disease: CABG vs. Stents?; Swimming Lessons & Drowning Risk in Children

3-1-2009:  Aspirin & Colorectal Cancer Prevention; Fish Oil & Respiratory Infections in Children

2-22-2009:  Health Differences Between Americans & Europeans; Lycopene & Prostate Cancer

2-15-2009:  Statin Drugs & Death Rates; Physical Activity, Breast Cancer & Sex Hormones

2-8-2009:  Hormone Replacement Therapy (HRT) & Breast Cancer; Stool DNA Testing & Cancer of the Colon & Rectum

2-1-2009:   Obesity and the Complications of Diverticulosis (Diverticulitis & Bleeding); Obesity, Weight Loss & Urinary Incontinence

1-25-2009:  Prostate Cancer, Fatigue & Exercise; Does your Surgeon “Warm-up” Before Surgery?

1-18-2009:  Cancer and Vitamins; Teenagers, MySpace and Risky Behaviors

1-11-2009:  Exercise Reverses Some Effects of Fatty Meals; Vitamin C and Blood Pressure

1-4-2009:  Secondhand Smoke & Heart Attack Risk; Poor Physical Fitness During Childhood & Heart Disease Risk During Adulthood

12-28-2008:  Stress & Your Risk of Heart Attack; Vitamin D & the Prevention of Colon & Rectal Polyps

12-21-2008:  Breast Cancer Incidence & Hormone Replacement Therapy; Circumcision & the Risk of HPV & HIV Infection

12-14-2008:  Vitamin E, Vitamin C and Selenium Do Not Prevent Cancer;  Postscript: A Possible Cure for Down’s Syndrome

12-7-2008:  Generic vs. Brand-Name Drugs, Stress & Breast Cancer Survival

11-30-2008:    A Possible Cure for Down’s Syndrome?; Smoking & Cognitive Decline; Calcium & Vitamin D & Breast Cancer Risk

11-23-2008:  Breast Cancer & Fish Oil; Lymphedema after Breast Cancer Treatment; Vasectomy & Prostate Cancer Risk

11-16-2008:  Vitamin E & Vitamin C: No Impact on Cardiovascular Disease Risk; Does Lack of Sleep Increase Stroke & Heart Attack Risk in Hypertensive Patients?

11-9-2008:  Statins Cut Heart Attack Risk Even with Normal Cholesterol Levels; Statins & PSA Level

11-2-2008:  Radiation Treatment of Prostate Cancer & Second Cancers; Sexual Content on TV & Teen Pregnancy Risk

10-26-2008:  Smoking & Quality of Life

10-19-2008:  Agent Orange & Prostate Cancer

10-12-2008:  Pomegranate Juice & Prostate Cancer

10-5-2008:  Central Obesity & Dementia; Diet, Vitamin D, Calcium, & Colon Cancer

9-28-2008:  Publication & Citation Bias in Favor of Industry-Funded Research?

9-21-2008:  Does Tylenol® (Acetaminophen) Cause Asthma?

9-14-208:   Arthroscopic Knee Surgery- No Better than Placebo?; A Healthy Lifestyle Prevents Stroke

8-23-2008:  Alcohol Abuse Before & After Military Deployment; Running & Age; Running & Your Testicles

8-12-2008:  Green Tea & Diabetes; Breastfeeding & Adult Cholesterol Levels; Fish Oil & Senile Macular Degeneration

8-3-2008:   Exercise & Weight Loss; Green Tea, Folic Acid & Breast Cancer Risk; Foreign Language Interpreters & ICU Patients

7-26-2008:  Viagra & Sexual Function in Women; Patient-Reported Adverse Hospital Events; Curcumin & Pancreatic Cancer

7-13-2008:  Erectile Dysfunction & Frequency of Sex; Muscle Strength & Mortality in Men; Cryoablation for Prostate Cancer

7-6-2008:  Sleep, Melatonin & Breast Cancer Risk; Mediterranean Diet & Cancer Risk; New Treatment for Varicose Veins

6-29-2008:  Bone Marrow Stem Cells & Liver Failure; Vitamin D & Colorectal Cancer Survival; Green Tea & Colorectal Cancer

6-22-2008:  Obesity, Lifestyle & Heart Disease; Effects of Lifestyle & Nutrition on Prostate Cancer; Ginkgo Biloba, Ulcerative Colitis & Colorectal Cancer

6-15-2008:  Preventable Deaths after Coronary Artery Bypass Graft (CABG) Surgery; Green Tea & Colorectal Cancer; Attention-Deficit/Hyperactivity Disorder (ADHD) & St. John’s Wort

6-8-2008:  Vitamin D & Prostate Cancer Risk; Radiofrequency Ablation (RFA) of Kidney (Renal) Cancer; Antisense Telomerase & Cancer

6-2-2008:  Acute Coronary Syndrome- Do You Know the Symptoms?; Green Tea & Lung Cancer; Episiotomy & Subsequent Deliveries- An Unkind Cut

5-25-2008:  Early Childhood Screening Predicts Later Behavioral Problems; Psychiatric Disorders Among Parents of Autistic Children; Social & Psychiatric Profiles of Young Adults Born Prematurely

5-18-2008:  Can Statins Reverse Coronary Artery Disease?; Does Breast Ultrasound Improve Breast Cancer Detection?; Preventive Care Services at Veterans Administration (VA) Medical Centers

5-11-2008:  Smoking Cessation & Risk of Death; Childhood Traumas & Adult Suicide Risk; “White Coat Hypertension” & Risk of Cardiovascular Disease

5-4-2008:  Super-Size Me: Fast Food’s Effects on Your Liver; Exercise, Weight & Coronary Artery Disease; Contamination of Surgical Instruments in the Operating Room

4-27-2008:  Stents vs. Bypass Surgery for Coronary Artery Disease; The “DASH” Hypertension Diet & Cardiovascular Disease Prevention; Testosterone Therapy for Women with Decreased Sexual Desire & Function

4-20-2008:  BRCA Breast Cancer Mutations & MRI Scans; Bladder Cancer Prevention with Broccoli?; Diabetes: Risk of Death Due to Heart Attack & Stroke

4-13-2008:  Breast Cancer Recurrence & Hormone Replacement Therapy (HRT); Carotid Artery Disease: Surgery vs. Stents?; Statin Drugs & Cancer Prevention

4-6-2008:  Human Papilloma Virus (HPV), Pap Smear Results & Cervical Cancer; Human Papilloma Virus (HPV) Infection & Oral Cancer; Hormone Replacement Therapy (HRT) & the Risk of Gastroesophageal Reflux Disorder (GERD)

3-30-2008:  Abdominal Obesity & the Risk of Death in Women; Folic Acid Pretreatment & Heart Attacks; Pancreatic Cancer Regression after Injections of Bacteria

3-23-2008:  Age of Transfused Blood & Risk of Complications after Surgery; Obesity, Blood Pressure & Heart Size in Children

3-16-2008:  Benefits of a Full Drug Coverage Plan for Medicare Patients?; Parent-Teen Conversations about Sex; Soy (Genistein) & Prostate Cancer

3-9-2008:  Flat Colorectal Adenomas & Cancer; Health Risks after Stopping Hormone Replacement Therapy (HRT); Television, Children & Obesity 

3-2-2008:  Medication & Risk of Death After Heart Attack; Hormone Replacement Therapy (HRT) & Mammogram Results; Selenium: Cancer, Heart Disease & Death

2-23-2008:  Universal Healthcare Insurance Study; Glucosamine & Arthritis

2-17-2008:  Exceptional Longevity in Men; Testosterone & Risk of Prostate Cancer; Smoking & Pre-malignant Colorectal Polyps

2-10-2008:  Thrombus Aspiration from Coronary Arteries; Intensive Management of Diabetes & Death; Possible Cure for  Down's Syndrome?

2-3-2008:  Vitamin D & Cardiovascular Health; Vitamin D & Breast Cancer; Green Tea & Colorectal Cancer

1-27-2008:  Colorectal Cancer, Esophageal Cancer & Pancreatic Cancer: Update from the 2008 American Society of Clinical Oncology's Gastrointestinal Cancers Symposium

1-20-2008:  Testosterone Levels & Risk of Fractures in Elderly Men; Air Pollution & DNA Damage in Sperm; Statins & Trauma Survival in the Elderly

1-12-2008:  Statins, Diabetes & Stroke and Obesity; GERD & Esophageal Cancer

1-7-2008:  Testosterone Supplements in Elderly Men; Colorectal Cancer-- Reasons for Poor Compliance with Screening Recommendations

12-31-2007:  Minority Women, Hormone Replacement Therapy & Breast Cancer; Does Health Insurance Improve Health?

12-23-2007:  Is Coffee Safe After a Heart Attack?; Impact of Divorce on the Environment; Hypertension & the Risk of Dementia; Emotional Vitality & the Risk of Heart Disease

12-16-2007:   Honey vs. Dextromethorphan vs. No Treatment for Kids with Night-Time Cough, Acupuncture & Hot Flashes in Women with Breast Cancer, Physical Activity & the Risk of Death, Mediterranean Diet & Mortality 

12-11-2007:  Bias in Medical Research; Carbon Nanotubes & Radiofrequency: A New Weapon Against Cancer?; Childhood Obesity & Risk of Adult Heart Disease

12-2-2007:  Obesity & Risk of Cancer; Testosterone Level & Risk of Death; Drug Company Funding of Research & Results; Smoking & the Risk of Colon & Rectal Cancer 

 


Dr. Wascher's Home Page


 

 

 

Email ItEmail It | Print ItPrint It | CommentsComments (0) | TrackbacksTrackbacks (0) | Flag as offensiveFlag as Offensive

Diet, Soy & Breast Cancer Risk

 

 

 

 

 

 

 

(Click above image for TV36 interview of Dr. Wascher)

 

 

 

 

 

 

 

 

 (Anticipated Publication Date: March 2010)

 

 

 

Health Report:

 

 

Diet, Soy & Breast Cancer Risk

 

"A critical weekly review of important new research findings for health-conscious readers..."

By, Robert A. Wascher, MD, FACS

 

Updated: 06/07/2009

 

The information in this column is intended for informational purposes only, and does not constitute medical advice or recommendations by the author. Please consult with your physician before making any lifestyle or medication changes, or if you have any other concerns regarding your health.

 

DIET, SOY & BREAST CANCER RISK

Last week’s column reviewed new clinical research findings suggesting that higher levels of soy-derived isoflavones in the diet, and in the blood, may significantly reduce the risk of prostate cancer. This week, I will be discussing a new research study that makes similar claims regarding the prevention of breast cancer.

Breast cancer in women is, in several important ways, analogous to prostate cancer in men. Like prostate cancer, most breast cancer cells are fuelled by the body’s sex hormones (androgens stimulate prostate cancer growth, while estrogen in women stimulates breast cancer growth). Prostate cancer is the number one cause of cancer in men, and breast cancer is the number one cause of cancer in men. Approximately 192,000 cases of each of these cancers will be diagnosed in 2009, with prostate cancer accounting for about one-fourth of all cancers afflicting men, while breast cancer also represents about one-fourth of all cancers that affect women. Prostate cancer is the second most common cause of cancer death in men, and, analogously, breast cancer is the number two cause of cancer death in women. More than 27,000 men will die of prostate cancer in 2009, while more than 40,000 women will succumb to breast cancer this year.

In last week’s column (Diet & Prostate Cancer Risk), I reviewed an innovative clinical research study that assessed both the dietary intake of soy-derived isoflavones and the concentration of these dietary nutrients in the blood. Isoflavones belong to a larger group of dietary compounds that are, collectively, referred to as phytoestrogens, as these nutrients are able to stimulate (albeit weakly) chemical receptors for the sex hormone estrogen. In a newly published clinical study, in the American Journal of Clinical Nutrition, the results of a large prospective Chinese women’s health study add to previous similar research in suggesting that a diet rich in soybean-derived products, especially when consumed before and during adolescence, may be associated with a decreased overall risk of developing breast cancer later in life.

In this prospective public health study, more than 73,000 Chinese adolescent girls and women were followed for an average of 7.4 years. All of the participants in this very large study completed validated dietary surveys, and the incidence of new breast cancers among this very large group of Chinese women was then compared to their self-reported intake of soy-based foods.

The results of this study were rather striking, and were highly statistically significant when comparing the incidence of breast cancer among women with the highest levels of soy intake versus the women with the least soy intake. In this epidemiological study, the women who reported the highest regular dietary intake of soy-based foods were, overall, nearly 60 percent less likely to be diagnosed with premenopausal breast cancer during the course of this clinical research trial. This dramatic reduction in the risk of premenopausal breast cancer was observed in both the women who reported high levels of soy-derived foods in their diet and in the women who frequently consumed foods that were generally rich in isoflavones.

While this particular study did not measure isoflavone levels in the blood, as was done in the prostate cancer study that I reviewed last week, its results, nonetheless, mirror the findings of other similar epidemiological studies.

As with all survey-based disease prevention studies, of course, there is the potential for significant bias in this particular research study, and studies such as these cannot, by themselves, prove a “cause-and-effect” mechanism behind the clinical findings that they reveal. However, such studies, when conducted prospectively and with a high degree of scientific integrity, can still suggest potentially important disease prevention strategies. When the results of studies such as these appear to be especially compelling, they should then be followed-up by large, prospective randomized, placebo-controlled clinical research studies that provide so-called “Level I” clinical evidence.

Previous studies that have supported a role for soy consumption in breast cancer prevention have suggested that the increased consumption of soy-derived isoflavones before and around the time of adolescence is critically important, when the female breast is actively developing, and that this apparent protective effect of soy foods against breast cancer diminishes greatly after breast development is completed in early adulthood. (At the same time, however, the weakly estrogenic effects of dietary isoflavones have raised concerns about soy intake among women with a prior history of breast cancer, although there is no convincing scientific data, yet, showing that dietary isoflavones increase the risk of breast cancer recurrence.)

Another caveat that must be mentioned regarding the findings of this particular study is that the potentially beneficial effects of soy-derived foods, and of dietary isoflavones in general, in preventing breast cancer were observed in a homogeneous population of Asian women. Even if high levels of isoflavones in the diet really are protective against breast cancer, as this epidemiological study strongly suggests, it is still unclear whether or not this putative cancer prevention benefit applies equally to non-Asian women as well. Once again, only well-balanced, prospective, randomized, placebo-controlled clinical studies can confirm or contradict the findings of this very large Chinese public health study. Fortunately, there are several such studies underway at this time.

I will have much more to say, of course, regarding diet and breast cancer prevention, as well as many other evidence-based lifestyle and dietary strategies to reduce your risk of developing all of the top ten cancer killers, in my forthcoming book, “A Cancer Prevention Guide for the Human Race,” which is expected to be available in the spring of 2010.

Finally, although I don’t, as a rule, include links to other websites within this column, I am making an exception for The Prostate Cancer Charity in the United Kingdom. This cancer awareness charity is competing in an online contest to have their prostate cancer public service announcement displayed on London buses at no charge. Please click the following link, and cast your online vote for this charity’s worthy cause (you can cast a vote for them on a daily basis): Bluefrog - The Prostate Cancer Charity

 

Disclaimer: As always, my advice to readers is to seek the advice of your physician before making any significant changes in medications, diet, or level of physical activity.

Dr. Wascher is an oncologic surgeon, a professor of surgery, a widely published author, and a Surgical Oncologist at the Kaiser Permanente healthcare system in Orange County, California/.

 

Send your feedback to Dr. Wascher at:  rwascher@doctorwascher.net

 

Dr. Wascher's Biography

 

Links to Other Health & Wellness Sites  

 

http://doctorwascher.com/

 

 

Copyright 2009

Robert A. Wascher, MD, FACS

All rights reserved

 

 

 

Dr. Wascher's Archives:

5-24-2009: Diabetes, Glucose Control & Death

5-17-2009: Drug Company Marketing & Physician Prescribing Bias

5-10-2009: Hemorrhoids & Surgery

5-3-2009: Statin Drugs & Blood Clots (Thromboembolism)

4-26-2009: Are We Really Losing the War on Cancer?

4-19-2009: Exercise in Middle Age & Risk of Death

4-12-2009: Can Chronic Stress Harm Your Heart?

4-5-2009: Does PSA Testing for Prostate Cancer Save Lives?

3-22-2009: CABG Surgery vs. PCI in Diabetics with Coronary Artery Disease; Sweetened Beverages and Coronary Artery Disease

3-15-2009: Depression, Stress, Anger & Heart Disease

3-8-2009: Coronary Artery Disease: CABG vs. Stents?; Swimming Lessons & Drowning Risk in Children

3-1-2009: Aspirin & Colorectal Cancer Prevention; Fish Oil & Respiratory Infections in Children

2-22-2009: Health Differences Between Americans & Europeans; Lycopene & Prostate Cancer

2-15-2009: Statin Drugs & Death Rates; Physical Activity, Breast Cancer & Sex Hormones

2-8-2009: Hormone Replacement Therapy (HRT) & Breast Cancer; Stool DNA Testing & Cancer of the Colon & Rectum

2-1-2009: Obesity and the Complications of Diverticulosis (Diverticulitis & Bleeding); Obesity, Weight Loss & Urinary Incontinence

1-25-2009: Prostate Cancer, Fatigue & Exercise; Does your Surgeon “Warm-up” Before Surgery?

1-18-2009: Cancer and Vitamins; Teenagers, MySpace and Risky Behaviors

1-11-2009: Exercise Reverses Some Effects of Fatty Meals; Vitamin C and Blood Pressure

1-4-2009: Secondhand Smoke & Heart Attack Risk; Poor Physical Fitness During Childhood & Heart Disease Risk During Adulthood

12-28-2008: Stress & Your Risk of Heart Attack; Vitamin D & the Prevention of Colon & Rectal Polyps

12-21-2008: Breast Cancer Incidence & Hormone Replacement Therapy; Circumcision & the Risk of HPV & HIV Infection

12-14-2008: Vitamin E, Vitamin C and Selenium Do Not Prevent Cancer; Postscript: A Possible Cure for Down’s Syndrome

12-7-2008: Generic vs. Brand-Name Drugs, Stress & Breast Cancer Survival

11-30-2008: A Possible Cure for Down’s Syndrome?; Smoking & Cognitive Decline; Calcium & Vitamin D & Breast Cancer Risk

11-23-2008: Breast Cancer & Fish Oil; Lymphedema after Breast Cancer Treatment; Vasectomy & Prostate Cancer Risk

11-16-2008: Vitamin E & Vitamin C: No Impact on Cardiovascular Disease Risk; Does Lack of Sleep Increase Stroke & Heart Attack Risk in Hypertensive Patients?

11-9-2008: Statins Cut Heart Attack Risk Even with Normal Cholesterol Levels; Statins & PSA Level

11-2-2008: Radiation Treatment of Prostate Cancer & Second Cancers; Sexual Content on TV & Teen Pregnancy Risk

10-26-2008: Smoking & Quality of Life

10-19-2008: Agent Orange & Prostate Cancer

10-12-2008: Pomegranate Juice & Prostate Cancer

10-5-2008: Central Obesity & Dementia; Diet, Vitamin D, Calcium, & Colon Cancer

9-28-2008: Publication & Citation Bias in Favor of Industry-Funded Research?

9-21-2008: Does Tylenol® (Acetaminophen) Cause Asthma?

9-14-208: Arthroscopic Knee Surgery- No Better than Placebo?; A Healthy Lifestyle Prevents Stroke

8-23-2008: Alcohol Abuse Before & After Military Deployment; Running & Age; Running & Your Testicles

8-12-2008: Green Tea & Diabetes; Breastfeeding & Adult Cholesterol Levels; Fish Oil & Senile Macular Degeneration

8-3-2008: Exercise & Weight Loss; Green Tea, Folic Acid & Breast Cancer Risk; Foreign Language Interpreters & ICU Patients

7-26-2008: Viagra & Sexual Function in Women; Patient-Reported Adverse Hospital Events; Curcumin & Pancreatic Cancer

7-13-2008: Erectile Dysfunction & Frequency of Sex; Muscle Strength & Mortality in Men; Cryoablation for Prostate Cancer

7-6-2008: Sleep, Melatonin & Breast Cancer Risk; Mediterranean Diet & Cancer Risk; New Treatment for Varicose Veins

6-29-2008: Bone Marrow Stem Cells & Liver Failure; Vitamin D & Colorectal Cancer Survival; Green Tea & Colorectal Cancer

6-22-2008: Obesity, Lifestyle & Heart Disease; Effects of Lifestyle & Nutrition on Prostate Cancer; Ginkgo Biloba, Ulcerative Colitis & Colorectal Cancer

6-15-2008: Preventable Deaths after Coronary Artery Bypass Graft (CABG) Surgery; Green Tea & Colorectal Cancer; Attention-Deficit/Hyperactivity Disorder (ADHD) & St. John’s Wort

6-8-2008: Vitamin D & Prostate Cancer Risk; Radiofrequency Ablation (RFA) of Kidney (Renal) Cancer; Antisense Telomerase & Cancer

6-2-2008: Acute Coronary Syndrome- Do You Know the Symptoms?; Green Tea & Lung Cancer; Episiotomy & Subsequent Deliveries- An Unkind Cut

5-25-2008: Early Childhood Screening Predicts Later Behavioral Problems; Psychiatric Disorders Among Parents of Autistic Children; Social & Psychiatric Profiles of Young Adults Born Prematurely

5-18-2008: Can Statins Reverse Coronary Artery Disease?; Does Breast Ultrasound Improve Breast Cancer Detection?; Preventive Care Services at Veterans Administration (VA) Medical Centers

5-11-2008: Smoking Cessation & Risk of Death; Childhood Traumas & Adult Suicide Risk; “White Coat Hypertension” & Risk of Cardiovascular Disease

5-4-2008: Super-Size Me: Fast Food’s Effects on Your Liver; Exercise, Weight & Coronary Artery Disease; Contamination of Surgical Instruments in the Operating Room

4-27-2008: Stents vs. Bypass Surgery for Coronary Artery Disease; The “DASH” Hypertension Diet & Cardiovascular Disease Prevention; Testosterone Therapy for Women with Decreased Sexual Desire & Function

4-20-2008: BRCA Breast Cancer Mutations & MRI Scans; Bladder Cancer Prevention with Broccoli?; Diabetes: Risk of Death Due to Heart Attack & Stroke

4-13-2008: Breast Cancer Recurrence & Hormone Replacement Therapy (HRT); Carotid Artery Disease: Surgery vs. Stents?; Statin Drugs & Cancer Prevention

4-6-2008: Human Papilloma Virus (HPV), Pap Smear Results & Cervical Cancer; Human Papilloma Virus (HPV) Infection & Oral Cancer; Hormone Replacement Therapy (HRT) & the Risk of Gastroesophageal Reflux Disorder (GERD)

3-30-2008: Abdominal Obesity & the Risk of Death in Women; Folic Acid Pretreatment & Heart Attacks; Pancreatic Cancer Regression after Injections of Bacteria

3-23-2008: Age of Transfused Blood & Risk of Complications after Surgery; Obesity, Blood Pressure & Heart Size in Children

3-16-2008: Benefits of a Full Drug Coverage Plan for Medicare Patients?; Parent-Teen Conversations about Sex; Soy (Genistein) & Prostate Cancer

3-9-2008: Flat Colorectal Adenomas & Cancer; Health Risks after Stopping Hormone Replacement Therapy (HRT); Television, Children & Obesity

3-2-2008: Medication & Risk of Death After Heart Attack; Hormone Replacement Therapy (HRT) & Mammogram Results; Selenium: Cancer, Heart Disease & Death

2-23-2008: Universal Healthcare Insurance Study; Glucosamine & Arthritis

2-17-2008: Exceptional Longevity in Men; Testosterone & Risk of Prostate Cancer; Smoking & Pre-malignant Colorectal Polyps

2-10-2008: Thrombus Aspiration from Coronary Arteries; Intensive Management of Diabetes & Death; Possible Cure for Down's Syndrome?

2-3-2008: Vitamin D & Cardiovascular Health; Vitamin D & Breast Cancer; Green Tea & Colorectal Cancer

1-27-2008: Colorectal Cancer, Esophageal Cancer & Pancreatic Cancer: Update from the 2008 American Society of Clinical Oncology's Gastrointestinal Cancers Symposium

1-20-2008: Testosterone Levels & Risk of Fractures in Elderly Men; Air Pollution & DNA Damage in Sperm; Statins & Trauma Survival in the Elderly

1-12-2008: Statins, Diabetes & Stroke and Obesity; GERD & Esophageal Cancer

1-7-2008: Testosterone Supplements in Elderly Men; Colorectal Cancer-- Reasons for Poor Compliance with Screening Recommendations

12-31-2007: Minority Women, Hormone Replacement Therapy & Breast Cancer; Does Health Insurance Improve Health?

12-23-2007: Is Coffee Safe After a Heart Attack?; Impact of Divorce on the Environment; Hypertension & the Risk of Dementia; Emotional Vitality & the Risk of Heart Disease

12-16-2007: Honey vs. Dextromethorphan vs. No Treatment for Kids with Night-Time Cough, Acupuncture & Hot Flashes in Women with Breast Cancer, Physical Activity & the Risk of Death, Mediterranean Diet & Mortality

12-11-2007: Bias in Medical Research; Carbon Nanotubes & Radiofrequency: A New Weapon Against Cancer?; Childhood Obesity & Risk of Adult Heart Disease

12-2-2007: Obesity & Risk of Cancer; Testosterone Level & Risk of Death; Drug Company Funding of Research & Results; Smoking & the Risk of Colon & Rectal Cancer

 

Dr. Wascher's Home Page

Email ItEmail It | Print ItPrint It | CommentsComments (0) | TrackbacksTrackbacks (0) | Flag as offensiveFlag as Offensive

Diet and Prostate Cancer Risk

 

 

 

Health Report:


Diet & Prostate Cancer Risk

 



"A critical weekly review of important new research findings for health-conscious readers..."

 

By, Robert A. Wascher, MD, FACS

Updated:  05/31/2009


The information in this column is intended for informational purposes only, and does not constitute medical advice or recommendations by the author.  Please consult with your physician before making any lifestyle or medication changes, or if you have any other concerns regarding your health.


 

 

DIET & PROSTATE CANCER RISK

The prostate gland is a walnut-sized gland that is attached to the bottom of the bladder. The prostate gland wraps around the male urethra as it arises from the bladder, and several ducts that run between the prostate gland and the urethra allow the prostatic secretions to be expelled into the urethra at the time of ejaculation. These prostatic secretions, which constitute about 20 percent of the volume of semen, help to create the optimal chemical environment for sperm to thrive and migrate within the female genital tract, thereby enhancing sperm function. 

In 2009, an estimated 192,000 new cases of prostate cancer will be diagnosed, and approximately 27,000 men will die of this disease in the same year. Prostate cancer is the most common non-skin cancer that occurs in men, and is the second most common cause of cancer death in men. Prostate cancer afflicts 1 out of every 6 American men during their lifetimes, and accounts for 25 percent of all cancer diagnoses in men (similar to the percentage of breast cancer cases among all cancer cases diagnosed in women). As with the great majority of breast cancer cases, most prostate cancers appear to be stimulated to grow and spread by sex hormones produced by the gonads (and, specifically, by testosterone and other androgens produced by the testes, and by other tissues in the body). 

There continues to be considerable debate about the impact of diet on prostate cancer risk, as a result of the contradictory conclusions of most epidemiological research studies regarding dietary factors and cancer risk, including prostate cancer (which is, in turn, a reflection of the relatively low scientific power of dietary survey-based studies, in general). Now, a large new prospective European clinical study has raised the possibility that the level of some dietary nutrients (isoflavones) in the blood may actually have an impact on prostate cancer risk. This study’s findings appear in the current volume of the British Journal of Cancer.

The patient volunteers in this particular study were part of a huge and ongoing prospective clinical research study, the European Prospective Investigation into Cancer and Nutrition study (EPIC study). Among the approximately 500,000 participants in the EPIC study, 950 men who were newly diagnosed with prostate cancer during the course of the study and 1,042 men who had no evidence of prostate cancer were evaluated for this particular prostate cancer sub-study. 

Isoflavones belong to a group of compounds referred to as phytoestrogens, which are found in certain foods. Phytoestrogens are substances found in certain edible plants, and are known to have weak estrogen-like effects (estrogen is the dominant female sex hormone). Soybeans, and soybean-derived soy proteins, represent the richest source of dietary isoflavones, although some other types of beans, nuts, fruits and vegetables contain low concentrations of isoflavones.   Lignans are another group of natural plant-based compounds that are considered to be phytoestrogens. Lignans are found in flax seeds, whole wheat flour, tea, some fruits, and other cereal grains.

In this prostate cancer prevention study, all of the patient volunteers had their blood tested for phytoestrogens at the time that they entered into the study. An especially interesting, and important, aspect of this study is that blood levels of isoflavones and lignans were tested in all of these 1,992 men, and before prostate cancer was diagnosed in the 950 men who were diagnosed with this form of cancer during the course of this study. Additionally, all of the study participants completed the usual dietary and general health surveys that are commonly used in epidemiological studies.   Thus, this particular cancer prevention study relied not only on subjective and bias-prone dietary surveys, but also upon objective measurements of isoflavone and lignan concentrations in the blood of all of these men.

While prostate cancer risk did not appear to vary with the concentration of lignans in the blood, the concentration of the isoflavone phytoestrogen genistein in the blood did, in fact, correlate with prostate cancer risk. The results of this study revealed that high serum concentrations of genistein were associated with a 26 percent relative reduction in the risk of developing prostate cancer. 

This study builds upon a previous Japanese study, which also measured phytoestrogen levels in the blood, and which reported a decrease in prostate cancer risk with high blood levels of genistein, although this observation, in the Japanese study, did not quite reach the level of statistical significance that is needed to scientifically validate such research findings. (The EPIC Study’s findings regarding genistein and prostate cancer risk did, however, meet this “statistically significant” threshold.)

In summary, therefore, this innovative prospective clinical research study identified an apparent significant reduction in the risk of developing prostate cancer among older men who had high levels of the isoflavone genistein circulating in their blood. As phytoestrogens are absorbed in the GI tract from plants containing high concentrations of these compounds, and as clinical studies based solely upon dietary surveys are notoriously inaccurate, this particular study’s direct measurement of phytoestrogen levels in the blood of its patient volunteers is a critically important innovation, and considerably increases the likelihood that the findings of this study are clinically significantly.

I will have much more to say, dear readers, about diet and prostate cancer prevention, as well as many other clinical evidence-based lifestyle and dietary strategies to reduce your risk of developing all of the top ten cancer killers, in my forthcoming book, “A Cancer Prevention Guide for the Human Race,” which should be available in the spring of 2010.




Disclaimer:  As always, my advice to readers is to seek the advice of your physician before making any significant changes in medications, diet, or level of physical activity


 

Dr. Wascher is an oncologic surgeon, a professor of surgery, a widely published author, and a Surgical Oncologist at the Kaiser Permanente healthcare system in Orange County, California

 


 

Click here for TV36 interview of Dr. Wascher




Send your feedback to Dr. Wascher at:
 

rwascher@doctorwascher.net


 

Dr. Wascher's Biography


Links to Other Health & Wellness Sites


http://doctorwascher.com


 

Copyright 2009

  

Robert A. Wascher, MD, FACS

  

All rights reserved


Dr. Wascher's Archives:

5-24-2009: Diabetes, Glucose Control & Death

5-17-2009: Drug Company Marketing & Physician Prescribing Bias

5-10-2009: Hemorrhoids & Surgery

5-3-2009: Statin Drugs & Blood Clots (Thromboembolism)

4-26-2009: Are We Really Losing the War on Cancer?

4-19-2009:   Exercise in Middle Age & Risk of Death

4-12-2009: Can Chronic Stress Harm Your Heart?

4-5-2009: Does PSA Testing for Prostate Cancer Save Lives?

3-22-2009: CABG Surgery vs. PCI in Diabetics with Coronary Artery Disease; Sweetened Beverages and Coronary Artery Disease

3-15-2009: Depression, Stress, Anger & Heart Disease

3-8-2009: Coronary Artery Disease: CABG vs. Stents?; Swimming Lessons & Drowning Risk in Children

3-1-2009: Aspirin & Colorectal Cancer Prevention; Fish Oil & Respiratory Infections in Children

2-22-2009: Health Differences Between Americans & Europeans; Lycopene & Prostate Cancer

2-15-2009: Statin Drugs & Death Rates; Physical Activity, Breast Cancer & Sex Hormones

2-8-2009: Hormone Replacement Therapy (HRT) & Breast Cancer; Stool DNA Testing & Cancer of the Colon & Rectum

2-1-2009:   Obesity and the Complications of Diverticulosis (Diverticulitis & Bleeding); Obesity, Weight Loss & Urinary Incontinence

1-25-2009: Prostate Cancer, Fatigue & Exercise; Does your Surgeon “Warm-up” Before Surgery?

1-18-2009: Cancer and Vitamins; Teenagers, MySpace and Risky Behaviors

1-11-2009: Exercise Reverses Some Effects of Fatty Meals; Vitamin C and Blood Pressure

1-4-2009: Secondhand Smoke & Heart Attack Risk; Poor Physical Fitness During Childhood & Heart Disease Risk During Adulthood

12-28-2008: Stress & Your Risk of Heart Attack; Vitamin D & the Prevention of Colon & Rectal Polyps

12-21-2008: Breast Cancer Incidence & Hormone Replacement Therapy; Circumcision & the Risk of HPV & HIV Infection

12-14-2008: Vitamin E, Vitamin C and Selenium Do Not Prevent Cancer; Postscript: A Possible Cure for Down’s Syndrome

12-7-2008: Generic vs. Brand-Name Drugs, Stress & Breast Cancer Survival

11-30-2008:   A Possible Cure for Down’s Syndrome?; Smoking & Cognitive Decline; Calcium & Vitamin D & Breast Cancer Risk

11-23-2008:  Breast Cancer & Fish Oil; Lymphedema after Breast Cancer Treatment; Vasectomy & Prostate Cancer Risk

11-16-2008:  Vitamin E & Vitamin C: No Impact on Cardiovascular Disease Risk; Does Lack of Sleep Increase Stroke & Heart Attack Risk in Hypertensive Patients?

11-9-2008:  Statins Cut Heart Attack Risk Even with Normal Cholesterol Levels; Statins & PSA Level

11-2-2008:  Radiation Treatment of Prostate Cancer & Second Cancers; Sexual Content on TV & Teen Pregnancy Risk

10-26-2008:  Smoking & Quality of Life

10-19-2008:  Agent Orange & Prostate Cancer

10-12-2008:  Pomegranate Juice & Prostate Cancer

10-5-2008:  Central Obesity & Dementia; Diet, Vitamin D, Calcium, & Colon Cancer

9-28-2008:  Publication & Citation Bias in Favor of Industry-Funded Research?

9-21-2008:  Does Tylenol® (Acetaminophen) Cause Asthma?

9-14-208:   Arthroscopic Knee Surgery- No Better than Placebo?; A Healthy Lifestyle Prevents Stroke

8-23-2008:  Alcohol Abuse Before & After Military Deployment; Running & Age; Running & Your Testicles

8-12-2008:  Green Tea & Diabetes; Breastfeeding & Adult Cholesterol Levels; Fish Oil & Senile Macular Degeneration

8-3-2008:   Exercise & Weight Loss; Green Tea, Folic Acid & Breast Cancer Risk; Foreign Language Interpreters & ICU Patients

7-26-2008:  Viagra & Sexual Function in Women; Patient-Reported Adverse Hospital Events; Curcumin & Pancreatic Cancer

7-13-2008:  Erectile Dysfunction & Frequency of Sex; Muscle Strength & Mortality in Men; Cryoablation for Prostate Cancer

7-6-2008:  Sleep, Melatonin & Breast Cancer Risk; Mediterranean Diet & Cancer Risk; New Treatment for Varicose Veins

6-29-2008:  Bone Marrow Stem Cells & Liver Failure; Vitamin D & Colorectal Cancer Survival; Green Tea & Colorectal Cancer

6-22-2008:  Obesity, Lifestyle & Heart Disease; Effects of Lifestyle & Nutrition on Prostate Cancer; Ginkgo Biloba, Ulcerative Colitis & Colorectal Cancer

6-15-2008:  Preventable Deaths after Coronary Artery Bypass Graft (CABG) Surgery; Green Tea & Colorectal Cancer; Attention-Deficit/Hyperactivity Disorder (ADHD) & St. John’s Wort

6-8-2008:  Vitamin D & Prostate Cancer Risk; Radiofrequency Ablation (RFA) of Kidney (Renal) Cancer; Antisense Telomerase & Cancer

6-2-2008:  Acute Coronary Syndrome- Do You Know the Symptoms?; Green Tea & Lung Cancer; Episiotomy & Subsequent Deliveries- An Unkind Cut

5-25-2008:  Early Childhood Screening Predicts Later Behavioral Problems; Psychiatric Disorders Among Parents of Autistic Children; Social & Psychiatric Profiles of Young Adults Born Prematurely

5-18-2008:  Can Statins Reverse Coronary Artery Disease?; Does Breast Ultrasound Improve Breast Cancer Detection?; Preventive Care Services at Veterans Administration (VA) Medical Centers

5-11-2008:  Smoking Cessation & Risk of Death; Childhood Traumas & Adult Suicide Risk; “White Coat Hypertension” & Risk of Cardiovascular Disease

5-4-2008:  Super-Size Me: Fast Food’s Effects on Your Liver; Exercise, Weight & Coronary Artery Disease; Contamination of Surgical Instruments in the Operating Room

4-27-2008:  Stents vs. Bypass Surgery for Coronary Artery Disease; The “DASH” Hypertension Diet & Cardiovascular Disease Prevention; Testosterone Therapy for Women with Decreased Sexual Desire & Function

4-20-2008:  BRCA Breast Cancer Mutations & MRI Scans; Bladder Cancer Prevention with Broccoli?; Diabetes: Risk of Death Due to Heart Attack & Stroke

4-13-2008:  Breast Cancer Recurrence & Hormone Replacement Therapy (HRT); Carotid Artery Disease: Surgery vs. Stents?; Statin Drugs & Cancer Prevention

4-6-2008:  Human Papilloma Virus (HPV), Pap Smear Results & Cervical Cancer; Human Papilloma Virus (HPV) Infection & Oral Cancer; Hormone Replacement Therapy (HRT) & the Risk of Gastroesophageal Reflux Disorder (GERD)

3-30-2008:  Abdominal Obesity & the Risk of Death in Women; Folic Acid Pretreatment & Heart Attacks; Pancreatic Cancer Regression after Injections of Bacteria

3-23-2008:  Age of Transfused Blood & Risk of Complications after Surgery; Obesity, Blood Pressure & Heart Size in Children

3-16-2008:  Benefits of a Full Drug Coverage Plan for Medicare Patients?; Parent-Teen Conversations about Sex; Soy (Genistein) & Prostate Cancer

3-9-2008:  Flat Colorectal Adenomas & Cancer; Health Risks after Stopping Hormone Replacement Therapy (HRT); Television, Children & Obesity 

3-2-2008:  Medication & Risk of Death After Heart Attack; Hormone Replacement Therapy (HRT) & Mammogram Results; Selenium: Cancer, Heart Disease & Death

2-23-2008:  Universal Healthcare Insurance Study; Glucosamine & Arthritis

2-17-2008:  Exceptional Longevity in Men; Testosterone & Risk of Prostate Cancer; Smoking & Pre-malignant Colorectal Polyps

2-10-2008:  Thrombus Aspiration from Coronary Arteries; Intensive Management of Diabetes & Death; Possible Cure for  Down's Syndrome?

2-3-2008:  Vitamin D & Cardiovascular Health; Vitamin D & Breast Cancer; Green Tea & Colorectal Cancer

1-27-2008:  Colorectal Cancer, Esophageal Cancer & Pancreatic Cancer: Update from the 2008 American Society of Clinical Oncology's Gastrointestinal Cancers Symposium

1-20-2008:  Testosterone Levels & Risk of Fractures in Elderly Men; Air Pollution & DNA Damage in Sperm; Statins & Trauma Survival in the Elderly

1-12-2008:  Statins, Diabetes & Stroke and Obesity; GERD & Esophageal Cancer

1-7-2008:  Testosterone Supplements in Elderly Men; Colorectal Cancer-- Reasons for Poor Compliance with Screening Recommendations

12-31-2007:  Minority Women, Hormone Replacement Therapy & Breast Cancer; Does Health Insurance Improve Health?

12-23-2007:  Is Coffee Safe After a Heart Attack?; Impact of Divorce on the Environment; Hypertension & the Risk of Dementia; Emotional Vitality & the Risk of Heart Disease

12-16-2007:   Honey vs. Dextromethorphan vs. No Treatment for Kids with Night-Time Cough, Acupuncture & Hot Flashes in Women with Breast Cancer, Physical Activity & the Risk of Death, Mediterranean Diet & Mortality 

12-11-2007:  Bias in Medical Research; Carbon Nanotubes & Radiofrequency: A New Weapon Against Cancer?; Childhood Obesity & Risk of Adult Heart Disease

12-2-2007:  Obesity & Risk of Cancer; Testosterone Level & Risk of Death; Drug Company Funding of Research & Results; Smoking & the Risk of Colon & Rectal Cancer 


Dr. Wascher's Home Page


Email ItEmail It | Print ItPrint It | CommentsComments (0) | TrackbacksTrackbacks (0) | Flag as offensiveFlag as Offensive

Drug Company Marketing & Physician Prescribing Bias

 

 

 

Health Report:


Drug Company Marketing & Physician Prescribing Bias

 



"A critical weekly review of important new research findings for health-conscious readers..."

 

By, Robert A. Wascher, MD, FACS

Updated:  05/17/2009


The information in this column is intended for informational purposes only, and does not constitute medical advice or recommendations by the author.  Please consult with your physician before making any lifestyle or medication changes, or if you have any other concerns regarding your health.


 

 

DRUG COMPANY MARKETING & PHYSICIAN PRESCRIBING BIAS

We physicians tend to be a rather independent lot, and most of us would like to believe that we prescribe treatments to patients based purely upon the best available objective clinical evidence. 

Although there are far fewer doctors who are accepting golfing vacations, or other expensive gifts, from drug companies these days, the pharmaceutical industry still spends billions of dollars every year on marketing outreach activities directed at physicians. These costly promotional activities include frequent sales rep visits to doctors’ offices, the sponsorship of free medical education activities for physicians, the provision of free meals to doctors and their staff, as well as free trinkets (including pens and other inexpensive items containing product logos), and, yes, the occasional vacation thinly disguised as a “continuing medical education” opportunity. Additionally, physicians with specialty expertise in certain areas are often compensated to deliver dinner lectures to other physicians, with the lecture content provided solely by the sponsoring drug or medical device manufacturer.

In years past, these sorts of interactions between physicians and the drug and medical device industries were considered to be completely acceptable, and both physicians and these industries blithely maintained that clinical treatment decisions were not being altered, in the least, by the cozy and often lucrative relationships that doctors enjoyed with these deep-pocketed companies. However, more recently, there has been a growing sense within the medical community that these costly marketing outreach activities by drug and medical device companies probably do influence physicians and surgeons to change their patient care decisions. These still-evolving views have been receiving increased exposure in recent articles and editorials in major U.S. newspapers, including the New York Times, and these reports have often focused upon individual and prominent physicians and surgeons who have apparently been swayed in favor of certain drugs and surgical implants by their fiduciary relationship with the very same companies that produce and market these medical products. As a result of the growing number of such reports (in both the lay press and the medical press), an increasing number of health care organizations and physician advocacy groups have recently come out on record as opposing physician participation in activities that involve the transfer of money or other “high-value” services or gifts from drug and medical device manufacturers. But old habits die hard, and many physicians continue to enthusiastically embrace drug company marketing activities, and the gifts that often accompany such activities.

An intriguing new study, just published in the Archives of Internal Medicine, adds to a growing body of research literature suggesting that even gifts of nominal value probably influence physician decision-making when it comes to prescribing medications. In this innovative randomized, prospective, controlled study, 352 third-year and fourth-year medical students at two different U.S. medical schools were selected to participate in an ongoing and prospective review of their drug prescribing attitudes. The two medical schools were specifically selected due to their very different policies towards drug company marketing and promotional activities. One of the medical schools had very restrictive policies in place that discouraged interactions with drug company sales reps, while the other medical school had very liberal policies in place regarding interactions between medical personnel and drug company sales reps.

Some of these medical student volunteers (the treatment group) were intentionally exposed to typical promotional activity interactions with drug company sales reps, including the distribution of inexpensive promotional gifts, such as ink pens and other typical logo-emblazoned drug company trinkets. During the course of this study, the medical students in the “treatment group” were not informed that their interactions with drug company sales reps were actually a part of the clinical research study of drug prescribing attitudes that they had volunteered to participate in! 

The treatment group of medical students at each medical school was intentionally exposed to promotional visits from sales reps for the drug Lipitor, a cholesterol-lowering statin drug, while the other group of students (the control group) was not exposed to any such marketing visits. I should point out that Lipitor (atorvastatin) is still protected by patent, and as such, it is an expensive drug, while the other statin that was assessed in this research study, Zocor (simvastatin), has recently gone off patient, and is now available as a much less expensive prescription drug alternative to Lipitor. 

The 352 medical students, from both the study’s treatment groups and control groups, were all subsequently tested for their attitudes towards prescribing either Lipitor or Zocor, using a previously validated test known as the Implicit Association Test. 

Among the fourth-year students in the treatment group at the permissive medical school, exposure to promotional activities sponsored by Lipitor sales reps (including the distribution of inexpensive promotional items) significantly increased these students’ implicit preference, by a margin of almost 20 percent, for prescribing Lipitor over the less expensive generic statin drug (Zocor), when compared to the students at the same school who were in the control group.

Among the fourth year medical students attending the medical school that had strict policies in place regarding drug company marketing and promotional activities, the medical students exposed to the Lipitor sales rep’s marketing and promotion activities were actually significantly less likely to favor prescribing the more expensive statin drug over the generic Zocor (and by a margin of 30 percent!).  (Third-year medical students, who were just beginning their clinical clerkships, did not appear to be swayed, one way or the other, by their interactions with drug company sales reps.)

The findings in this study, that physicians-in-training at medical centers with permissive attitudes towards drug company marketing activities were more likely to prescribe these same drug companies’ more expensive drugs, has been confirmed by previous research studies. The twist in this particular research study, however, are the novel findings within the group of medical students studying at a medical school where a more critical and restrictive approach towards drug company product marketing and promotion is enforced. Under these more stringent conditions, promotional interactions with drug reps were actually associated with a more negative view towards prescribing the more expensive drug being marketed by the sales reps!  

Needless to say, the findings of this study strongly suggest that the pernicious influence of pharmaceutical drug reps on doctors’ prescribing habits can likely be minimized, if not reversed, by enacting strict limitations on marketing interactions with drug company sales reps, on the one hand, and senior medical students and resident physicians, on the other hand, while these physicians are still in training. At the same time, I believe that there is still an important role for ongoing interactions between physicians and representatives from the pharmaceutical and medical device industries. However, finding the proper balance in such relationships, and eliminating influences on physician prescribing and practice that are not supported by any available clinical evidence, is critically important, in my view. 

Finally, a few more comments on this topic before I conclude this week’s column:

Many people reading this column might ask why a study such as this is even necessary, as our understanding of basic human nature would lead almost anyone to predict that exposing medical students and doctors to marketing and promotional activities by drug manufacturers would, inevitably, result in prescribing habits that are biased in favor of these same manufacturers’ drugs. However, another almost universal flaw in our nature, and one which is especially prevalent among physicians, is our unshakable belief that we can control the degree to which external forces influence our most important decisions. Indeed, this has long been the perspective of most physicians and physician advocacy groups. At the same time, drug and medical device manufacturers have understood, very well, that the prescribing habits of physicians can, indeed, be significantly influenced by costly marketing and promotional activities.

Over the past 5 years, as increasing research data has become available to confirm what most people would argue is really a matter of common sense, I have had to concede to myself that the pharmaceutical and medical device industries would probably not be spending millions and millions of dollars every year on free meals, cheap logo-embossed pens, and other freebies, if these activities did not favorably influence at least some physicians to preferentially prescribe their more expensive patent-protected medications, instead of equally effective and far cheaper equivalent generic drugs. As a result of my own soul-searching, I have stopped accepting frequent invitations to join drug company speakers’ bureaus, and I no longer regularly attend continuing medical education seminars sponsored by drug companies, particularly when the content of such lectures is provided directly by the sponsoring pharmaceutical company. This change in practice has brought me the twin benefits of a clearer conscience and fewer evenings spent away from my family. (A third potential benefit is that I am eating far fewer unhealthy meals at expensive steak houses these days….)

As I have already opined, however, there is an important role for an ethically clean relationship between physicians and medical industry representatives. In my own practice as a comprehensive Surgical Oncologist, for example, I often must rely upon representatives from medical technology companies to support my use of complex and emerging cancer treatment modalities, especially in the operating room. Like any relationship that has the potential for abuse, though, I find that I must constantly be vigilant to assure that I remain on comfortable ethical territory with regards to my interactions with these industry reps. 

For other columns dealing with these issues, please click the following links:   

http://doctorwascher.com/Archives/12-7-08.htm

http://doctorwascher.com/Archives/9-28-08.htm

  




Disclaimer:  As always, my advice to readers is to seek the advice of your physician before making any significant changes in medications, diet, or level of physical activity


 

Dr. Wascher is an oncologic surgeon, a professor of surgery, a widely published author, and a Surgical Oncologist at the Kaiser Permanente healthcare system in Orange County, California

 


 http://doctorwascher.com/cancerpreventionbookcover.GIF

(Anticipated Publication Date: March 2010)




Send your feedback to Dr. Wascher at:
 rwascher@doctorwascher.net


 

Dr. Wascher's Biography


Links to Other Health & Wellness Sites


http://doctorwascher.com


 

Copyright 2009

  

Robert A. Wascher, MD, FACS

  

All rights reserved


Dr. Wascher's Archives:

5-10-2009: Hemorrhoids & Surgery

5-3-2009: Statin Drugs & Blood Clots (Thromboembolism)

4-26-2009: Are We Really Losing the War on Cancer?

4-19-2009:   Exercise in Middle Age & Risk of Death

4-12-2009: Can Chronic Stress Harm Your Heart?

4-5-2009: Does PSA Testing for Prostate Cancer Save Lives?

3-22-2009: CABG Surgery vs. PCI in Diabetics with Coronary Artery Disease; Sweetened Beverages and Coronary Artery Disease

3-15-2009: Depression, Stress, Anger & Heart Disease

3-8-2009: Coronary Artery Disease: CABG vs. Stents?; Swimming Lessons & Drowning Risk in Children

3-1-2009: Aspirin & Colorectal Cancer Prevention; Fish Oil & Respiratory Infections in Children

2-22-2009: Health Differences Between Americans & Europeans; Lycopene & Prostate Cancer

2-15-2009: Statin Drugs & Death Rates; Physical Activity, Breast Cancer & Sex Hormones

2-8-2009: Hormone Replacement Therapy (HRT) & Breast Cancer; Stool DNA Testing & Cancer of the Colon & Rectum

2-1-2009:   Obesity and the Complications of Diverticulosis (Diverticulitis & Bleeding); Obesity, Weight Loss & Urinary Incontinence

1-25-2009: Prostate Cancer, Fatigue & Exercise; Does your Surgeon “Warm-up” Before Surgery?

1-18-2009: Cancer and Vitamins; Teenagers, MySpace and Risky Behaviors

1-11-2009: Exercise Reverses Some Effects of Fatty Meals; Vitamin C and Blood Pressure

1-4-2009: Secondhand Smoke & Heart Attack Risk; Poor Physical Fitness During Childhood & Heart Disease Risk During Adulthood

12-28-2008: Stress & Your Risk of Heart Attack; Vitamin D & the Prevention of Colon & Rectal Polyps

12-21-2008: Breast Cancer Incidence & Hormone Replacement Therapy; Circumcision & the Risk of HPV & HIV Infection

12-14-2008: Vitamin E, Vitamin C and Selenium Do Not Prevent Cancer; Postscript: A Possible Cure for Down’s Syndrome

12-7-2008: Generic vs. Brand-Name Drugs, Stress & Breast Cancer Survival

11-30-2008:   A Possible Cure for Down’s Syndrome?; Smoking & Cognitive Decline; Calcium & Vitamin D & Breast Cancer Risk

11-23-2008:  Breast Cancer & Fish Oil; Lymphedema after Breast Cancer Treatment; Vasectomy & Prostate Cancer Risk

11-16-2008:  Vitamin E & Vitamin C: No Impact on Cardiovascular Disease Risk; Does Lack of Sleep Increase Stroke & Heart Attack Risk in Hypertensive Patients?

11-9-2008:  Statins Cut Heart Attack Risk Even with Normal Cholesterol Levels; Statins & PSA Level

11-2-2008:  Radiation Treatment of Prostate Cancer & Second Cancers; Sexual Content on TV & Teen Pregnancy Risk

10-26-2008:  Smoking & Quality of Life

10-19-2008:  Agent Orange & Prostate Cancer

10-12-2008:  Pomegranate Juice & Prostate Cancer

10-5-2008:  Central Obesity & Dementia; Diet, Vitamin D, Calcium, & Colon Cancer

9-28-2008:  Publication & Citation Bias in Favor of Industry-Funded Research?

9-21-2008:  Does Tylenol® (Acetaminophen) Cause Asthma?

9-14-208:   Arthroscopic Knee Surgery- No Better than Placebo?; A Healthy Lifestyle Prevents Stroke

8-23-2008:  Alcohol Abuse Before & After Military Deployment; Running & Age; Running & Your Testicles

8-12-2008:  Green Tea & Diabetes; Breastfeeding & Adult Cholesterol Levels; Fish Oil & Senile Macular Degeneration

8-3-2008:   Exercise & Weight Loss; Green Tea, Folic Acid & Breast Cancer Risk; Foreign Language Interpreters & ICU Patients

7-26-2008:  Viagra & Sexual Function in Women; Patient-Reported Adverse Hospital Events; Curcumin & Pancreatic Cancer

7-13-2008:  Erectile Dysfunction & Frequency of Sex; Muscle Strength & Mortality in Men; Cryoablation for Prostate Cancer

7-6-2008:  Sleep, Melatonin & Breast Cancer Risk; Mediterranean Diet & Cancer Risk; New Treatment for Varicose Veins

6-29-2008:  Bone Marrow Stem Cells & Liver Failure; Vitamin D & Colorectal Cancer Survival; Green Tea & Colorectal Cancer

6-22-2008:  Obesity, Lifestyle & Heart Disease; Effects of Lifestyle & Nutrition on Prostate Cancer; Ginkgo Biloba, Ulcerative Colitis & Colorectal Cancer

6-15-2008:  Preventable Deaths after Coronary Artery Bypass Graft (CABG) Surgery; Green Tea & Colorectal Cancer; Attention-Deficit/Hyperactivity Disorder (ADHD) & St. John’s Wort

6-8-2008:  Vitamin D & Prostate Cancer Risk; Radiofrequency Ablation (RFA) of Kidney (Renal) Cancer; Antisense Telomerase & Cancer

6-2-2008:  Acute Coronary Syndrome- Do You Know the Symptoms?; Green Tea & Lung Cancer; Episiotomy & Subsequent Deliveries- An Unkind Cut

5-25-2008:  Early Childhood Screening Predicts Later Behavioral Problems; Psychiatric Disorders Among Parents of Autistic Children; Social & Psychiatric Profiles of Young Adults Born Prematurely

5-18-2008:  Can Statins Reverse Coronary Artery Disease?; Does Breast Ultrasound Improve Breast Cancer Detection?; Preventive Care Services at Veterans Administration (VA) Medical Centers

5-11-2008:  Smoking Cessation & Risk of Death; Childhood Traumas & Adult Suicide Risk; “White Coat Hypertension” & Risk of Cardiovascular Disease

5-4-2008:  Super-Size Me: Fast Food’s Effects on Your Liver; Exercise, Weight & Coronary Artery Disease; Contamination of Surgical Instruments in the Operating Room

4-27-2008:  Stents vs. Bypass Surgery for Coronary Artery Disease; The “DASH” Hypertension Diet & Cardiovascular Disease Prevention; Testosterone Therapy for Women with Decreased Sexual Desire & Function

4-20-2008:  BRCA Breast Cancer Mutations & MRI Scans; Bladder Cancer Prevention with Broccoli?; Diabetes: Risk of Death Due to Heart Attack & Stroke

4-13-2008:  Breast Cancer Recurrence & Hormone Replacement Therapy (HRT); Carotid Artery Disease: Surgery vs. Stents?; Statin Drugs & Cancer Prevention

4-6-2008:  Human Papilloma Virus (HPV), Pap Smear Results & Cervical Cancer; Human Papilloma Virus (HPV) Infection & Oral Cancer; Hormone Replacement Therapy (HRT) & the Risk of Gastroesophageal Reflux Disorder (GERD)

3-30-2008:  Abdominal Obesity & the Risk of Death in Women; Folic Acid Pretreatment & Heart Attacks; Pancreatic Cancer Regression after Injections of Bacteria

3-23-2008:  Age of Transfused Blood & Risk of Complications after Surgery; Obesity, Blood Pressure & Heart Size in Children

3-16-2008:  Benefits of a Full Drug Coverage Plan for Medicare Patients?; Parent-Teen Conversations about Sex; Soy (Genistein) & Prostate Cancer

3-9-2008:  Flat Colorectal Adenomas & Cancer; Health Risks after Stopping Hormone Replacement Therapy (HRT); Television, Children & Obesity 

3-2-2008:  Medication & Risk of Death After Heart Attack; Hormone Replacement Therapy (HRT) & Mammogram Results; Selenium: Cancer, Heart Disease & Death

2-23-2008:  Universal Healthcare Insurance Study; Glucosamine & Arthritis

2-17-2008:  Exceptional Longevity in Men; Testosterone & Risk of Prostate Cancer; Smoking & Pre-malignant Colorectal Polyps

2-10-2008:  Thrombus Aspiration from Coronary Arteries; Intensive Management of Diabetes & Death; Possible Cure for  Down's Syndrome?

2-3-2008:  Vitamin D & Cardiovascular Health; Vitamin D & Breast Cancer; Green Tea & Colorectal Cancer

1-27-2008:  Colorectal Cancer, Esophageal Cancer & Pancreatic Cancer: Update from the 2008 American Society of Clinical Oncology's Gastrointestinal Cancers Symposium

1-20-2008:  Testosterone Levels & Risk of Fractures in Elderly Men; Air Pollution & DNA Damage in Sperm; Statins & Trauma Survival in the Elderly

1-12-2008:  Statins, Diabetes & Stroke and Obesity; GERD & Esophageal Cancer

1-7-2008:  Testosterone Supplements in Elderly Men; Colorectal Cancer-- Reasons for Poor Compliance with Screening Recommendations

12-31-2007:  Minority Women, Hormone Replacement Therapy & Breast Cancer; Does Health Insurance Improve Health?

12-23-2007:  Is Coffee Safe After a Heart Attack?; Impact of Divorce on the Environment; Hypertension & the Risk of Dementia; Emotional Vitality & the Risk of Heart Disease

12-16-2007:   Honey vs. Dextromethorphan vs. No Treatment for Kids with Night-Time Cough, Acupuncture & Hot Flashes in Women with Breast Cancer, Physical Activity & the Risk of Death, Mediterranean Diet & Mortality 

12-11-2007:  Bias in Medical Research; Carbon Nanotubes & Radiofrequency: A New Weapon Against Cancer?; Childhood Obesity & Risk of Adult Heart Disease

12-2-2007:  Obesity & Risk of Cancer; Testosterone Level & Risk of Death; Drug Company Funding of Research & Results; Smoking & the Risk of Colon & Rectal Cancer 


Dr. Wascher's Home Page


Email ItEmail It | Print ItPrint It | CommentsComments (0) | TrackbacksTrackbacks (0) | Flag as offensiveFlag as Offensive

Hemorrhoids & Surgery

 

Health Report:


Hemorrhoids & Surgery

 



"A critical weekly review of important new research findings for health-conscious readers..."

 

By, Robert A. Wascher, MD, FACS

Updated:  05/10/2009


The information in this column is intended for informational purposes only, and does not constitute medical advice or recommendations by the author.  Please consult with your physician before making any lifestyle or medication changes, or if you have any other concerns regarding your health.


 

 

HEMORRHOIDS & SURGERY

This week’s topic is a very sensitive one, indeed! Hemorrhoids have, presumably, afflicted mankind ever since we began walking upright. Hemorrhoids are, basically, dilated (varicose) veins that normally line the anorectal canal. As these hemorrhoidal veins enlarge, inflammation can develop, causing the characteristic symptoms of swelling, itching, burning, pain, and frequently, the passage of bright red blood with bowel movements. As hemorrhoids dilate further, the blood flow within these veins can become so sluggish that blood clots can arise. When external hemorrhoids become acutely clotted (thrombosed), they can cause exquisite anorectal pain and swelling (internal hemorrhoids are generally painless, because they are located within the lower rectal canal, which does not contain pain-sensing nerve fibers). 

When internal hemorrhoids become significantly dilated and inflamed, they may protrude (prolapse) from the anus, requiring the patient to manually push them back into the anorectal canal (in some cases, internal hemorrhoids may prolapsed so severely that the patient may be unable to “reduce” them back into the anorectal canal, thus requiring semi-urgent surgical treatment).   

Bright red blood on the toilet paper, blood in one’s underwear, and the passage of excessive mucus from the rectum may all occur with significant internal or (and) external hemorrhoidal disease.

Unfortunately, hemorrhoids are a very common and vexing health problem. By the age of 50, at least half of all people will have symptomatic hemorrhoids. (Women also often experience the unpleasant symptoms of hemorrhoids during pregnancy, when the changes of pregnancy cause hemorrhoidal veins to enlarge and protrude, although, in most cases, these pregnancy-associated hemorrhoids will resolve following delivery.) 

The precise causes of hemorrhoids continue to be debated, but most experts agree that a combination of anatomy and lifestyle factors probably account for the vast majority of cases. Due to our upright posture, blood tends to pool in the thin-walled veins that line the anorectal canal. Standing, and especially sitting, for prolonged periods of time, encourages this gravity-related pooling of blood in the anorectal veins, as well as the progressive dilation of these veins over time. Other important factors in the development of hemorrhoids include a low fiber diet, a lack of exercise, and poor toilet habits. 

In general, the longer we spend sitting on the toilet to do our “business,” the more likely we are to develop hemorrhoids. Sitting on the toilet with our derrières hanging flaccidly in mid-air for prolonged periods of time encourages the pooling of blood in the anorectal veins, and the relaxation of our anal sphincters that occurs while we are engaged in passing stool further encourages the dilated internal hemorrhoidal veins to prolapse out of the anorectal canal, which further encourages swelling and dilation of these delicate structures. Chronic constipation (which is often associated with inadequate dietary fiber and inadequate physical activity) further complicates matters, as constipated people spend more time sitting on the pot. Straining to defecate is particularly bad, as it forces blood, under pressure, back into hemorrhoidal veins, causing them to balloon out, and to dilate further.

Good bowel habits cannot be overemphasized when it comes to living a hemorrhoid-free life (or, at least, a life that is not unduly influenced by hemorrhoidal symptoms). So, forget about reading your favorite magazine or novel while you are doing your “business.” The longer you sit on the toilet, the more likely you are to develop symptomatic hemorrhoids. So, get rid of the reading rack next to the toilet! Also, when you feel the urge to strain, resist it! (Finally, don’t delay when the urge to defecate occurs, as this will contribute to constipation, as well.)

Because of the particular etiologic factors associated with the development of symptomatic hemorrhoids, most cases will respond well to some fairly simple lifestyle modifications. First and foremost, a diet rich in fiber and water will help you to more easily pass your stools, allowing you to spend less time on the potty, and alleviating the urge to strain when defecating. Likewise, getting enough exercise to stimulate normal bowel function is important (and regular exercise is not beneficial only for your GI tract, alone, of course!). Avoiding overly aggressive anal hygiene is also important, as excessively vigorous or frequent washing of the anal skin can cause irritation of this sensitive area and the underlying anorectal veins.

Despite adopting a bowel-healthy lifestyle, however, some people will still develop symptomatic hemorrhoids, unfortunately. In addition to the lifestyle modifications that I’ve already discussed, warm baths (especially after bowel movements) can ease the burning and itching of hemorrhoids. The sparing use of anti-inflammatory creams or suppositories can also help to reduce the annoying symptoms of mild-to-moderate hemorrhoidal disease. Occasionally, chronic constipation that does not improve with increased dietary fiber and liquids (and increased exercise) may require the use of non-laxative stool softeners, such as docusate sodium (the frequent or regular use of laxative-type medications will only worsen constipation over the long run).

Despite taking all of these recommended steps, however, persistently symptomatic hemorrhoids may require various interventions by a physician, however. Once again, less radical approaches to symptomatic hemorrhoids should be attempted prior to more radical measures. There are several different interventional approaches to bothersome hemorrhoids that are currently available, and these approaches often differ depending upon whether the offending hemorrhoids are internal or external (or both).

For acutely thrombosed (clotted) external hemorrhoids, your doctor can extract the blood clot from inflamed external hemorrhoids under local anesthesia in his or her office. Generally speaking, this approach is most beneficial within the first 2 or 3 days after the onset of thrombosis and pain, and will expedite resolution of the exquisite pain that usually accompanies the formation of a blood clot in external hemorrhoids. However, several clinical studies have shown that performing a “thrombectomy” of thrombosed external hemorrhoids more than 2 or 3 days after the acute onset of symptoms is generally of little benefit to patients as, by this time, the acute inflammatory response to the blood clot generally begins to subside (instead of surgical clot extraction, most patients will, at this point, do better with warm baths and the temporary use of anti-inflammatory hemorrhoidal creams). 

Especially severe itching, burning, swelling, and bleeding from non-thrombosed external hemorrhoids may, in some cases, require invasive surgical intervention (hemorrhoidectomy)l, although this more aggressive approach is necessary only in the minority of patients, fortunately.

Prolapsing or bleeding internal hemorrhoids can also fail to respond to the conservative measures that I have described. Because the tissues in and around internal hemorrhoids are not capable of sensing pain, there are several different “minimally-invasive” therapies available, short of surgical resection (hemorrhoidectomy). These treatments include rubber-band ligation (“banding”), sclerotherapy, and infra-red coagulation. (Although other, newer approaches to the management of internal hemorrhoids have been used recently, we don’t yet have the same long-term experience and documented outcomes available with these treatments, like we have with the more established procedures that I’ve listed.)

Rubber-band ligation involves the use of as simple device that places a constricting rubber-band around the base of symptomatic internal hemorrhoids. The blood supply to the hemorrhoids is strangulated by the rubber-band, causing the hemorrhoids to, essentially, die and slough-off after a couple of days. The rubber-band must be carefully placed by the physician, such that the entire thickness of the rectal wall is not included in the rubber-band, lest a full-thickness injury to the rectal wall occur. Also, occasionally, significant bleeding can occur when the hemorrhoid begins to slough-off. Placement of the rubber-band around the area of transition between the internal anorectal canal (which cannot sense pain) and the external anal canal (which is exquisitely sensitive to pain) can lead to severe anorectal pain. In the vast majority of cases, however, the use of rubber-band ligation of internal hemorrhoids, by an experienced physician, is a well-tolerated and effective treatment for symptomatic internal hemorrhoids that are refractory to more conservative treatments.

Sclerotherapy of internal hemorrhoids involves the injection of irritating substances (sclerosants) into the tissues around symptomatic hemorrhoids, which leads to scarring and shrinkage of the offending hemorrhoid or hemorrhoids. This method of treatment is less effective, however, for very large internal hemorrhoids.

Infrared coagulation of internal hemorrhoids uses heat that is painlessly generated by a special infrared probe to shrink symptomatic hemorrhoids, primarily by causing the blood within the dilated hemorrhoid to form a blot clot. As with acutely thrombosed external hemorrhoids, the blood clots formed within internal hemorrhoids by the infrared coagulator initiates an inflammatory response which, in most cases, leads to the eventual scarring and shrinkage of the hemorrhoid. Because the application of high temperatures to external hemorrhoids would be terrifically painful, infrared coagulation can only be used on internal hemorrhoids. As is the case with sclerotherapy, very large internal hemorrhoids may not be effectively or completely treated using infrared coagulation alone.

For patients in whom all of the above methods fail, hemorrhoidectomy may be an option to consider for severely symptomatic external or (and) internal hemorrhoids. The classic and time-tested approach to persistently symptomatic hemorrhoidal disease has been to surgically excise the offending hemorrhoids, in addition to the skin overlying external hemorrhoids and the mucus membranes overlying internal hemorrhoids. For carefully selected patients with severe hemorrhoidal symptoms that are refractory to less invasive treatments, hemorrhoidectomy can dramatically improve the patient’s quality of life, but only after what is, unfortunately, a typically painful recovery from this most radical of approaches to hemorrhoids.

Because of the typically unpleasant postoperative recovery from traditional hemorrhoid surgery, clinical researchers have long sought a less painful method of dealing with severe hemorrhoidal disease that is refractory to less invasive treatment methods. One recent and promising innovation has been the adaptation of circular surgical stapling devices to allow for hemorrhoid excisions, thus eliminating the need to make large and painful surgical incisions within the anorectal canal. Preliminary research data has suggested that the use of these circular staples, to perform a so-called stapled hemorrhoidectomy, may be associated with less pain, and a more rapid recovery, than conventional surgical hemorrhoidectomy. Now, a new prospective, randomized clinical surgical research trial adds additional useful data regarding the relative risks and benefits of traditional versus stapled hemorrhoidectomy.

This new study, just published in the journal Gut, randomly assigned 182 adult patients with symptomatic hemorrhoids to undergo either traditional “excisional” hemorrhoidectomy or stapled hemorrhoidectomy. All of these patients were then closely followed, at regular predefined intervals, for an average of one year following hemorrhoidectomy. 

The results of this study were similar, with regards to postoperative pain, as have been reported in previous non-randomized studies. While there were no significant differences between the two groups of patients in terms of residual or recurrent hemorrhoidal symptoms at one year following hemorrhoidectomy, the patients who underwent stapled hemorrhoidectomy reported, on average, significantly less pain in the early postoperative period when compared to the patients who underwent conventional hemorrhoidectomy. At the same time, while the overall rate of complications appeared to be equivalent between the two different procedures, the patients who underwent stapled hemorrhoidectomy reported a greater sense of urgency to have a bowel movement when compared to the “excisional” hemorrhoidectomy patients. Also, despite comparable overall relief of hemorrhoidal symptoms at one year following hemorrhoidectomy, the patients who had undergone conventional “excisional” hemorrhoidectomy reported fewer episodes of persistent or recurrent prolapsing internal hemorrhoids when compared to the stapled hemorrhoidectomy patients. Thus, at one year following hemorrhoidectomy, the patients who underwent stapled hemorrhoidectomy more frequently required retreatment for recurrent prolapsing hemorrhoids than did the patients who were treated with conventional hemorrhoidectomy.

Despite the significant long-term differences in outcomes between these two approaches to hemorrhoidectomy, including the higher rate of recurrence of symptomatic prolapsing hemorrhoids following stapled hemorrhoidectomy, the patients who underwent stapled hemorrhoidectomy were significantly more satisfied with the stapled approach to hemorrhoidectomy, and particularly the early outcomes of their operations (at 6 weeks and 12 weeks following hemorrhoidectomy), when compared to the patients who had been randomized to undergo conventional hemorrhoidectomy. Thus, the reduction in early postoperative pain achieved with stapled hemorrhoidectomy (when compared to conventional hemorrhoidectomy) was substantial enough to override patient concerns about the subsequent increased risk of hemorrhoidal relapse, as well as an increased sense of fecal urgency.

Before my tens of thousands of readers with symptomatic hemorrhoids run to their local neighborhood proctologists to ask for a stapled hemorrhoidectomy, I want to emphasize, once again, that both of these approaches to hemorrhoidectomy constitute major surgical operations, and both are associated with a small (but not insignificant) risk of complications, including bleeding, infection, recurrence of hemorrhoids, and a temporary or permanent compromise in the ability to control the passage of flatus or bowel movements (incontinence). Thus, hemorrhoidectomy, by any method, should be reserved for the minority of patients with severe hemorrhoidal symptoms that have been refractory to all other forms of treatment.

  




Disclaimer:  As always, my advice to readers is to seek the advice of your physician before making any significant changes in medications, diet, or level of physical activity


 

Dr. Wascher is an oncologic surgeon, a professor of surgery, a widely published author, and a Surgical Oncologist at the Kaiser Permanente healthcare system in Orange County, California



Send your feedback to Dr. Wascher at:
 rwascher@doctorwascher.net


 

Dr. Wascher's Biography


Links to Other Health & Wellness Sites


http://doctorwascher.com


 

Copyright 2009

  

Robert A. Wascher, MD, FACS

  

All rights reserved


Dr. Wascher's Archives:

5-3-2009: Statin Drugs & Blood Clots (Thromboembolism)

4-26-2009: Are We Really Losing the War on Cancer?

4-19-2009:   Exercise in Middle Age & Risk of Death

4-12-2009: Can Chronic Stress Harm Your Heart?

4-5-2009: Does PSA Testing for Prostate Cancer Save Lives?

3-22-2009: CABG Surgery vs. PCI in Diabetics with Coronary Artery Disease; Sweetened Beverages and Coronary Artery Disease

3-15-2009: Depression, Stress, Anger & Heart Disease

3-8-2009: Coronary Artery Disease: CABG vs. Stents?; Swimming Lessons & Drowning Risk in Children

3-1-2009: Aspirin & Colorectal Cancer Prevention; Fish Oil & Respiratory Infections in Children

2-22-2009: Health Differences Between Americans & Europeans; Lycopene & Prostate Cancer

2-15-2009: Statin Drugs & Death Rates; Physical Activity, Breast Cancer & Sex Hormones

2-8-2009: Hormone Replacement Therapy (HRT) & Breast Cancer; Stool DNA Testing & Cancer of the Colon & Rectum

2-1-2009:   Obesity and the Complications of Diverticulosis (Diverticulitis & Bleeding); Obesity, Weight Loss & Urinary Incontinence

1-25-2009: Prostate Cancer, Fatigue & Exercise; Does your Surgeon “Warm-up” Before Surgery?

1-18-2009: Cancer and Vitamins; Teenagers, MySpace and Risky Behaviors

1-11-2009: Exercise Reverses Some Effects of Fatty Meals; Vitamin C and Blood Pressure

1-4-2009: Secondhand Smoke & Heart Attack Risk; Poor Physical Fitness During Childhood & Heart Disease Risk During Adulthood

12-28-2008: Stress & Your Risk of Heart Attack; Vitamin D & the Prevention of Colon & Rectal Polyps

12-21-2008: Breast Cancer Incidence & Hormone Replacement Therapy; Circumcision & the Risk of HPV & HIV Infection

12-14-2008: Vitamin E, Vitamin C and Selenium Do Not Prevent Cancer; Postscript: A Possible Cure for Down’s Syndrome

12-7-2008: Generic vs. Brand-Name Drugs, Stress & Breast Cancer Survival

11-30-2008:   A Possible Cure for Down’s Syndrome?; Smoking & Cognitive Decline; Calcium & Vitamin D & Breast Cancer Risk

11-23-2008:  Breast Cancer & Fish Oil; Lymphedema after Breast Cancer Treatment; Vasectomy & Prostate Cancer Risk

11-16-2008:  Vitamin E & Vitamin C: No Impact on Cardiovascular Disease Risk; Does Lack of Sleep Increase Stroke & Heart Attack Risk in Hypertensive Patients?

11-9-2008:  Statins Cut Heart Attack Risk Even with Normal Cholesterol Levels; Statins & PSA Level

11-2-2008:  Radiation Treatment of Prostate Cancer & Second Cancers; Sexual Content on TV & Teen Pregnancy Risk

10-26-2008:  Smoking & Quality of Life

10-19-2008:  Agent Orange & Prostate Cancer

10-12-2008:  Pomegranate Juice & Prostate Cancer

10-5-2008:  Central Obesity & Dementia; Diet, Vitamin D, Calcium, & Colon Cancer

9-28-2008:  Publication & Citation Bias in Favor of Industry-Funded Research?

9-21-2008:  Does Tylenol® (Acetaminophen) Cause Asthma?

9-14-208:   Arthroscopic Knee Surgery- No Better than Placebo?; A Healthy Lifestyle Prevents Stroke

8-23-2008:  Alcohol Abuse Before & After Military Deployment; Running & Age; Running & Your Testicles

8-12-2008:  Green Tea & Diabetes; Breastfeeding & Adult Cholesterol Levels; Fish Oil & Senile Macular Degeneration

8-3-2008:   Exercise & Weight Loss; Green Tea, Folic Acid & Breast Cancer Risk; Foreign Language Interpreters & ICU Patients

7-26-2008:  Viagra & Sexual Function in Women; Patient-Reported Adverse Hospital Events; Curcumin & Pancreatic Cancer

7-13-2008:  Erectile Dysfunction & Frequency of Sex; Muscle Strength & Mortality in Men; Cryoablation for Prostate Cancer

7-6-2008:  Sleep, Melatonin & Breast Cancer Risk; Mediterranean Diet & Cancer Risk; New Treatment for Varicose Veins

6-29-2008:  Bone Marrow Stem Cells & Liver Failure; Vitamin D & Colorectal Cancer Survival; Green Tea & Colorectal Cancer

6-22-2008:  Obesity, Lifestyle & Heart Disease; Effects of Lifestyle & Nutrition on Prostate Cancer; Ginkgo Biloba, Ulcerative Colitis & Colorectal Cancer

6-15-2008:  Preventable Deaths after Coronary Artery Bypass Graft (CABG) Surgery; Green Tea & Colorectal Cancer; Attention-Deficit/Hyperactivity Disorder (ADHD) & St. John’s Wort

6-8-2008:  Vitamin D & Prostate Cancer Risk; Radiofrequency Ablation (RFA) of Kidney (Renal) Cancer; Antisense Telomerase & Cancer

6-2-2008:  Acute Coronary Syndrome- Do You Know the Symptoms?; Green Tea & Lung Cancer; Episiotomy & Subsequent Deliveries- An Unkind Cut

5-25-2008:  Early Childhood Screening Predicts Later Behavioral Problems; Psychiatric Disorders Among Parents of Autistic Children; Social & Psychiatric Profiles of Young Adults Born Prematurely

5-18-2008:  Can Statins Reverse Coronary Artery Disease?; Does Breast Ultrasound Improve Breast Cancer Detection?; Preventive Care Services at Veterans Administration (VA) Medical Centers

5-11-2008:  Smoking Cessation & Risk of Death; Childhood Traumas & Adult Suicide Risk; “White Coat Hypertension” & Risk of Cardiovascular Disease

5-4-2008:  Super-Size Me: Fast Food’s Effects on Your Liver; Exercise, Weight & Coronary Artery Disease; Contamination of Surgical Instruments in the Operating Room

4-27-2008:  Stents vs. Bypass Surgery for Coronary Artery Disease; The “DASH” Hypertension Diet & Cardiovascular Disease Prevention; Testosterone Therapy for Women with Decreased Sexual Desire & Function

4-20-2008:  BRCA Breast Cancer Mutations & MRI Scans; Bladder Cancer Prevention with Broccoli?; Diabetes: Risk of Death Due to Heart Attack & Stroke

4-13-2008:  Breast Cancer Recurrence & Hormone Replacement Therapy (HRT); Carotid Artery Disease: Surgery vs. Stents?; Statin Drugs & Cancer Prevention

4-6-2008:  Human Papilloma Virus (HPV), Pap Smear Results & Cervical Cancer; Human Papilloma Virus (HPV) Infection & Oral Cancer; Hormone Replacement Therapy (HRT) & the Risk of Gastroesophageal Reflux Disorder (GERD)

3-30-2008:  Abdominal Obesity & the Risk of Death in Women; Folic Acid Pretreatment & Heart Attacks; Pancreatic Cancer Regression after Injections of Bacteria

3-23-2008:  Age of Transfused Blood & Risk of Complications after Surgery; Obesity, Blood Pressure & Heart Size in Children

3-16-2008:  Benefits of a Full Drug Coverage Plan for Medicare Patients?; Parent-Teen Conversations about Sex; Soy (Genistein) & Prostate Cancer

3-9-2008:  Flat Colorectal Adenomas & Cancer; Health Risks after Stopping Hormone Replacement Therapy (HRT); Television, Children & Obesity 

3-2-2008:  Medication & Risk of Death After Heart Attack; Hormone Replacement Therapy (HRT) & Mammogram Results; Selenium: Cancer, Heart Disease & Death

2-23-2008:  Universal Healthcare Insurance Study; Glucosamine & Arthritis

2-17-2008:  Exceptional Longevity in Men; Testosterone & Risk of Prostate Cancer; Smoking & Pre-malignant Colorectal Polyps

2-10-2008:  Thrombus Aspiration from Coronary Arteries; Intensive Management of Diabetes & Death; Possible Cure for  Down's Syndrome?

2-3-2008:  Vitamin D & Cardiovascular Health; Vitamin D & Breast Cancer; Green Tea & Colorectal Cancer

1-27-2008:  Colorectal Cancer, Esophageal Cancer & Pancreatic Cancer: Update from the 2008 American Society of Clinical Oncology's Gastrointestinal Cancers Symposium

1-20-2008:  Testosterone Levels & Risk of Fractures in Elderly Men; Air Pollution & DNA Damage in Sperm; Statins & Trauma Survival in the Elderly

1-12-2008:  Statins, Diabetes & Stroke and Obesity; GERD & Esophageal Cancer

1-7-2008:  Testosterone Supplements in Elderly Men; Colorectal Cancer-- Reasons for Poor Compliance with Screening Recommendations

12-31-2007:  Minority Women, Hormone Replacement Therapy & Breast Cancer; Does Health Insurance Improve Health?

12-23-2007:  Is Coffee Safe After a Heart Attack?; Impact of Divorce on the Environment; Hypertension & the Risk of Dementia; Emotional Vitality & the Risk of Heart Disease

12-16-2007:   Honey vs. Dextromethorphan vs. No Treatment for Kids with Night-Time Cough, Acupuncture & Hot Flashes in Women with Breast Cancer, Physical Activity & the Risk of Death, Mediterranean Diet & Mortality 

12-11-2007:  Bias in Medical Research; Carbon Nanotubes & Radiofrequency: A New Weapon Against Cancer?; Childhood Obesity & Risk of Adult Heart Disease

12-2-2007:  Obesity & Risk of Cancer; Testosterone Level & Risk of Death; Drug Company Funding of Research & Results; Smoking & the Risk of Colon & Rectal Cancer 


Dr. Wascher's Home Page


Email ItEmail It | Print ItPrint It | CommentsComments (0) | TrackbacksTrackbacks (0) | Flag as offensiveFlag as Offensive

Statin Drugs & Blood Clots (Thromboembolism)

 

 

 

Health Report:


Statin Drugs & Blood Clots (Thromboembolism)

 



"A critical weekly review of important new research findings for health-conscious readers..."

 

By, Robert A. Wascher, MD, FACS

Updated:  05/3/2009


The information in this column is intended for informational purposes only, and does not constitute medical advice or recommendations by the author.  Please consult with your physician before making any lifestyle or medication changes, or if you have any other concerns regarding your health.


  

STATIN DRUGS & BLOOD CLOTS (THROMBOEMBOLISM)

As I’ve mentioned in previous columns, the statin class of cholesterol-lowering drugs have revolutionized the management of elevated cholesterol levels, and have been shown, by multiple clinical studies, to significantly decrease the incidence of serious cardiovascular events, including fatal heart attacks (myocardial infarction) and strokes. 

The statins were originally developed for their ability to block a key enzyme required for the body’s synthesis of cholesterol.  Thus, the statins decrease total cholesterol levels in the blood and, most importantly, they specifically reduce LDL (the “bad cholesterol”) levels.   Numerous clinical research studies have shown that statin drugs reduce the risk of heart disease and heart attacks in patients with elevated cholesterol levels.  Additional research has also strongly suggested that statins can also reduce the risk of cardiovascular disease even in patients with normal cholesterol levels.  More recently, additional research into the biochemical function of these powerful drugs has also revealed other mechanisms of action in addition to their known direct effects on cholesterol synthesis and metabolism.  One of the most clinically important additional mechanisms of action of statins appears to be their ability to reduce inflammation throughout the body.  These anti-inflammatory effects have been linked not only to the statins’ ability to reduce cardiovascular disease, but also to their ability to potentially reduce the risk of stroke and, perhaps, even the risk of some cancers, as well.  However, the data supporting these additional potential benefits of statins has been less convincing than that for cardiovascular disease reduction.  I should also stress that not all claims currently being made for statins are likely to turn out to be true, and that, as with all medications, statins have been associated with potentially serious side effects (most notably, injury to the liver and to muscle tissue).  However, as I have observed before, it is difficult to think of any other recently developed class of medications that have accumulated a more impressive reputation for preventing life-threatening diseases than the statins (not surprisingly, the statin class of drugs remain the most commonly prescribed class of medications in the United States).

The good news regarding the potential beneficial health effects of statin drugs continues to roll in. For example, in recent weeks, clinical research data has been presented suggesting that statins may reduce the risk of prostate cancer, and may also be able to slow the growth of tumors in men who already have prostate cancer (it should be noted, however, once again, that there have been conflicting research results published, thus far, regarding the ability of statin drugs to reduce cancer risks, and to shrink tumors in patients who already have cancer).  

This week, another important new clinical research study on statin drugs has just been published. In this new study, which appears in the New England Journal of Medicine, the potential effects of statin drugs in preventing blood clots of the veins was assessed in a huge randomized, placebo-controlled, double-blind, prospective clinical research trial. Nearly 18,000 clinically healthy men and women participated in this very important clinical research trial. All participants in this study had normal LDL cholesterol levels, but they also all had elevated levels of C-Reactive Protein (CRP), a protein in the blood that is associated both with chronic inflammation and an elevated risk of cardiovascular disease. These 17,802 patient volunteers were randomized to receive either a statin pill (rosuvastatin, 20 milligrams per day) or an identical placebo pill (sugar pill). This huge group of patients were then followed, for as long as 5 years, and were observed for evidence of blood clot formation within the large veins of the body (deep venous thrombosis), as well as the presence of blood clots that had migrated to the veins of the lungs (pulmonary embolism). The results of this study, as I will discuss shortly, were quite remarkable.

Venous thromboembolic (VTE) disorders are a major cause of disability and death throughout the world. Deep venous thrombosis (DVT) results when blood clots form within the deep veins of the body (most commonly within the large veins of the legs and pelvis). A variety of conditions and circumstances can lead to DVT formation. These include decreased blood flow, or “stasis,” involving the body’s deep veins, injury or inflammation of the internal surfaces (endothelium) of these veins, and any underlying health condition that increases the blood’s tendency to form blood clots (hypercoagulable state). Pulmonary embolism (PE) is a potentially life-threatening condition, and most commonly arises in patients who have already developed DVT (PE occurs when chunks of DVT-associated clots break away and travel to the lung). When the lung’s circulation becomes clogged-up with these itinerant clots (emboli), patients may experience shortness of breath, chest pain, or in serious cases of PE, complete cardiovascular collapse and death. 

VTE remains an underappreciated cause of serious illness, disability, and death. Patients with severe or repeated cases of DVT often develop chronic swelling, pain, and skin damage of the affected extremities, due to the progressive destruction of the one-way valves in the large veins of the lower body that help to prevent pooling of blood in these dependent areas of the body (post-thrombotic syndrome). Patients who survive significant PEs may also go on to develop permanent damage to the venous circulation of the lungs, leaving them with decreased blood flow to the lungs (pulmonary hypertension) and, in severe cases, chronic shortness of breath, lung injury, and heart damage (PE also remains the most common cause of unexpected death in hospitalized patients). An estimated 900,000 new cases of VTE occur in the United States every year, and as many as one-third of these cases of VTE are fatal, which makes VTE a more common cause of death than either heart attacks or strokes! As these statistics suggest, VTE remains a very serious public health problem in the United States, and throughout much of the world, as well.

In view of the seriousness of VTE as a public health problem, the findings of this newly published statin study are potentially very significant. Among the 17,802 patients who participated in this prospective clinical trial, a total of 94 patients developed VTE, with 60 cases occurring in the placebo group and only 34 cases occurring in the statin group. This represents a nearly 45 percent overall reduction in the risk of VTE associated with the daily use of the statin drug rosuvastatin. When the researchers looked at potential risk factors for VTE among these 94 patients, additional important information was discovered, as well. Among patients with known VTE risk factors (including cancer, recent major trauma, recent major surgery, or hospitalization for other reasons), the use of a statin drug reduced the risk of VTE by nearly 50 percent. Among patients without any known risk factors for VTE, the daily use of rosuvastatin reduced the risk of VTE by about 40 percent. When looking specifically of the risk of PE, the statin group of patients experienced a 23 percent risk reduction for PE, while the risk of DVT, specifically, was reduced by a whopping 55 percent in the statin group. 

The results of this study are quite remarkable, and they suggest that daily statin use may reduce the risk of VTE by nearly 50 percent, especially in people who are already at increased risk for VTE (whether or not all of the currently available statin drugs can provide VTE protection equivalent to rosuvastatin is unknown at this time, although all high-activity statins should, in theory, provide comparable protection). This highly significant VTE prevention effect is, of course, a potential “health bonus” in addition to the cardiovascular disease reduction effect that statin drugs were originally designed for. If you fall into a high-risk category for VTE, and you also have coexisting risk factors for cardiovascular disease, then you should certainly discuss statin drug therapy with your primary physician, based upon the findings of this pivotal clinical research trial.

 



Disclaimer:  As always, my advice to readers is to seek the advice of your physician before making any significant changes in medications, diet, or level of physical activity


 

Dr. Wascher is an oncologic surgeon, a professor of surgery, a widely published author, and a Surgical Oncologist at the Kaiser Permanente healthcare system in Orange County, California



Send your feedback to Dr. Wascher at:
 rwascher@doctorwascher.net


 

Dr. Wascher's Biography


Links to Other Health & Wellness Sites


http://doctorwascher.com


 

Copyright 2009

  

Robert A. Wascher, MD, FACS

  

All rights reserved


Dr. Wascher's Archives:

4-26-2009: Are We Really Losing the War on Cancer?

4-19-2009:   Exercise in Middle Age & Risk of Death

4-12-2009: Can Chronic Stress Harm Your Heart?

4-5-2009: Does PSA Testing for Prostate Cancer Save Lives?

3-22-2009: CABG Surgery vs. PCI in Diabetics with Coronary Artery Disease; Sweetened Beverages and Coronary Artery Disease

3-15-2009: Depression, Stress, Anger & Heart Disease

3-8-2009: Coronary Artery Disease: CABG vs. Stents?; Swimming Lessons & Drowning Risk in Children

3-1-2009: Aspirin & Colorectal Cancer Prevention; Fish Oil & Respiratory Infections in Children

2-22-2009: Health Differences Between Americans & Europeans; Lycopene & Prostate Cancer

2-15-2009: Statin Drugs & Death Rates; Physical Activity, Breast Cancer & Sex Hormones

2-8-2009: Hormone Replacement Therapy (HRT) & Breast Cancer; Stool DNA Testing & Cancer of the Colon & Rectum

2-1-2009:   Obesity and the Complications of Diverticulosis (Diverticulitis & Bleeding); Obesity, Weight Loss & Urinary Incontinence

1-25-2009: Prostate Cancer, Fatigue & Exercise; Does your Surgeon “Warm-up” Before Surgery?

1-18-2009: Cancer and Vitamins; Teenagers, MySpace and Risky Behaviors

1-11-2009: Exercise Reverses Some Effects of Fatty Meals; Vitamin C and Blood Pressure

1-4-2009: Secondhand Smoke & Heart Attack Risk; Poor Physical Fitness During Childhood & Heart Disease Risk During Adulthood

12-28-2008: Stress & Your Risk of Heart Attack; Vitamin D & the Prevention of Colon & Rectal Polyps

12-21-2008: Breast Cancer Incidence & Hormone Replacement Therapy; Circumcision & the Risk of HPV & HIV Infection

12-14-2008: Vitamin E, Vitamin C and Selenium Do Not Prevent Cancer; Postscript: A Possible Cure for Down’s Syndrome

12-7-2008: Generic vs. Brand-Name Drugs, Stress & Breast Cancer Survival

11-30-2008:   A Possible Cure for Down’s Syndrome?; Smoking & Cognitive Decline; Calcium & Vitamin D & Breast Cancer Risk

11-23-2008:  Breast Cancer & Fish Oil; Lymphedema after Breast Cancer Treatment; Vasectomy & Prostate Cancer Risk

11-16-2008:  Vitamin E & Vitamin C: No Impact on Cardiovascular Disease Risk; Does Lack of Sleep Increase Stroke & Heart Attack Risk in Hypertensive Patients?

11-9-2008:  Statins Cut Heart Attack Risk Even with Normal Cholesterol Levels; Statins & PSA Level

11-2-2008:  Radiation Treatment of Prostate Cancer & Second Cancers; Sexual Content on TV & Teen Pregnancy Risk

10-26-2008:  Smoking & Quality of Life

10-19-2008:  Agent Orange & Prostate Cancer

10-12-2008:  Pomegranate Juice & Prostate Cancer

10-5-2008:  Central Obesity & Dementia; Diet, Vitamin D, Calcium, & Colon Cancer

9-28-2008:  Publication & Citation Bias in Favor of Industry-Funded Research?

9-21-2008:  Does Tylenol® (Acetaminophen) Cause Asthma?

9-14-208:   Arthroscopic Knee Surgery- No Better than Placebo?; A Healthy Lifestyle Prevents Stroke

8-23-2008:  Alcohol Abuse Before & After Military Deployment; Running & Age; Running & Your Testicles

8-12-2008:  Green Tea & Diabetes; Breastfeeding & Adult Cholesterol Levels; Fish Oil & Senile Macular Degeneration

8-3-2008:   Exercise & Weight Loss; Green Tea, Folic Acid & Breast Cancer Risk; Foreign Language Interpreters & ICU Patients

7-26-2008:  Viagra & Sexual Function in Women; Patient-Reported Adverse Hospital Events; Curcumin & Pancreatic Cancer

7-13-2008:  Erectile Dysfunction & Frequency of Sex; Muscle Strength & Mortality in Men; Cryoablation for Prostate Cancer

7-6-2008:  Sleep, Melatonin & Breast Cancer Risk; Mediterranean Diet & Cancer Risk; New Treatment for Varicose Veins

6-29-2008:  Bone Marrow Stem Cells & Liver Failure; Vitamin D & Colorectal Cancer Survival; Green Tea & Colorectal Cancer

6-22-2008:  Obesity, Lifestyle & Heart Disease; Effects of Lifestyle & Nutrition on Prostate Cancer; Ginkgo Biloba, Ulcerative Colitis & Colorectal Cancer

6-15-2008:  Preventable Deaths after Coronary Artery Bypass Graft (CABG) Surgery; Green Tea & Colorectal Cancer; Attention-Deficit/Hyperactivity Disorder (ADHD) & St. John’s Wort

6-8-2008:  Vitamin D & Prostate Cancer Risk; Radiofrequency Ablation (RFA) of Kidney (Renal) Cancer; Antisense Telomerase & Cancer

6-2-2008:  Acute Coronary Syndrome- Do You Know the Symptoms?; Green Tea & Lung Cancer; Episiotomy & Subsequent Deliveries- An Unkind Cut

5-25-2008:  Early Childhood Screening Predicts Later Behavioral Problems; Psychiatric Disorders Among Parents of Autistic Children; Social & Psychiatric Profiles of Young Adults Born Prematurely

5-18-2008:  Can Statins Reverse Coronary Artery Disease?; Does Breast Ultrasound Improve Breast Cancer Detection?; Preventive Care Services at Veterans Administration (VA) Medical Centers

5-11-2008:  Smoking Cessation & Risk of Death; Childhood Traumas & Adult Suicide Risk; “White Coat Hypertension” & Risk of Cardiovascular Disease

5-4-2008:  Super-Size Me: Fast Food’s Effects on Your Liver; Exercise, Weight & Coronary Artery Disease; Contamination of Surgical Instruments in the Operating Room

4-27-2008:  Stents vs. Bypass Surgery for Coronary Artery Disease; The “DASH” Hypertension Diet & Cardiovascular Disease Prevention; Testosterone Therapy for Women with Decreased Sexual Desire & Function

4-20-2008:  BRCA Breast Cancer Mutations & MRI Scans; Bladder Cancer Prevention with Broccoli?; Diabetes: Risk of Death Due to Heart Attack & Stroke

4-13-2008:  Breast Cancer Recurrence & Hormone Replacement Therapy (HRT); Carotid Artery Disease: Surgery vs. Stents?; Statin Drugs & Cancer Prevention

4-6-2008:  Human Papilloma Virus (HPV), Pap Smear Results & Cervical Cancer; Human Papilloma Virus (HPV) Infection & Oral Cancer; Hormone Replacement Therapy (HRT) & the Risk of Gastroesophageal Reflux Disorder (GERD)

3-30-2008:  Abdominal Obesity & the Risk of Death in Women; Folic Acid Pretreatment & Heart Attacks; Pancreatic Cancer Regression after Injections of Bacteria

3-23-2008:  Age of Transfused Blood & Risk of Complications after Surgery; Obesity, Blood Pressure & Heart Size in Children

3-16-2008:  Benefits of a Full Drug Coverage Plan for Medicare Patients?; Parent-Teen Conversations about Sex; Soy (Genistein) & Prostate Cancer

3-9-2008:  Flat Colorectal Adenomas & Cancer; Health Risks after Stopping Hormone Replacement Therapy (HRT); Television, Children & Obesity 

3-2-2008:  Medication & Risk of Death After Heart Attack; Hormone Replacement Therapy (HRT) & Mammogram Results; Selenium: Cancer, Heart Disease & Death

2-23-2008:  Universal Healthcare Insurance Study; Glucosamine & Arthritis

2-17-2008:  Exceptional Longevity in Men; Testosterone & Risk of Prostate Cancer; Smoking & Pre-malignant Colorectal Polyps

2-10-2008:  Thrombus Aspiration from Coronary Arteries; Intensive Management of Diabetes & Death; Possible Cure for  Down's Syndrome?

2-3-2008:  Vitamin D & Cardiovascular Health; Vitamin D & Breast Cancer; Green Tea & Colorectal Cancer

1-27-2008:  Colorectal Cancer, Esophageal Cancer & Pancreatic Cancer: Update from the 2008 American Society of Clinical Oncology's Gastrointestinal Cancers Symposium

1-20-2008:  Testosterone Levels & Risk of Fractures in Elderly Men; Air Pollution & DNA Damage in Sperm; Statins & Trauma Survival in the Elderly

1-12-2008:  Statins, Diabetes & Stroke and Obesity; GERD & Esophageal Cancer

1-7-2008:  Testosterone Supplements in Elderly Men; Colorectal Cancer-- Reasons for Poor Compliance with Screening Recommendations

12-31-2007:  Minority Women, Hormone Replacement Therapy & Breast Cancer; Does Health Insurance Improve Health?

12-23-2007:  Is Coffee Safe After a Heart Attack?; Impact of Divorce on the Environment; Hypertension & the Risk of Dementia; Emotional Vitality & the Risk of Heart Disease

12-16-2007:   Honey vs. Dextromethorphan vs. No Treatment for Kids with Night-Time Cough, Acupuncture & Hot Flashes in Women with Breast Cancer, Physical Activity & the Risk of Death, Mediterranean Diet & Mortality 

12-11-2007:  Bias in Medical Research; Carbon Nanotubes & Radiofrequency: A New Weapon Against Cancer?; Childhood Obesity & Risk of Adult Heart Disease

12-2-2007:  Obesity & Risk of Cancer; Testosterone Level & Risk of Death; Drug Company Funding of Research & Results; Smoking & the Risk of Colon & Rectal Cancer 


Dr. Wascher's Home Page


Email ItEmail It | Print ItPrint It | CommentsComments (0) | TrackbacksTrackbacks (0) | Flag as offensiveFlag as Offensive

Are We Really Losing the War on Cancer?

 

 

Health Report:


Are We Really Losing the War on Cancer?

 



"A critical weekly review of important new research findings for health-conscious readers..."

 

By, Robert A. Wascher, MD, FACS

Updated:  04/26/2009


The information in this column is intended for informational purposes only, and does not constitute medical advice or recommendations by the author.  Please consult with your physician before making any lifestyle or medication changes, or if you have any other concerns regarding your health.


 

 

ARE WE REALLY LOSING THE WAR ON CANCER?

A recent article in the New York Times (New York Times) suggests that we are winning the war against cardiovascular disease, but losing the war on cancer. The article leads in by citing President Richard Nixon’s 1971 announcement of his goal to cure cancer by 1976, in time for the Nation’s bicentennial celebration. After more than a hundred billion of dollars of research invested in cancer biology, prevention, and treatment between 1950 and 2005, the article continues, the death rate for cancer has decreased by a paltry 5 percent while, during the same period, the death rate for cardiovascular disease has dropped 64 percent, and death rates due to flu and pneumonia have declined by nearly 60 percent. The author of this article then goes on to cite the case of an unfortunate woman who, despite living a very healthy lifestyle, still contracted breast cancer, which went on to metastasize to her lungs.

This New York Times piece concludes that the promise of cancer prevention through lifestyle modification, and our overall progress in improving survival through the development of more effective cancer treatments, has been greatly overstated. In an interview with a nationally renowned colorectal cancer specialist, in the same article, incremental improvements in survival among patients with advanced cancers are portrayed as essentially insignificant. By the time one reads to the end of this New York Times article, it is easy to come to the conclusion that we have utterly failed, despite having invested more than a hundred billion dollars in cancer research over the past 5 or 6 decades, in our war against a disease that most experts believe has already supplanted heart disease as the number one cause of premature death in the United States, and throughout much of the world. However, as is often the case, the big picture is rather more complex than what was presented in this brief newspaper article.

Unlike cardiovascular disease, which results from increasingly well understood and relatively straightforward biological and genetic processes, cancer arises from a staggering number of biological and genetic processes gone awry. In fact, the very term “cancer,” when used in its usual context to infer a single disease entity, is, in fact, a collection of approximately 150 separate and distinct diseases which share a few common biological traits. These cancer-specific traits include the ability of malignant cells to endlessly divide until they form tumors, or masses, composed of cancer cells; and the capability of these cancer cells to break away from their parent tumors and spread, or metastasize, to distant sites throughout the body. Aside from these few critical similarities in biological behavior, however, individual types of cancer can vary from other types of cancer in their underlying cellular biology by about as much as heart disease varies from appendicitis (even within a single patient, diverse populations of genetically different cancer cells frequently coexist). Although inflammation plays a critical role in both heart disease and appendicitis, the underlying mechanisms that give rise to these two very different diseases are not the same at all. The treatments for heart disease and appendicitis are, needless to say, also quite different. Finally, the prognosis associated with heart disease is dramatically different than for appendicitis, as well. Thus, simplistic commentaries about a lack of progress in reaching the goal of curing all 150 types of cancer is, on its face, tantamount to engaging in profound naïveté and incorrect thinking, in my view.

It is true, however, as the New York Times article points out, that as we have deepened our understanding of the molecular processes by which normal and cancer cells sustain themselves and reproduce, we have had to concede that the biological and genetic processes underlying cancer development and progression are infinitely more complex, varied, and bewildering than was appreciated back in the 1970s, when confident predictions about a “cure for cancer” were loosely bandied about. It is also true that we have recently entered the “molecular era” of cancer treatment, whereby incredibly expensive “targeted therapies” are increasingly being used to extend the lives of individual cancer patients by, in many cases, only a few weeks, or, at best, by only a few months.

But is all of this nihilism justified when it comes to the cumulative progress that has been made, thus far, in understanding cancer biology (which is the fundamental key to developing more effective cancer therapies), and in developing more effective cancer treatments? As a Surgical Oncologist, when I look back over the past 20 years since I began my medical training, I see stunning advances in our understanding of cancer biology, in the effectiveness of our cancer prevention programs, and in the efficacy (and reduced toxicity) of our primary cancer treatments. However, rather than focusing purely upon anecdotal clinical experiences, it is very important to review some important epidemiological data that, I believe, offers a more balanced overview of the strides that we have made in cancer prevention and treatment over the past few decades.

According to the American Cancer Society, nearly 1 in 2 men, and almost 1 of every 3 women, will be diagnosed with cancer at some point in their lifetimes. Nearly 1.5 million Americans will be diagnosed with a new cancer in 2009, and nearly 11 million Americans are now living with a current or previous diagnosis of cancer. Almost 600,000 people will die of their cancers in 2009, amounting to approximately 1,500 deaths per day. These are, to be sure, sobering public health figures, but, once again, taking a more balanced and holistic view, there are many glimmers of progress and hope to be found if one looks at recent cancer statistics in greater detail.

First of all, despite the dismal 5 percent improvement in cancer survival rates between 1950 and 2005 cited by the New York Times article, more recent data from the American Cancer Society and the Centers for Disease Control are, in fact, far more encouraging. If one compares overall 5-year cancer survival rates (which equates to a high likelihood of cure for most types of cancer) among patients diagnosed with cancer between 1975 and 1977 with the 5-year survival rates for patients who were diagnosed between 1996 and 2003, the improvement in average 5-year survival is actually rather astounding. The average 5-year survival rate for all patients diagnosed with cancer was only about 50 percent in the mid-1970s, while patients who were diagnosed with the same types of cancers between 1996 and 2003 experienced an average 5-year survival rate of 66 percent! In public health terms, this 15 percent improvement in survival is actually a dramatic and highly significant accomplishment, and speaks to the enormous (although incomplete) progress that we have made in cancer prevention, cancer screening, and cancer treatment. Moreover, there is every reason to believe that patients who have been diagnosed with cancer since 2003 will enjoy an even greater likelihood, on average, of remaining free of cancer 5 years after their diagnosis, as we continue to improve upon our ability to detect cancers at an earlier and more curable stage, and as our treatments for many types of cancer continue to incrementally improve as well. 

Not only has the death rate due to cancer dropped significantly in recent years, but we are also doing a better job of preventing cancers as well (although we still have a long way to go in the area of cancer screening and prevention). In looking at recently published cancer incidence data collected between 2002 and 2005, we see, for the first time ever, a small but significant decrease in the incidence of new cancers in the United States, amounting to an average annual decrease of just under 1 percent. During this same period, the overall cancer death rate also decreased by almost 2 percent per year. (This data was reported in November of 2008 by the American Cancer Society, the National Cancer Institute, and the Centers for Disease Control.) These truly historic declines in cancer incidence and cancer death rates are the result of the same incremental but sustained improvements in cancer prevention, screening, and treatment that were largely disdained by the New York Times article. While these improvements in cancer incidence and cancer death rates may not seem enormous in absolute terms, in view of the prevalence of cancer in our society, the public health impact of these improving cancer trends cannot be understated, in my view. Still, not all of the news in this updated cancer incidence and survival report was favorable. Although death rates for 10 of the 15 most common causes of cancer-related death declined in the years between 2002 and 2005, cancer-related death rates actually increased for cancers of the esophagus, particularly in Caucasian men, as well as for cancers of the bladder, pancreas, and liver. 

Even among some of the cancers where the overall death rates are declining, there is still some unfavorable news to be found. For example, lung cancer death rates have been slowly declining, overall, but when you look more carefully at the statistics for the number one cancer killer of both men and women in the United States, the data is a little bit more complicated. Deaths due to lung cancer have, indeed, been slowly falling among men since the 1990s, following years of declining smoking rates among men. During this same period, however, smoking rates among women have been rising, and the incidence of lung cancer-related deaths among women has continued to increase as well, not surprisingly. Because of the lag time between behaviors that cause cancer and the actual development of those cancers, we are only now beginning to see a leveling-off of the death rate due to lung cancer in women, although the incidence of new cases of lung cancer in women is still continuing to gradually increase (albeit at a slower rate than before).

Also, there are significant regional differences in cancer incidence and cancer-associated death trends in the United States. Once again, taking lung cancer as an example, we see that lung cancer death rates declined by almost 3 percent per year in California between 1996 and 2005, which is about twice the rate of decline that was observed among other states in the Midwest and the South. These discrepant results directly mirror the impact of anti-smoking ordinances enacted in California, and the absence of such public health policies and ordinances throughout much of the Midwest and the South. Statistics such as these demonstrate that lifestyle modifications really can dramatically impact upon the incidence of certain cancers, and (obviously) upon the death rates associated with these same cancers. 

While the gradual overall decline in the death rate due to lung cancer is a direct result of decreasing smoking rates in our population, there are other examples of recent and significant reductions in cancer incidence due to changes in lifestyle, as well. For example, the recently observed decline in new breast cancer cases among postmenopausal women is now thought to be due to, in great part, a significant decrease in the number of women who are currently taking hormone replacement therapy for the symptoms of menopause. Colorectal cancer rates have also been declining for several years now, and most experts believe that this has occurred because more pre-cancerous colon and rectal polyps are being identified and removed during screening colonoscopy in patients who are compliant with colorectal cancer screening guidelines. 

Therefore, I believe that we have been making sustained progress in cancer prevention, although not nearly enough progress when you consider that our best clinical estimates are that somewhere between 60 and 80 percent of new cancer cases can be prevented through behavioral, lifestyle, and dietary modifications. (Although our treatments for most types of cancers are gradually improving, an ounce of cancer prevention is still worth a ton of cancer cure.) 

When one looks at the most common causes of cancer-related deaths in the United States (and in most other industrialized countries), the cancer survival picture, while far from ideal, looks much brighter than was portrayed in this recent New York Times piece. Significant declines in the death rates associated with three of the most common causes of cancer deaths, in both men and women, have been reported since the early 1990s for cancers of the colon and rectum, prostate, and breast, as well as for the number one cause of cancer death in men, lung cancer (hopefully, the death rate for lung cancer in women, which is also, by far, the most common cause of cancer-related death in women, will soon begin to fall as well). Contrary to the dismal picture painted in this brief and overly generalized New York Times article, survival rates even for patients with advanced cancers of the lung, colon, rectum, breast and prostate have actually continued to significantly, albeit incrementally, improve over the past two decades as our therapies have improved. 

Yes, we still have much work left to accomplish in preventing and curing cancers. However, things are hardly as bleak as was described in this widely disseminated New York Times article when it comes to our sustained and ongoing improvements in cancer prevention, screening, and treatment. While the exponentially rising cost of cancer screening and new cancer treatments is a very serious issue, given our already grossly underfunded healthcare system in the United States, an overly nihilistic assessment of our progress in the war on cancer is, at the same time, unwarranted and unfair. The complexity of cancer, as a biological entity, has only recently come to be fully appreciated. As our understanding of the molecular underpinnings of cancer biology continues to grow, I predict that we will continue to make sizable gains in cancer prevention and cancer treatment outcomes. While a universal cure for all types of cancer is not likely to be achieved within my lifetime, I can honestly say that this is a wonderful and hope-filled era for cancer research and treatment, and for many cancer patients, and speaking more personally, for cancer physicians like me, as well. 

In my forthcoming book, “A Cancer Prevention Guide for the Human Race,” I look forward to thoroughly reviewing a broad spectrum of clinical and scientific data regarding specific lifestyle and dietary factors that appear to be promising as cancer risk reduction strategies. At the same time, I will also discuss the growing body of research data that has recently called into question many of the popular dietary and other lifestyle approaches that have been marketed and hyped as cancer prevention strategies. Look for publication of this important new evidence-based approach to cancer prevention in early 2010.

 



Disclaimer:  As always, my advice to readers is to seek the advice of your physician before making any significant changes in medications, diet, or level of physical activity


 

Dr. Wascher is an oncologic surgeon, a professor of surgery, a widely published author, and a Surgical Oncologist at the Kaiser Permanente healthcare system in Orange County, California



Send your feedback to Dr. Wascher at:
 rwascher@doctorwascher.net


 

Dr. Wascher's Biography


Links to Other Health & Wellness Sites


http://doctorwascher.com


 

Copyright 2009

  

Robert A. Wascher, MD, FACS

  

All rights reserved


Dr. Wascher's Archives:

4-19-2009:   Exercise in Middle Age & Risk of Death

4-12-2009: Can Chronic Stress Harm Your Heart?

4-5-2009: Does PSA Testing for Prostate Cancer Save Lives?

3-22-2009: CABG Surgery vs. PCI in Diabetics with Coronary Artery Disease; Sweetened Beverages and Coronary Artery Disease

3-15-2009: Depression, Stress, Anger & Heart Disease

3-8-2009: Coronary Artery Disease: CABG vs. Stents?; Swimming Lessons & Drowning Risk in Children

3-1-2009: Aspirin & Colorectal Cancer Prevention; Fish Oil & Respiratory Infections in Children

2-22-2009: Health Differences Between Americans & Europeans; Lycopene & Prostate Cancer

2-15-2009: Statin Drugs & Death Rates; Physical Activity, Breast Cancer & Sex Hormones

2-8-2009: Hormone Replacement Therapy (HRT) & Breast Cancer; Stool DNA Testing & Cancer of the Colon & Rectum

2-1-2009:   Obesity and the Complications of Diverticulosis (Diverticulitis & Bleeding); Obesity, Weight Loss & Urinary Incontinence

1-25-2009: Prostate Cancer, Fatigue & Exercise; Does your Surgeon “Warm-up” Before Surgery?

1-18-2009: Cancer and Vitamins; Teenagers, MySpace and Risky Behaviors

1-11-2009: Exercise Reverses Some Effects of Fatty Meals; Vitamin C and Blood Pressure

1-4-2009: Secondhand Smoke & Heart Attack Risk; Poor Physical Fitness During Childhood & Heart Disease Risk During Adulthood

12-28-2008: Stress & Your Risk of Heart Attack; Vitamin D & the Prevention of Colon & Rectal Polyps

12-21-2008: Breast Cancer Incidence & Hormone Replacement Therapy; Circumcision & the Risk of HPV & HIV Infection

12-14-2008: Vitamin E, Vitamin C and Selenium Do Not Prevent Cancer; Postscript: A Possible Cure for Down’s Syndrome

12-7-2008: Generic vs. Brand-Name Drugs, Stress & Breast Cancer Survival

11-30-2008:   A Possible Cure for Down’s Syndrome?; Smoking & Cognitive Decline; Calcium & Vitamin D & Breast Cancer Risk

11-23-2008:  Breast Cancer & Fish Oil; Lymphedema after Breast Cancer Treatment; Vasectomy & Prostate Cancer Risk

11-16-2008:  Vitamin E & Vitamin C: No Impact on Cardiovascular Disease Risk; Does Lack of Sleep Increase Stroke & Heart Attack Risk in Hypertensive Patients?

11-9-2008:  Statins Cut Heart Attack Risk Even with Normal Cholesterol Levels; Statins & PSA Level

11-2-2008:  Radiation Treatment of Prostate Cancer & Second Cancers; Sexual Content on TV & Teen Pregnancy Risk

10-26-2008:  Smoking & Quality of Life

10-19-2008:  Agent Orange & Prostate Cancer

10-12-2008:  Pomegranate Juice & Prostate Cancer

10-5-2008:  Central Obesity & Dementia; Diet, Vitamin D, Calcium, & Colon Cancer

9-28-2008:  Publication & Citation Bias in Favor of Industry-Funded Research?

9-21-2008:  Does Tylenol® (Acetaminophen) Cause Asthma?

9-14-208:   Arthroscopic Knee Surgery- No Better than Placebo?; A Healthy Lifestyle Prevents Stroke

8-23-2008:  Alcohol Abuse Before & After Military Deployment; Running & Age; Running & Your Testicles

8-12-2008:  Green Tea & Diabetes; Breastfeeding & Adult Cholesterol Levels; Fish Oil & Senile Macular Degeneration

8-3-2008:   Exercise & Weight Loss; Green Tea, Folic Acid & Breast Cancer Risk; Foreign Language Interpreters & ICU Patients

7-26-2008:  Viagra & Sexual Function in Women; Patient-Reported Adverse Hospital Events; Curcumin & Pancreatic Cancer

7-13-2008:  Erectile Dysfunction & Frequency of Sex; Muscle Strength & Mortality in Men; Cryoablation for Prostate Cancer

7-6-2008:  Sleep, Melatonin & Breast Cancer Risk; Mediterranean Diet & Cancer Risk; New Treatment for Varicose Veins

6-29-2008:  Bone Marrow Stem Cells & Liver Failure; Vitamin D & Colorectal Cancer Survival; Green Tea & Colorectal Cancer

6-22-2008:  Obesity, Lifestyle & Heart Disease; Effects of Lifestyle & Nutrition on Prostate Cancer; Ginkgo Biloba, Ulcerative Colitis & Colorectal Cancer

6-15-2008:  Preventable Deaths after Coronary Artery Bypass Graft (CABG) Surgery; Green Tea & Colorectal Cancer; Attention-Deficit/Hyperactivity Disorder (ADHD) & St. John’s Wort

6-8-2008:  Vitamin D & Prostate Cancer Risk; Radiofrequency Ablation (RFA) of Kidney (Renal) Cancer; Antisense Telomerase & Cancer

6-2-2008:  Acute Coronary Syndrome- Do You Know the Symptoms?; Green Tea & Lung Cancer; Episiotomy & Subsequent Deliveries- An Unkind Cut

5-25-2008:  Early Childhood Screening Predicts Later Behavioral Problems; Psychiatric Disorders Among Parents of Autistic Children; Social & Psychiatric Profiles of Young Adults Born Prematurely

5-18-2008:  Can Statins Reverse Coronary Artery Disease?; Does Breast Ultrasound Improve Breast Cancer Detection?; Preventive Care Services at Veterans Administration (VA) Medical Centers

5-11-2008:  Smoking Cessation & Risk of Death; Childhood Traumas & Adult Suicide Risk; “White Coat Hypertension” & Risk of Cardiovascular Disease

5-4-2008:  Super-Size Me: Fast Food’s Effects on Your Liver; Exercise, Weight & Coronary Artery Disease; Contamination of Surgical Instruments in the Operating Room

4-27-2008:  Stents vs. Bypass Surgery for Coronary Artery Disease; The “DASH” Hypertension Diet & Cardiovascular Disease Prevention; Testosterone Therapy for Women with Decreased Sexual Desire & Function

4-20-2008:  BRCA Breast Cancer Mutations & MRI Scans; Bladder Cancer Prevention with Broccoli?; Diabetes: Risk of Death Due to Heart Attack & Stroke

4-13-2008:  Breast Cancer Recurrence & Hormone Replacement Therapy (HRT); Carotid Artery Disease: Surgery vs. Stents?; Statin Drugs & Cancer Prevention

4-6-2008:  Human Papilloma Virus (HPV), Pap Smear Results & Cervical Cancer; Human Papilloma Virus (HPV) Infection & Oral Cancer; Hormone Replacement Therapy (HRT) & the Risk of Gastroesophageal Reflux Disorder (GERD)

3-30-2008:  Abdominal Obesity & the Risk of Death in Women; Folic Acid Pretreatment & Heart Attacks; Pancreatic Cancer Regression after Injections of Bacteria

3-23-2008:  Age of Transfused Blood & Risk of Complications after Surgery; Obesity, Blood Pressure & Heart Size in Children

3-16-2008:  Benefits of a Full Drug Coverage Plan for Medicare Patients?; Parent-Teen Conversations about Sex; Soy (Genistein) & Prostate Cancer

3-9-2008:  Flat Colorectal Adenomas & Cancer; Health Risks after Stopping Hormone Replacement Therapy (HRT); Television, Children & Obesity 

3-2-2008:  Medication & Risk of Death After Heart Attack; Hormone Replacement Therapy (HRT) & Mammogram Results; Selenium: Cancer, Heart Disease & Death

2-23-2008:  Universal Healthcare Insurance Study; Glucosamine & Arthritis

2-17-2008:  Exceptional Longevity in Men; Testosterone & Risk of Prostate Cancer; Smoking & Pre-malignant Colorectal Polyps

2-10-2008:  Thrombus Aspiration from Coronary Arteries; Intensive Management of Diabetes & Death; Possible Cure for  Down's Syndrome?

2-3-2008:  Vitamin D & Cardiovascular Health; Vitamin D & Breast Cancer; Green Tea & Colorectal Cancer

1-27-2008:  Colorectal Cancer, Esophageal Cancer & Pancreatic Cancer: Update from the 2008 American Society of Clinical Oncology's Gastrointestinal Cancers Symposium

1-20-2008:  Testosterone Levels & Risk of Fractures in Elderly Men; Air Pollution & DNA Damage in Sperm; Statins & Trauma Survival in the Elderly

1-12-2008:  Statins, Diabetes & Stroke and Obesity; GERD & Esophageal Cancer

1-7-2008:  Testosterone Supplements in Elderly Men; Colorectal Cancer-- Reasons for Poor Compliance with Screening Recommendations

12-31-2007:  Minority Women, Hormone Replacement Therapy & Breast Cancer; Does Health Insurance Improve Health?

12-23-2007:  Is Coffee Safe After a Heart Attack?; Impact of Divorce on the Environment; Hypertension & the Risk of Dementia; Emotional Vitality & the Risk of Heart Disease

12-16-2007:   Honey vs. Dextromethorphan vs. No Treatment for Kids with Night-Time Cough, Acupuncture & Hot Flashes in Women with Breast Cancer, Physical Activity & the Risk of Death, Mediterranean Diet & Mortality 

12-11-2007:  Bias in Medical Research; Carbon Nanotubes & Radiofrequency: A New Weapon Against Cancer?; Childhood Obesity & Risk of Adult Heart Disease

12-2-2007:  Obesity & Risk of Cancer; Testosterone Level & Risk of Death; Drug Company Funding of Research & Results; Smoking & the Risk of Colon & Rectal Cancer 


Dr. Wascher's Home Page


Email ItEmail It | Print ItPrint It | CommentsComments (0) | TrackbacksTrackbacks (0) | Flag as offensiveFlag as Offensive

Exercise in Middle Age & Risk of Death

 

 

Health Report:


Exercise in Middle Age & Risk of Death

 



"A critical weekly review of important new research findings for health-conscious readers..."

 

By, Robert A. Wascher, MD, FACS

Updated:  04/19/2009


The information in this column is intended for informational purposes only, and does not constitute medical advice or recommendations by the author.  Please consult with your physician before making any lifestyle or medication changes, or if you have any other concerns regarding your health.


 EXERCISE IN MIDDLE AGE & RISK OF DEATH

We all know that getting regular exercise is an important part of staying healthy. Low levels of physical activity have been directly linked to a higher risk of cardiovascular disease and cancer, which are the two most common causes of death throughout most of the world. We also know that even moderate levels of increased physical activity can improve overall health and reduce the risk of developing life-threatening diseases, while higher levels of regular exercise provide even greater protection against illness and premature death. Ideally, we should all engage in regular and vigorous physical exercise throughout our entire lives, beginning in childhood and continuing into the latter years of our lives. If you’ve already reached middle age, however, and you haven’t exactly been a regular at your local neighborhood gym, what clinical or scientific evidence is there that starting a new exercise regimen can substantially improve your prospects of living a longer and healthier life when compared to your more fit same-age peers? A new prospective long-term clinical research study, performed in Sweden and just published in the British Medical Journal, includes some very important data that will, hopefully, provide sedentary middle-aged folks with an even greater incentive to slip on some exercise togs, and hit the gym or track right away.

In this prospective cohort study, 2,205 men, all of whom were 50 years old when they entered the study between 1970 and 1973, were followed for an average of more than 35 years. All of these participating men were re-evaluated at ages 60, 70, 77, and 82 years of age. These men were divided into distinct groups, based upon their self-reported levels of physical activity at the time they entered into this research study, and at each point of re-evaluation. In order to accurately categorize these men in terms of their average levels of physical activity, a previously validated questionnaire was utilized. The men who answered “yes” to the following question were placed in the “low activity” group: “Do you spend most of your time reading, watching TV, going to the cinema, or engaging in other mostly sedentary activities?” The men who answered “yes” to the following question (and “no” to the other three questions) were placed in the “medium activity” group: “Do you often go walking or cycling for pleasure?” Finally, men who answered “yes” to the following two questions were placed in the “high activity” group: “Do you engage in any active recreational sports or heavy gardening at least 3 hours every week” and “Do you regularly engage in hard physical training or competitive sport?”

The annual death rates for this cohort of middle-aged men were then observed for nearly 4 decades, and their risk of death as a function of physical activity levels was then analyzed. Additionally, improvements in death rates associated with increasing levels of physical activity were also compared with improvements in death rates associated with smoking cessation among these men, which makes this very long-term prospective clinical research study very unique.

One particularly important finding of this study was that the men who continued to live a sedentary lifestyle were twice as likely to die prematurely as the men who began the study in the “high level of physical activity” group, which is consistent with the findings of other similar public health studies. When looking more closely at each of the three groups of men, based upon their levels of physical activity, the researchers found that the risk of death (mortality) over a period of approximately 35 years was 27, 24, and 18 per “1,000 person-years” of life among the men with low, medium and high levels of physical activity, respectively. The men who increased their levels of physical activity from “low activity” to “high activity” experienced a 32 percent relative reduction in their risk of mortality, while the “low activity” physical activity group of men who increased their level of physical activity to the “medium” level experienced a 22 percent relative reduction in their risk of death. A critically important observation in this study was that after 10 years of “high” level physical activity, the middle-aged men who had began this study while in the “low activity” group had attained a death rate that was essentially identical to that of the men who had been in the “high activity” group from the very beginning of this study. It should also be noted that during the first 5 years of increased exercise and physical activity, the men who had transitioned from the “low activity” group to the “high activity” group actually had a somewhat higher level of mortality when compared to the men who were already in the “high activity” group at the beginning of the study. After 10 years of sustained “high” level physical activity, however, the men who had started out in the “low activity” group had achieved the same approximately 50 percent reduction in mortality (when compared to the men who remained in the “low activity” group) as was observed in the men who had been in the “high activity” group from the very beginning of this very long-term clinical research study.

Improvements in mortality rates for this cohort of middle-aged men as a result of smoking cessation were also evaluated and, in turn, were compared with the improvements in mortality rates that were observed among the men who boosted their physical activity levels during the course of this study. Cessation of smoking for 10 years reduced the risk of death in these men by about 40 percent (when compared to the men who continued to smoke), while increasing one’s level of physical activity from the lowest level to the highest level resulted in a 49 percent reduction in mortality after 10 years. One important limitation of this study is, of course, that women were not included. However, while the exact magnitude of benefit from increased levels of physical activity may or may not be identical between men and women, there is ample clinical research data available showing that mortality rates decline for both men and women with increasing levels of regular physical activity.

In summary, this important public health study has shown that sedentary middle-aged men who increase their levels of regular physical activity (from “low activity” to “high activity”) for at least 10 years are able to achieve the same level of mortality risk reduction (when compared with men who continue to live a sedentary life) as is observed in other middle-aged men who have spent at least 35 years exercising at the same high level. Moreover, improvements in mortality among middle-aged men who change from low levels to high levels of regular physical activity for at least 10 years appears to be comparable to giving up smoking for at least 10 years. The twin lessons from this study are, therefore, that (1) it is never too late to get up off of the couch and start exercising if you want to maximally reduce your risk of premature death, and (2) throwing away your cigarettes will also significantly decrease your risk of an early and otherwise preventable death (needless to say, implementing both of these important lifestyle changes will tremendously reduce your risk of an early and preventable death!). As a reminder, I recommend that you receive a thorough physical examination by your physician before you embark on a new exercise program, and that you begin your new fitness program in a gradual, graded manner to reduce your risk of injury. 

 



Disclaimer:  As always, my advice to readers is to seek the advice of your physician before making any significant changes in medications, diet, or level of physical activity


 

Dr. Wascher is an oncologic surgeon, a professor of surgery, a widely published author, and a Surgical Oncologist at the Kaiser Permanente healthcare system in Orange County, California



Send your feedback to Dr. Wascher at:
 rwascher@doctorwascher.net


 Dr. Wascher's Biography


Links to Other Health & Wellness Sites


http://doctorwascher.com


 

Copyright 2009

  

Robert A. Wascher, MD, FACS

  

All rights reserved


Dr. Wascher's Archives:

4-12-2009: Can Chronic Stress Harm Your Heart?

4-5-2009: Does PSA Testing for Prostate Cancer Save Lives?

3-22-2009: CABG Surgery vs. PCI in Diabetics with Coronary Artery Disease; Sweetened Beverages and Coronary Artery Disease

3-15-2009: Depression, Stress, Anger & Heart Disease

3-8-2009: Coronary Artery Disease: CABG vs. Stents?; Swimming Lessons & Drowning Risk in Children

3-1-2009: Aspirin & Colorectal Cancer Prevention; Fish Oil & Respiratory Infections in Children

2-22-2009: Health Differences Between Americans & Europeans; Lycopene & Prostate Cancer

2-15-2009: Statin Drugs & Death Rates; Physical Activity, Breast Cancer & Sex Hormones

2-8-2009: Hormone Replacement Therapy (HRT) & Breast Cancer; Stool DNA Testing & Cancer of the Colon & Rectum

2-1-2009:   Obesity and the Complications of Diverticulosis (Diverticulitis & Bleeding); Obesity, Weight Loss & Urinary Incontinence

1-25-2009: Prostate Cancer, Fatigue & Exercise; Does your Surgeon “Warm-up” Before Surgery?

1-18-2009: Cancer and Vitamins; Teenagers, MySpace and Risky Behaviors

1-11-2009: Exercise Reverses Some Effects of Fatty Meals; Vitamin C and Blood Pressure

1-4-2009: Secondhand Smoke & Heart Attack Risk; Poor Physical Fitness During Childhood & Heart Disease Risk During Adulthood

12-28-2008: Stress & Your Risk of Heart Attack; Vitamin D & the Prevention of Colon & Rectal Polyps

12-21-2008: Breast Cancer Incidence & Hormone Replacement Therapy; Circumcision & the Risk of HPV & HIV Infection

12-14-2008: Vitamin E, Vitamin C and Selenium Do Not Prevent Cancer; Postscript: A Possible Cure for Down’s Syndrome

12-7-2008: Generic vs. Brand-Name Drugs, Stress & Breast Cancer Survival

11-30-2008:   A Possible Cure for Down’s Syndrome?; Smoking & Cognitive Decline; Calcium & Vitamin D & Breast Cancer Risk

11-23-2008:  Breast Cancer & Fish Oil; Lymphedema after Breast Cancer Treatment; Vasectomy & Prostate Cancer Risk

11-16-2008:  Vitamin E & Vitamin C: No Impact on Cardiovascular Disease Risk; Does Lack of Sleep Increase Stroke & Heart Attack Risk in Hypertensive Patients?

11-9-2008:  Statins Cut Heart Attack Risk Even with Normal Cholesterol Levels; Statins & PSA Level

11-2-2008:  Radiation Treatment of Prostate Cancer & Second Cancers; Sexual Content on TV & Teen Pregnancy Risk

10-26-2008:  Smoking & Quality of Life

10-19-2008:  Agent Orange & Prostate Cancer

10-12-2008:  Pomegranate Juice & Prostate Cancer

10-5-2008:  Central Obesity & Dementia; Diet, Vitamin D, Calcium, & Colon Cancer

9-28-2008:  Publication & Citation Bias in Favor of Industry-Funded Research?

9-21-2008:  Does Tylenol® (Acetaminophen) Cause Asthma?

9-14-208:   Arthroscopic Knee Surgery- No Better than Placebo?; A Healthy Lifestyle Prevents Stroke

8-23-2008:  Alcohol Abuse Before & After Military Deployment; Running & Age; Running & Your Testicles

8-12-2008:  Green Tea & Diabetes; Breastfeeding & Adult Cholesterol Levels; Fish Oil & Senile Macular Degeneration

8-3-2008:   Exercise & Weight Loss; Green Tea, Folic Acid & Breast Cancer Risk; Foreign Language Interpreters & ICU Patients

7-26-2008:  Viagra & Sexual Function in Women; Patient-Reported Adverse Hospital Events; Curcumin & Pancreatic Cancer

7-13-2008:  Erectile Dysfunction & Frequency of Sex; Muscle Strength & Mortality in Men; Cryoablation for Prostate Cancer

7-6-2008:  Sleep, Melatonin & Breast Cancer Risk; Mediterranean Diet & Cancer Risk; New Treatment for Varicose Veins

6-29-2008:  Bone Marrow Stem Cells & Liver Failure; Vitamin D & Colorectal Cancer Survival; Green Tea & Colorectal Cancer

6-22-2008:  Obesity, Lifestyle & Heart Disease; Effects of Lifestyle & Nutrition on Prostate Cancer; Ginkgo Biloba, Ulcerative Colitis & Colorectal Cancer

6-15-2008:  Preventable Deaths after Coronary Artery Bypass Graft (CABG) Surgery; Green Tea & Colorectal Cancer; Attention-Deficit/Hyperactivity Disorder (ADHD) & St. John’s Wort

6-8-2008:  Vitamin D & Prostate Cancer Risk; Radiofrequency Ablation (RFA) of Kidney (Renal) Cancer; Antisense Telomerase & Cancer

6-2-2008:  Acute Coronary Syndrome- Do You Know the Symptoms?; Green Tea & Lung Cancer; Episiotomy & Subsequent Deliveries- An Unkind Cut

5-25-2008:  Early Childhood Screening Predicts Later Behavioral Problems; Psychiatric Disorders Among Parents of Autistic Children; Social & Psychiatric Profiles of Young Adults Born Prematurely

5-18-2008:  Can Statins Reverse Coronary Artery Disease?; Does Breast Ultrasound Improve Breast Cancer Detection?; Preventive Care Services at Veterans Administration (VA) Medical Centers

5-11-2008:  Smoking Cessation & Risk of Death; Childhood Traumas & Adult Suicide Risk; “White Coat Hypertension” & Risk of Cardiovascular Disease

5-4-2008:  Super-Size Me: Fast Food’s Effects on Your Liver; Exercise, Weight & Coronary Artery Disease; Contamination of Surgical Instruments in the Operating Room

4-27-2008:  Stents vs. Bypass Surgery for Coronary Artery Disease; The “DASH” Hypertension Diet & Cardiovascular Disease Prevention; Testosterone Therapy for Women with Decreased Sexual Desire & Function

4-20-2008:  BRCA Breast Cancer Mutations & MRI Scans; Bladder Cancer Prevention with Broccoli?; Diabetes: Risk of Death Due to Heart Attack & Stroke

4-13-2008:  Breast Cancer Recurrence & Hormone Replacement Therapy (HRT); Carotid Artery Disease: Surgery vs. Stents?; Statin Drugs & Cancer Prevention

4-6-2008:  Human Papilloma Virus (HPV), Pap Smear Results & Cervical Cancer; Human Papilloma Virus (HPV) Infection & Oral Cancer; Hormone Replacement Therapy (HRT) & the Risk of Gastroesophageal Reflux Disorder (GERD)

3-30-2008:  Abdominal Obesity & the Risk of Death in Women; Folic Acid Pretreatment & Heart Attacks; Pancreatic Cancer Regression after Injections of Bacteria

3-23-2008:  Age of Transfused Blood & Risk of Complications after Surgery; Obesity, Blood Pressure & Heart Size in Children

3-16-2008:  Benefits of a Full Drug Coverage Plan for Medicare Patients?; Parent-Teen Conversations about Sex; Soy (Genistein) & Prostate Cancer

3-9-2008:  Flat Colorectal Adenomas & Cancer; Health Risks after Stopping Hormone Replacement Therapy (HRT); Television, Children & Obesity 

3-2-2008:  Medication & Risk of Death After Heart Attack; Hormone Replacement Therapy (HRT) & Mammogram Results; Selenium: Cancer, Heart Disease & Death

2-23-2008:  Universal Healthcare Insurance Study; Glucosamine & Arthritis

2-17-2008:  Exceptional Longevity in Men; Testosterone & Risk of Prostate Cancer; Smoking & Pre-malignant Colorectal Polyps

2-10-2008:  Thrombus Aspiration from Coronary Arteries; Intensive Management of Diabetes & Death; Possible Cure for  Down's Syndrome?

2-3-2008:  Vitamin D & Cardiovascular Health; Vitamin D & Breast Cancer; Green Tea & Colorectal Cancer

1-27-2008:  Colorectal Cancer, Esophageal Cancer & Pancreatic Cancer: Update from the 2008 American Society of Clinical Oncology's Gastrointestinal Cancers Symposium

1-20-2008:  Testosterone Levels & Risk of Fractures in Elderly Men; Air Pollution & DNA Damage in Sperm; Statins & Trauma Survival in the Elderly

1-12-2008:  Statins, Diabetes & Stroke and Obesity; GERD & Esophageal Cancer

1-7-2008:  Testosterone Supplements in Elderly Men; Colorectal Cancer-- Reasons for Poor Compliance with Screening Recommendations

12-31-2007:  Minority Women, Hormone Replacement Therapy & Breast Cancer; Does Health Insurance Improve Health?

12-23-2007:  Is Coffee Safe After a Heart Attack?; Impact of Divorce on the Environment; Hypertension & the Risk of Dementia; Emotional Vitality & the Risk of Heart Disease

12-16-2007:   Honey vs. Dextromethorphan vs. No Treatment for Kids with Night-Time Cough, Acupuncture & Hot Flashes in Women with Breast Cancer, Physical Activity & the Risk of Death, Mediterranean Diet & Mortality 

12-11-2007:  Bias in Medical Research; Carbon Nanotubes & Radiofrequency: A New Weapon Against Cancer?; Childhood Obesity & Risk of Adult Heart Disease

12-2-2007:  Obesity & Risk of Cancer; Testosterone Level & Risk of Death; Drug Company Funding of Research & Results; Smoking & the Risk of Colon & Rectal Cancer 


Email ItEmail It | Print ItPrint It | CommentsComments (0) | TrackbacksTrackbacks (0) | Flag as offensiveFlag as Offensive

Can Chronic Stress Harm Your Heart?

 

 

 

Health Report:


Can Chronic Stress Harm Your Heart?

 



"A critical weekly review of important new research findings for health-conscious readers..."

 

By, Robert A. Wascher, MD, FACS

Updated:  04/12/2009


The information in this column is intended for informational purposes only, and does not constitute medical advice or recommendations by the author.  Please consult with your physician before making any lifestyle or medication changes, or if you have any other concerns regarding your health.


 

 

CAN CHRONIC STRESS HARM YOUR HEART?

As we all know, we are currently living in troubling times. Anxiety and depression are widespread as recently unemployed people struggle to find jobs, while currently employed people are in constant fear of losing their jobs. Retirement portfolios have been devastated by the dual implosion of home values and the stock market, leaving many older Americans with inadequate financial reserves to meet their needs during what should have been their “golden years.” The pervasive impact of the still ongoing contraction of the global economy has rippled throughout all levels of the socioeconomic ladder, leaving the majority of our population feeling anxious and stressed, and uncertain about our futures.

Recently, I was asked by the editors of another health education website to comment on a reader’s question regarding the mechanisms whereby prolonged psychological and emotional stress are able to cause heart disease. It is well known that people who are under a great deal of stress are more prone to engage in behaviors that are associated with the development of cardiovascular disease. Poor dietary habits, avoidance of exercise, excessive alcohol intake, and smoking are all behaviors that chronically stressed people often engage in, and which have all been linked to an increased risk of heart disease. In addition to these indirect links between chronic stress and heart disease, there is also some experimental animal data suggesting that sustained elevations of the “stress hormones” cortisol, epinephrine (also known as adrenaline), and norepinephrine (noradrenaline) in the blood may directly impair heart function. However, there has been very little experimental data, to date, confirming that chronically elevated levels of “stress hormones” can directly lead to damage and dysfunction of the heart in humans. 

Stress cardiomyopathy (SCM) has been described as a temporary but severe decline in heart function that is associated with periods of intense psychological, emotional, or physical stress, and occurs in patients with otherwise normal heart anatomy and function. In most cases, patients with SCM go on to recover normal heart function, although permanent damage to the heart’s muscle cells has been documented in some cases of SCM. Although the precise cause, or causes, of SCM are not well understood, previous studies of patients with severe SCM have shown elevated levels of “stress hormones” in their blood. Another potential clue regarding the pathophysiology of SCM is that patients with tumors that secrete epinephrine and norepinephrine (collectively referred to as catecholamines) can sometimes present with profound heart dysfunction as well. However, there has been no direct experimental proof, thus far, that SCM is directly caused by increased levels of catecholamine hormones in the blood. Now, a newly published clinical research study, just published in the Journal of the American College of Cardiology, provides potential evidence of such a link.

A fascinating retrospective study, performed at the Johns Hopkins University, evaluated 143 patients who were diagnosed with acute SCM between 2001 and 2008. Nine of these patients were actually documented to have acutely developed SCM following the administration of the catecholamine hormones epinephrine or dopamine. Three patients developed SCM after receiving dopamine while undergoing routine cardiac stress testing as outpatients. A fourth patient, a physician, developed SCM after intravenously injecting multiple vials of epinephrine during a suicide attempt. Four patients inadvertently received small doses of epinephrine injections directly into a vein (instead of into the tissues being operated upon) during surgical procedures, while the ninth patient inappropriately received an intravenous injection of epinephrine as treatment for a fainting spell. All of these patients developed chest pain after receiving catecholamine injections, and 6 of the 9 patients developed acute heart failure with the onset of SCM.

None of these 9 patients (average age was 44 years) had any prior clinical evidence of heart disease before receiving these catecholamine injections. In each of these 9 cases of SCM, ultrasound images of the left ventricle, the primary pumping chamber of the heart, revealed extensive abnormalities in heart muscle contraction and ventricular pumping function. EKG abnormalities suggestive of acute and moderately severe cardiac stress were also found in these 9 patients with acute catecholamine-induced SCM, while blood tests for Troponin-I, a protein that is released into the blood from damaged heart muscle cells, revealed elevated levels of this heart injury marker in all 9 patients as well. Seven of these 9 patients underwent coronary artery angiograms, and none of these 7 patients had any evidence of significant coronary artery disease by angiography. Fortunately, nearly complete recovery of left ventricular pumping function was observed in these 9 patients, on average, 7 days after the onset of SCM.

While 2 of these 9 patients clearly received an overdose of intravenous epinephrine, the remaining 7 patients received standard doses of catecholamines used for routine clinical diagnostic and therapeutic purposes. Notably, although this was a very small sample size, 7 of the 9 (78 percent) patients evaluated in this study were women. Although this intriguing study did not definitively identify a specific mechanism whereby increased blood levels of catecholamine “stress” hormones cause SCM, it does nonetheless strongly suggest that certain susceptible patients may be at increased risk of developing SCM-induced heart dysfunction due to excessive blood levels of catecholamines. In 8 of these 9 patients, acute SCM was precipitated by a single injection of either epinephrine or dopamine. Although we do not yet know why these particular patients were especially susceptible to catecholamine-induced SCM, these 9 cases raise the concern that long-term elevations of catecholamine “stress” hormones, in chronically stressed people with otherwise healthy hearts, may be capable of inducing acute or sub-acute cardiac dysfunction. Moreover, experimental animal data has shown that elevated levels of catecholamines can be directly toxic to the heart’s muscle cells and, thus, chronically elevated catecholamine levels may play a role in the eventual development of congestive heart failure in susceptible individuals. Since many of us are feeling chronically stressed-out today, and the vast majority of us will not develop SCM or congestive heart failure as a result of our high levels of stress, there are probably individual patient factors that increase the risk of stress-related cardiac dysfunction. These may include gender (7 of the 9 patients in this retrospective study were women), as well as specific, individual genetic factors. Until these potential “susceptibility factors” are better characterized, however, we are unable to determine which, if any, people might be at increased risk of stress-induced SCM, or other stress-related cardiac abnormalities, at the present time. However, this clinical study suggests that there may, indeed, be a direct potential link between high levels of stress and cardiac dysfunction. 

If you feel overwhelmed by stress, anxiety or depression, please seek help through your primary physician. At the same time, although it can be very difficult during times when you already feel overwhelmed, you should abstain from heart un-healthy behaviors, and also try to work some exercise into your schedule. As I have reported upon previously in this column, multiple studies have also revealed a link between getting less than 7 hours of sleep per night with an increased mortality rate. Hopefully, these hard times will pass soon, and our collective stress levels will soon begin to fall.



Disclaimer:  As always, my advice to readers is to seek the advice of your physician before making any significant changes in medications, diet, or level of physical activity


Dr. Wascher is an oncologic surgeon, a professor of surgery, a widely published author, and a Surgical Oncologist at the Kaiser Permanente healthcare system in Orange County, California



Send your feedback to Dr. Wascher at:
 rwascher@doctorwascher.net


 Dr. Wascher's Biography


Links to Other Health & Wellness Sites


http://doctorwascher.com


 

Copyright 2009

  

Robert A. Wascher, MD, FACS

  

All rights reserved


Dr. Wascher's Archives:

4-5-2009: Does PSA Testing for Prostate Cancer Save Lives?

3-22-2009: CABG Surgery vs. PCI in Diabetics with Coronary Artery Disease; Sweetened Beverages and Coronary Artery Disease

3-15-2009: Depression, Stress, Anger & Heart Disease

3-8-2009: Coronary Artery Disease: CABG vs. Stents?; Swimming Lessons & Drowning Risk in Children

3-1-2009: Aspirin & Colorectal Cancer Prevention; Fish Oil & Respiratory Infections in Children

2-22-2009: Health Differences Between Americans & Europeans; Lycopene & Prostate Cancer

2-15-2009: Statin Drugs & Death Rates; Physical Activity, Breast Cancer & Sex Hormones

2-8-2009: Hormone Replacement Therapy (HRT) & Breast Cancer; Stool DNA Testing & Cancer of the Colon & Rectum

2-1-2009:   Obesity and the Complications of Diverticulosis (Diverticulitis & Bleeding); Obesity, Weight Loss & Urinary Incontinence

1-25-2009: Prostate Cancer, Fatigue & Exercise; Does your Surgeon “Warm-up” Before Surgery?

1-18-2009: Cancer and Vitamins; Teenagers, MySpace and Risky Behaviors

1-11-2009: Exercise Reverses Some Effects of Fatty Meals; Vitamin C and Blood Pressure

1-4-2009: Secondhand Smoke & Heart Attack Risk; Poor Physical Fitness During Childhood & Heart Disease Risk During Adulthood

12-28-2008: Stress & Your Risk of Heart Attack; Vitamin D & the Prevention of Colon & Rectal Polyps

12-21-2008: Breast Cancer Incidence & Hormone Replacement Therapy; Circumcision & the Risk of HPV & HIV Infection

12-14-2008: Vitamin E, Vitamin C and Selenium Do Not Prevent Cancer; Postscript: A Possible Cure for Down’s Syndrome

12-7-2008: Generic vs. Brand-Name Drugs, Stress & Breast Cancer Survival

11-30-2008:   A Possible Cure for Down’s Syndrome?; Smoking & Cognitive Decline; Calcium & Vitamin D & Breast Cancer Risk

11-23-2008:  Breast Cancer & Fish Oil; Lymphedema after Breast Cancer Treatment; Vasectomy & Prostate Cancer Risk

11-16-2008:  Vitamin E & Vitamin C: No Impact on Cardiovascular Disease Risk; Does Lack of Sleep Increase Stroke & Heart Attack Risk in Hypertensive Patients?

11-9-2008:  Statins Cut Heart Attack Risk Even with Normal Cholesterol Levels; Statins & PSA Level

11-2-2008:  Radiation Treatment of Prostate Cancer & Second Cancers; Sexual Content on TV & Teen Pregnancy Risk

10-26-2008:  Smoking & Quality of Life

10-19-2008:  Agent Orange & Prostate Cancer

10-12-2008:  Pomegranate Juice & Prostate Cancer

10-5-2008:  Central Obesity & Dementia; Diet, Vitamin D, Calcium, & Colon Cancer

9-28-2008:  Publication & Citation Bias in Favor of Industry-Funded Research?

9-21-2008:  Does Tylenol® (Acetaminophen) Cause Asthma?

9-14-208:   Arthroscopic Knee Surgery- No Better than Placebo?; A Healthy Lifestyle Prevents Stroke

8-23-2008:  Alcohol Abuse Before & After Military Deployment; Running & Age; Running & Your Testicles

8-12-2008:  Green Tea & Diabetes; Breastfeeding & Adult Cholesterol Levels; Fish Oil & Senile Macular Degeneration

8-3-2008:   Exercise & Weight Loss; Green Tea, Folic Acid & Breast Cancer Risk; Foreign Language Interpreters & ICU Patients

7-26-2008:  Viagra & Sexual Function in Women; Patient-Reported Adverse Hospital Events; Curcumin & Pancreatic Cancer

7-13-2008:  Erectile Dysfunction & Frequency of Sex; Muscle Strength & Mortality in Men; Cryoablation for Prostate Cancer

7-6-2008:  Sleep, Melatonin & Breast Cancer Risk; Mediterranean Diet & Cancer Risk; New Treatment for Varicose Veins

6-29-2008:  Bone Marrow Stem Cells & Liver Failure; Vitamin D & Colorectal Cancer Survival; Green Tea & Colorectal Cancer

6-22-2008:  Obesity, Lifestyle & Heart Disease; Effects of Lifestyle & Nutrition on Prostate Cancer; Ginkgo Biloba, Ulcerative Colitis & Colorectal Cancer

6-15-2008:  Preventable Deaths after Coronary Artery Bypass Graft (CABG) Surgery; Green Tea & Colorectal Cancer; Attention-Deficit/Hyperactivity Disorder (ADHD) & St. John’s Wort

6-8-2008:  Vitamin D & Prostate Cancer Risk; Radiofrequency Ablation (RFA) of Kidney (Renal) Cancer; Antisense Telomerase & Cancer

6-2-2008:  Acute Coronary Syndrome- Do You Know the Symptoms?; Green Tea & Lung Cancer; Episiotomy & Subsequent Deliveries- An Unkind Cut

5-25-2008:  Early Childhood Screening Predicts Later Behavioral Problems; Psychiatric Disorders Among Parents of Autistic Children; Social & Psychiatric Profiles of Young Adults Born Prematurely

5-18-2008:  Can Statins Reverse Coronary Artery Disease?; Does Breast Ultrasound Improve Breast Cancer Detection?; Preventive Care Services at Veterans Administration (VA) Medical Centers

5-11-2008:  Smoking Cessation & Risk of Death; Childhood Traumas & Adult Suicide Risk; “White Coat Hypertension” & Risk of Cardiovascular Disease

5-4-2008:  Super-Size Me: Fast Food’s Effects on Your Liver; Exercise, Weight & Coronary Artery Disease; Contamination of Surgical Instruments in the Operating Room

4-27-2008:  Stents vs. Bypass Surgery for Coronary Artery Disease; The “DASH” Hypertension Diet & Cardiovascular Disease Prevention; Testosterone Therapy for Women with Decreased Sexual Desire & Function

4-20-2008:  BRCA Breast Cancer Mutations & MRI Scans; Bladder Cancer Prevention with Broccoli?; Diabetes: Risk of Death Due to Heart Attack & Stroke

4-13-2008:  Breast Cancer Recurrence & Hormone Replacement Therapy (HRT); Carotid Artery Disease: Surgery vs. Stents?; Statin Drugs & Cancer Prevention

4-6-2008:  Human Papilloma Virus (HPV), Pap Smear Results & Cervical Cancer; Human Papilloma Virus (HPV) Infection & Oral Cancer; Hormone Replacement Therapy (HRT) & the Risk of Gastroesophageal Reflux Disorder (GERD)

3-30-2008:  Abdominal Obesity & the Risk of Death in Women; Folic Acid Pretreatment & Heart Attacks; Pancreatic Cancer Regression after Injections of Bacteria

3-23-2008:  Age of Transfused Blood & Risk of Complications after Surgery; Obesity, Blood Pressure & Heart Size in Children

3-16-2008:  Benefits of a Full Drug Coverage Plan for Medicare Patients?; Parent-Teen Conversations about Sex; Soy (Genistein) & Prostate Cancer

3-9-2008:  Flat Colorectal Adenomas & Cancer; Health Risks after Stopping Hormone Replacement Therapy (HRT); Television, Children & Obesity 

3-2-2008:  Medication & Risk of Death After Heart Attack; Hormone Replacement Therapy (HRT) & Mammogram Results; Selenium: Cancer, Heart Disease & Death

2-23-2008:  Universal Healthcare Insurance Study; Glucosamine & Arthritis

2-17-2008:  Exceptional Longevity in Men; Testosterone & Risk of Prostate Cancer; Smoking & Pre-malignant Colorectal Polyps

2-10-2008:  Thrombus Aspiration from Coronary Arteries; Intensive Management of Diabetes & Death; Possible Cure for  Down's Syndrome?

2-3-2008:  Vitamin D & Cardiovascular Health; Vitamin D & Breast Cancer; Green Tea & Colorectal Cancer

1-27-2008:  Colorectal Cancer, Esophageal Cancer & Pancreatic Cancer: Update from the 2008 American Society of Clinical Oncology's Gastrointestinal Cancers Symposium

1-20-2008:  Testosterone Levels & Risk of Fractures in Elderly Men; Air Pollution & DNA Damage in Sperm; Statins & Trauma Survival in the Elderly

1-12-2008:  Statins, Diabetes & Stroke and Obesity; GERD & Esophageal Cancer

1-7-2008:  Testosterone Supplements in Elderly Men; Colorectal Cancer-- Reasons for Poor Compliance with Screening Recommendations

12-31-2007:  Minority Women, Hormone Replacement Therapy & Breast Cancer; Does Health Insurance Improve Health?

12-23-2007:  Is Coffee Safe After a Heart Attack?; Impact of Divorce on the Environment; Hypertension & the Risk of Dementia; Emotional Vitality & the Risk of Heart Disease

12-16-2007:   Honey vs. Dextromethorphan vs. No Treatment for Kids with Night-Time Cough, Acupuncture & Hot Flashes in Women with Breast Cancer, Physical Activity & the Risk of Death, Mediterranean Diet & Mortality 

12-11-2007:  Bias in Medical Research; Carbon Nanotubes & Radiofrequency: A New Weapon Against Cancer?; Childhood Obesity & Risk of Adult Heart Disease

12-2-2007:  Obesity & Risk of Cancer; Testosterone Level & Risk of Death; Drug Company Funding of Research & Results; Smoking & the Risk of Colon & Rectal Cancer 


Dr. Wascher's Home Page


Email ItEmail It | Print ItPrint It | CommentsComments (0) | TrackbacksTrackbacks (0) | Flag as offensiveFlag as Offensive

Does PSA Testing for Prostate Cancer Save Lives?

 

 

Health Report:


Does PSA Testing for Prostate Cancer Save Lives?

 



"A critical weekly review of important new research findings for health-conscious readers..."

 

By, Robert A. Wascher, MD, FACS

Updated:  04/05/2009


The information in this column is intended for informational purposes only, and does not constitute medical advice or recommendations by the author.  Please consult with your physician before making any lifestyle or medication changes, or if you have any other concerns regarding your health.


 

 

DOES PSA TESTING FOR PROSTATE CANCER SAVE LIVES?

Prostate cancer is the most commonly diagnosed non-skin cancer in men. Approximately 190,000 new cases of prostate cancer are diagnosed each year in the United States, and nearly 30,000 American men die of this form of cancer each year, making prostate cancer the second most common cause of cancer death in men (lung cancer, a nearly completely preventable form of cancer, remains the most common cause of cancer death in both men and women). Therefore, according to the American Cancer Society, approximately 1 in every 6 American men will be diagnosed with prostate cancer at some point in their lifetimes, while 1 out of every 35 men will die of this disease. 

The death rate due to prostate cancer began to decline in the early 1990s, at about the same time that prostate-specific antigen (PSA) testing became common in the United States. While, few experts dispute that using the PSA test to screen for prostate cancer has dramatically improved our ability to diagnose prostate cancer at a much earlier stage, there continues to be a great deal of debate about whether or not the widespread use of PSA testing has actually played a direct role in reducing the death rate due to prostate cancer. The clinical research data linking routine PSA testing with prostate cancer death rates has, to date, been contradictory, with some studies suggesting that routine PSA testing reduces the risk of dying of prostate cancer, while other studies have found no such relationship between PSA testing and prostate cancer death risk. Even among internationally renowned prostate cancer experts, there continues to be a great deal of disagreement regarding the potential benefits, if any, of routine PSA testing as a screening tool to detect prostate cancer. 

Much of the controversy regarding the potential value of PSA testing is, undoubtedly, related to the somewhat unique biology of prostate cancer when compared to other types of cancer. Most types of cancer, if left untreated, will continue to rapidly grow and spread, eventually leading to the death of their hosts. In many cases, however, prostate cancer remains a slow-growing disease that, in many men, causes few if any symptoms, and does not lead to death. Therefore, while many men with potentially aggressive prostate cancers are likely to owe their lives to a PSA test that diagnosed their cancer while still confined to the prostate gland, many other men with slow-growing and non-life-threatening prostate cancers will undergo unnecessary and aggressive prostate cancer treatments because their cancers were, likewise, detected by a PSA test. Since most approved treatments for prostate cancer are associated with a significant risk of complications, many prostate cancer experts worry that too many men are undergoing essentially unnecessary treatment for indolent prostate cancers that might never have been otherwise been detected (and, hence, treated) without a PSA blood test. This concern regarding the potential “overtreatment” of prostate cancer is the primary reason why some experts have advocated against routine PSA testing as a prostate cancer screening tool.

Two new randomized, prospective clinical trials, recently published in the New England Journal of Medicine, are likely to only add fuel to the ongoing debate regarding the routine use of PSA testing to screen for prostate cancer in otherwise healthy men:

The first clinical trial was performed in the United States, between 1993 and 2001. This Prostate, Lung, Colorectal, and Ovarian (PLCO) Screening Trial enrolled nearly 77,000 men, and divided them into two roughly equal groups. The first group was offered annual screening with PSA testing for a period of 6 years and digital rectal exams for 4 years. Among the men in this “screened group,” 85 percent underwent PSA testing and 86 percent underwent digital rectal examinations. The second group was not offered PSA testing or digital rectal examinations, although, as some critics of this study have pointed out, more than half of the men in the second group still actually received PSA testing from their personal physicians by the end of the study, and nearly half of the men in this “unscreened group” also reported receiving digital rectal examinations during the clinical study period, as well. After an average of 7 years of follow-up, 2,820 men in the “screened group” were diagnosed with prostate cancer, while 2,322 new cases of prostate cancer were diagnosed among the “unscreened group” of men. Although there was a 22 percent increase noted in the incidence of prostate cancer among the “screened group” of men when compared with those in the “unscreened group” (at an average of 10 years of follow-up), the death rate among the two groups of men with prostate cancer was essentially the same. Therefore, the authors of this study concluded that, while more cases of prostate cancer were detected among the group of men who underwent routine annual PSA testing and digital rectal examination (when compared to men who were not as rigorously screened), there was essentially no difference in the death rate between men who were rigorously screened and those who were not, after 10 years of observation.

The second prospective clinical study was performed in Europe, and evaluated more than 162,000 men (between the ages of 55 and 69 years) from 7 European countries. As with the previous study, the men participating in this study were randomly divided into two groups. The first group underwent PSA testing approximately every 4 years, while the men in the second group did not undergo PSA testing. This very large cohort of men was followed for an average of 9 years, during which 8.2 percent of the men in the PSA-screened group were diagnosed with prostate cancer and 4.8 percent of the men in the unscreened-group were diagnosed with prostate cancer. Unlike the American study (above), this very large European study found a small but significant improvement in survival among men who were routinely screened with PSA testing, with an observed 20 percent reduction in the risk of death due to prostate cancer among the men who had undergone routine PSA testing when compared to the men who were not tested. At the same time, the absolute difference in the risk of dying of prostate cancer between the two groups of men was quite small (0.71 deaths per 1,000 men), which translates into the need to screen 1,410 men, and to invasively treat 48 men with prostate cancer, before one death from prostate cancer could be prevented. Therefore, the results of this very large prospective, randomized clinical research trial appeared to confirm the concerns of those experts who believe that while routine PSA testing may save some lives, it also subjects many more men to unnecessary treatments that expose these men to all of the risks of such treatment, but without any potential benefit in terms of their prostate cancer.

While these two prospective clinical research trials provide additional ammunition to various camps of experts, the relatively short duration of follow-up included in both studies, in my mind, calls into question the finality of their conclusions. This is because most cases of prostate cancer are relatively slow-growing, and even patients with metastatic prostate cancer can live for many years while receiving hormonal therapy and other treatments. Therefore, it may actually be too early for either of these two studies to draw the respective conclusions that they have published. Indeed, because the death rate from prostate cancer is typically very low during the first 10 years following diagnosis, some experts have already offered a “middle-ground” recommendation for routine PSA testing, suggesting that men who are not likely to live more than 10 years, due to other ailments, should not undergo routine PSA testing. Along the same lines, many experts recommend that men over the age of 75 also not undergo routine PSA testing, as they are unlikely to actually die of prostate cancer if they should develop the disease at this stage of their lives. 

So, although the recent publication of these two very important prostate cancer screening trials has generated a great deal of discussion in both the lay and medical communities, they have not, in fact, appreciably altered the debate regarding the routine use of PSA testing as a screening tool for prostate cancer. Fundamentally, this debate will continue to rage on until we are able to accurately identify which cases of prostate cancer actually need to be treated, and which cases can be safely observed. At the present time, we simply cannot reliably determine which patients should undergo invasive treatments for prostate cancer and which patients can safely be offered only “watchful waiting,” and this is really the crux of the dilemma surrounding the issue of routine PSA testing, in my view. That leaves men (and their physicians) to make their decisions regarding routine PSA testing against a backdrop of confusing and contradictory research data, unfortunately. Therefore, at the present time, if you are 50 years old or older (or if you are 40 years old, or older, and you are an African-American man or you have a family history of prostate cancer), you should discuss the issue of PSA testing with your primary physician or your urologist before choosing to have a PSA blood test performed. 



Disclaimer:  As always, my advice to readers is to seek the advice of your physician before making any significant changes in medications, diet, or level of physical activity


 

Dr. Wascher is an oncologic surgeon, a professor of surgery, a widely published author, and a Surgical Oncologist at the Kaiser Permanente healthcare system in Orange County, California



Send your feedback to Dr. Wascher at:
 rwascher@doctorwascher.net


 

Dr. Wascher's Biography


Links to Other Health & Wellness Sites


http://doctorwascher.com


 

Copyright 2009

  

Robert A. Wascher, MD, FACS

  

All rights reserved


Dr. Wascher's Archives:

3-22-2009: CABG Surgery vs. PCI in Diabetics with Coronary Artery Disease; Sweetened Beverages and Coronary Artery Disease

3-15-2009: Depression, Stress, Anger & Heart Disease

3-8-2009: Coronary Artery Disease: CABG vs. Stents?; Swimming Lessons & Drowning Risk in Children

3-1-2009: Aspirin & Colorectal Cancer Prevention; Fish Oil & Respiratory Infections in Children

2-22-2009: Health Differences Between Americans & Europeans; Lycopene & Prostate Cancer

2-15-2009: Statin Drugs & Death Rates; Physical Activity, Breast Cancer & Sex Hormones

2-8-2009: Hormone Replacement Therapy (HRT) & Breast Cancer; Stool DNA Testing & Cancer of the Colon & Rectum

2-1-2009:   Obesity and the Complications of Diverticulosis (Diverticulitis & Bleeding); Obesity, Weight Loss & Urinary Incontinence

1-25-2009: Prostate Cancer, Fatigue & Exercise; Does your Surgeon “Warm-up” Before Surgery?

1-18-2009: Cancer and Vitamins; Teenagers, MySpace and Risky Behaviors

1-11-2009: Exercise Reverses Some Effects of Fatty Meals; Vitamin C and Blood Pressure

1-4-2009: Secondhand Smoke & Heart Attack Risk; Poor Physical Fitness During Childhood & Heart Disease Risk During Adulthood

12-28-2008: Stress & Your Risk of Heart Attack; Vitamin D & the Prevention of Colon & Rectal Polyps

12-21-2008: Breast Cancer Incidence & Hormone Replacement Therapy; Circumcision & the Risk of HPV & HIV Infection

12-14-2008: Vitamin E, Vitamin C and Selenium Do Not Prevent Cancer; Postscript: A Possible Cure for Down’s Syndrome

12-7-2008: Generic vs. Brand-Name Drugs, Stress & Breast Cancer Survival

11-30-2008:   A Possible Cure for Down’s Syndrome?; Smoking & Cognitive Decline; Calcium & Vitamin D & Breast Cancer Risk

11-23-2008:  Breast Cancer & Fish Oil; Lymphedema after Breast Cancer Treatment; Vasectomy & Prostate Cancer Risk

11-16-2008:  Vitamin E & Vitamin C: No Impact on Cardiovascular Disease Risk; Does Lack of Sleep Increase Stroke & Heart Attack Risk in Hypertensive Patients?

11-9-2008:  Statins Cut Heart Attack Risk Even with Normal Cholesterol Levels; Statins & PSA Level

11-2-2008:  Radiation Treatment of Prostate Cancer & Second Cancers; Sexual Content on TV & Teen Pregnancy Risk

10-26-2008:  Smoking & Quality of Life

10-19-2008:  Agent Orange & Prostate Cancer

10-12-2008:  Pomegranate Juice & Prostate Cancer

10-5-2008:  Central Obesity & Dementia; Diet, Vitamin D, Calcium, & Colon Cancer

9-28-2008:  Publication & Citation Bias in Favor of Industry-Funded Research?

9-21-2008:  Does Tylenol® (Acetaminophen) Cause Asthma?

9-14-208:   Arthroscopic Knee Surgery- No Better than Placebo?; A Healthy Lifestyle Prevents Stroke

8-23-2008:  Alcohol Abuse Before & After Military Deployment; Running & Age; Running & Your Testicles

8-12-2008:  Green Tea & Diabetes; Breastfeeding & Adult Cholesterol Levels; Fish Oil & Senile Macular Degeneration

8-3-2008:   Exercise & Weight Loss; Green Tea, Folic Acid & Breast Cancer Risk; Foreign Language Interpreters & ICU Patients

7-26-2008:  Viagra & Sexual Function in Women; Patient-Reported Adverse Hospital Events; Curcumin & Pancreatic Cancer

7-13-2008:  Erectile Dysfunction & Frequency of Sex; Muscle Strength & Mortality in Men; Cryoablation for Prostate Cancer

7-6-2008:  Sleep, Melatonin & Breast Cancer Risk; Mediterranean Diet & Cancer Risk; New Treatment for Varicose Veins

6-29-2008:  Bone Marrow Stem Cells & Liver Failure; Vitamin D & Colorectal Cancer Survival; Green Tea & Colorectal Cancer

6-22-2008:  Obesity, Lifestyle & Heart Disease; Effects of Lifestyle & Nutrition on Prostate Cancer; Ginkgo Biloba, Ulcerative Colitis & Colorectal Cancer

6-15-2008:  Preventable Deaths after Coronary Artery Bypass Graft (CABG) Surgery; Green Tea & Colorectal Cancer; Attention-Deficit/Hyperactivity Disorder (ADHD) & St. John’s Wort

6-8-2008:  Vitamin D & Prostate Cancer Risk; Radiofrequency Ablation (RFA) of Kidney (Renal) Cancer; Antisense Telomerase & Cancer

6-2-2008:  Acute Coronary Syndrome- Do You Know the Symptoms?; Green Tea & Lung Cancer; Episiotomy & Subsequent Deliveries- An Unkind Cut

5-25-2008:  Early Childhood Screening Predicts Later Behavioral Problems; Psychiatric Disorders Among Parents of Autistic Children; Social & Psychiatric Profiles of Young Adults Born Prematurely

5-18-2008:  Can Statins Reverse Coronary Artery Disease?; Does Breast Ultrasound Improve Breast Cancer Detection?; Preventive Care Services at Veterans Administration (VA) Medical Centers

5-11-2008:  Smoking Cessation & Risk of Death; Childhood Traumas & Adult Suicide Risk; “White Coat Hypertension” & Risk of Cardiovascular Disease

5-4-2008:  Super-Size Me: Fast Food’s Effects on Your Liver; Exercise, Weight & Coronary Artery Disease; Contamination of Surgical Instruments in the Operating Room

4-27-2008:  Stents vs. Bypass Surgery for Coronary Artery Disease; The “DASH” Hypertension Diet & Cardiovascular Disease Prevention; Testosterone Therapy for Women with Decreased Sexual Desire & Function

4-20-2008:  BRCA Breast Cancer Mutations & MRI Scans; Bladder Cancer Prevention with Broccoli?; Diabetes: Risk of Death Due to Heart Attack & Stroke

4-13-2008:  Breast Cancer Recurrence & Hormone Replacement Therapy (HRT); Carotid Artery Disease: Surgery vs. Stents?; Statin Drugs & Cancer Prevention

4-6-2008:  Human Papilloma Virus (HPV), Pap Smear Results & Cervical Cancer; Human Papilloma Virus (HPV) Infection & Oral Cancer; Hormone Replacement Therapy (HRT) & the Risk of Gastroesophageal Reflux Disorder (GERD)

3-30-2008:  Abdominal Obesity & the Risk of Death in Women; Folic Acid Pretreatment & Heart Attacks; Pancreatic Cancer Regression after Injections of Bacteria

3-23-2008:  Age of Transfused Blood & Risk of Complications after Surgery; Obesity, Blood Pressure & Heart Size in Children

3-16-2008:  Benefits of a Full Drug Coverage Plan for Medicare Patients?; Parent-Teen Conversations about Sex; Soy (Genistein) & Prostate Cancer

3-9-2008:  Flat Colorectal Adenomas & Cancer; Health Risks after Stopping Hormone Replacement Therapy (HRT); Television, Children & Obesity 

3-2-2008:  Medication & Risk of Death After Heart Attack; Hormone Replacement Therapy (HRT) & Mammogram Results; Selenium: Cancer, Heart Disease & Death

2-23-2008:  Universal Healthcare Insurance Study; Glucosamine & Arthritis

2-17-2008:  Exceptional Longevity in Men; Testosterone & Risk of Prostate Cancer; Smoking & Pre-malignant Colorectal Polyps

2-10-2008:  Thrombus Aspiration from Coronary Arteries; Intensive Management of Diabetes & Death; Possible Cure for  Down's Syndrome?

2-3-2008:  Vitamin D & Cardiovascular Health; Vitamin D & Breast Cancer; Green Tea & Colorectal Cancer

1-27-2008:  Colorectal Cancer, Esophageal Cancer & Pancreatic Cancer: Update from the 2008 American Society of Clinical Oncology's Gastrointestinal Cancers Symposium

1-20-2008:  Testosterone Levels & Risk of Fractures in Elderly Men; Air Pollution & DNA Damage in Sperm; Statins & Trauma Survival in the Elderly

1-12-2008:  Statins, Diabetes & Stroke and Obesity; GERD & Esophageal Cancer

1-7-2008:  Testosterone Supplements in Elderly Men; Colorectal Cancer-- Reasons for Poor Compliance with Screening Recommendations

12-31-2007:  Minority Women, Hormone Replacement Therapy & Breast Cancer; Does Health Insurance Improve Health?

12-23-2007:  Is Coffee Safe After a Heart Attack?; Impact of Divorce on the Environment; Hypertension & the Risk of Dementia; Emotional Vitality & the Risk of Heart Disease

12-16-2007:   Honey vs. Dextromethorphan vs. No Treatment for Kids with Night-Time Cough, Acupuncture & Hot Flashes in Women with Breast Cancer, Physical Activity & the Risk of Death, Mediterranean Diet & Mortality 

12-11-2007:  Bias in Medical Research; Carbon Nanotubes & Radiofrequency: A New Weapon Against Cancer?; Childhood Obesity & Risk of Adult Heart Disease

12-2-2007:  Obesity & Risk of Cancer; Testosterone Level & Risk of Death; Drug Company Funding of Research & Results; Smoking & the Risk of Colon & Rectal Cancer 


Dr. Wascher's Home Page


Email ItEmail It | Print ItPrint It | CommentsComments (0) | TrackbacksTrackbacks (0) | Flag as offensiveFlag as Offensive

CABG Surgery vs. PCI in Diabetics with Coronary Artery Disease; Sweetened Beverages and Coronary Artery Disease

 

 

 Health Report:


CABG Surgery vs. PCI in Diabetics with Coronary Artery Disease

 

Sweetened Beverages and Coronary Artery Disease

 



"A critical weekly review of important new research findings for health-conscious readers..."

 

By, Robert A. Wascher, MD, FACS

Updated:  03/22/2009


The information in this column is intended for informational purposes only, and does not constitute medical advice or recommendations by the author.  Please consult with your physician before making any lifestyle or medication changes, or if you have any other concerns regarding your health.


 

CABG SURGERY vs. PCI IN DIABETICS WITH CORONARY ARTERY DISEASE

Two weeks ago, I reported on a prospective randomized clinical trial that compared coronary artery bypass surgery (CABG) with coronary artery angioplasty and stent placement (percutaneous coronary intervention, or PCI). I noted that, based upon the early results of this clinical study, the jury may still be out regarding which of these two treatment approaches to coronary artery narrowing (stenosis) offers the best risk-to-benefit equation for most patients. Now, a new report, just published in The Lancet, has analyzed the results of 10 different prospective randomized clinical research trials comparing CABG with PCI in the treatment of coronary artery disease affecting multiple coronary arteries. 

Altogether, the 10 clinical trials evaluated in this report included 7,812 patient volunteers. After an average of 6 years of clinical follow-up, 575 of the 3,889 (15 percent) patients who underwent CABG died, while 628 of the 3,923 (16 percent) patients who underwent PCI died. Therefore, overall, there was no difference in survival between the two treatment groups within 6 years of coronary artery intervention. However, when the researchers analyzed certain groups of patients undergoing coronary artery interventions, they discovered that diabetic patients appeared to do much better following CABG, rather than PCI. Among the patients with diabetes, survival at 6 years after treatment was 30 percent greater among those diabetic patients who underwent CABG when compared to the diabetic patients who underwent PCI. Similarly, patients over the age of 65 also appeared to do better with CABG. Among patients over the age of 65, survival at 6 years was 18 percent better in the CABG group when compared to the PCI group. For all other patients, however, there was no statistically significant difference in survival at 6 years between those patients who underwent PCI and those who underwent the far more invasive CABG surgery. 

Approximately 1.5 million coronary artery interventions (CABG and PCI) are performed in the United States each year, and an estimated 25 percent of these patients have diabetes. So, a significant number of patients undergoing CABG and PCI also have diabetes. The results of this analysis are in keeping with the findings of previous studies showing that the coronary arteries of diabetic patients are more likely than those of non-diabetic patients to narrow again following PCI using balloon angioplasty, with or without the insertion of bare metal stents. However, recent advances in the development of drug-eluting stents and newer anti-clotting drugs have shown considerable promise in diabetic patients undergoing PCI with stent placement (among the 10 clinical studies included in this analysis, all patients receiving PCI underwent balloon angioplasty with or without bare metal stent placement, and no drug-eluting stents were utilized). Fortunately, there are several ongoing prospective randomized clinical research trials that will, hopefully, shed more light on the coronary artery restenosis rate in diabetic patients using the newer drug-eluting stents and glycoprotein IIb/IIIa inhibiting drugs. Unfortunately, we will have to await the publication of the findings of these ongoing clinical trials before PCI can truly be declared equal to CABG in diabetic patients. Therefore, at the present time, patients with diabetes, and especially diabetic patients with more advanced multi-vessel coronary artery disease (as well as diabetic patients with abnormal function of the primary pumping chamber of the heart, the left ventricle) are more likely to be advised to undergo CABG instead of PCI; although an increasing number of favorable-risk diabetic patients with complicated coronary artery disease are now being offered PCI with the newer drug-eluting stents and anti-clotting drugs. 

As I concluded 2 weeks ago, the ongoing improvements in minimally-invasive PCI have definitely narrowed the gap in clinical outcomes between PCI and CABG over the past 10 to 15 years, and it is no longer clear that CABG (which is much more invasive than PCI, and more likely to cause stroke than PCI) offers any significant survival benefit over PCI, although CABG does appear to still provide a longer duration of improvement in blood flow to the heart than PCI (however, PCI can often be repeated, when necessary), and CABG may still be more appropriate for patients with more advanced cases of multi-vessel coronary artery disease. 

Stay tuned, as I will continue to track the results of this very important area of clinical research, and I will keep readers updated as the ongoing “CABG vs. PCI” clinical research trials begin to report their results.

 

 

SWEETENED BEVERAGES AND CORONARY ARTERY DISEASE

We all know that we are in the midst of an epidemic of obesity in this country. Not only are adults heavier than ever before, but the incidence of overweight and obesity among our children has skyrocketed, and with this rising incidence of childhood and adolescent obesity, the incidence of other obesity-related diseases has also increased. 

Multiple prior studies have linked the regular consumption of sweetened sodas and juices with excessive weight gain in both children and adults, and with a rising incidence of diabetes among both the young and old.  Now, a new Harvard University clinical study of female nurses, just published in the American Journal of Clinical Nutrition, suggests that the regular consumption of sugary beverages may also significantly increase the risk of coronary artery disease as well.

In this prospective clinical study, nearly 90,000 women (ages 34 to 59) participating in the enormous Nurses’ Health Study were followed from 1980 through 2004. None of these women had any clinical signs or history of heart disease, stroke, or diabetes when they entered into this clinical research study. All of these women completed repeated and detailed dietary surveys during the 24-year follow-up period in this study. 

Among these 88,520 female nurses, 3,105 developed coronary artery disease during the 24-year follow-up period. When the researchers analyzed intake levels of sugary drinks, they discovered that the increasing consumption of sweetened beverages was associated with an increased risk of coronary artery disease. When compared to women who consumed less than one sugary drink per month, consuming one sugary drink per day increased the relative risk of coronary artery disease by 23 percent, while the consumption of 2 or more sugary drinks per day increased the relative risk of developing coronary artery disease by 35 percent. When the researchers then accounted for differences in body weight, overall dietary caloric intake, and the presence or absence of diabetes among these women volunteers, the risk of coronary artery disease associated with the consumption of sweetened beverages was diminished somewhat, but still remained significant. At the same time, artificially sweetened beverages were not associated, at all, with coronary artery disease risk.

In summary, this enormous and ongoing clinical research trial, with nearly 90,000 women participating, found that, over a 24-year observation period, increasing levels of sugary drink consumption were associated with increasing levels of risk for coronary artery disease. At the same time, beverages that were sweetened with non-caloric artificial sweeteners appeared to carry no associated risk of coronary artery disease. So, next time you reach for a bottle of sugar- or fructose-sweetened juice or soda pop, give it another thought before you pop the top!



Disclaimer:  As always, my advice to readers is to seek the advice of your physician before making any significant changes in medications, diet, or level of physical activity


 

Dr. Wascher is an oncologic surgeon, a professor of surgery, a widely published author, and a Surgical Oncologist at the Kaiser Permanente healthcare system in Orange County, California



Send your feedback to Dr. Wascher at:
 rwascher@doctorwascher.net


 

Dr. Wascher's Biography


Links to Other Health & Wellness Sites


http://doctorwascher.com


 

Copyright 2009

  

Robert A. Wascher, MD, FACS

  

All rights reserved


Dr. Wascher's Archives:

3-15-2009: Depression, Stress, Anger & Heart Disease

3-8-2009: Coronary Artery Disease: CABG vs. Stents?; Swimming Lessons & Drowning Risk in Children

3-1-2009: Aspirin & Colorectal Cancer Prevention; Fish Oil & Respiratory Infections in Children

2-22-2009: Health Differences Between Americans & Europeans; Lycopene & Prostate Cancer

2-15-2009: Statin Drugs & Death Rates; Physical Activity, Breast Cancer & Sex Hormones

2-8-2009: Hormone Replacement Therapy (HRT) & Breast Cancer; Stool DNA Testing & Cancer of the Colon & Rectum

2-1-2009:   Obesity and the Complications of Diverticulosis (Diverticulitis & Bleeding); Obesity, Weight Loss & Urinary Incontinence

1-25-2009: Prostate Cancer, Fatigue & Exercise; Does your Surgeon “Warm-up” Before Surgery?

1-18-2009: Cancer and Vitamins; Teenagers, MySpace and Risky Behaviors

1-11-2009: Exercise Reverses Some Effects of Fatty Meals; Vitamin C and Blood Pressure

1-4-2009: Secondhand Smoke & Heart Attack Risk; Poor Physical Fitness During Childhood & Heart Disease Risk During Adulthood

12-28-2008: Stress & Your Risk of Heart Attack; Vitamin D & the Prevention of Colon & Rectal Polyps

12-21-2008: Breast Cancer Incidence & Hormone Replacement Therapy; Circumcision & the Risk of HPV & HIV Infection

12-14-2008: Vitamin E, Vitamin C and Selenium Do Not Prevent Cancer; Postscript: A Possible Cure for Down’s Syndrome

12-7-2008: Generic vs. Brand-Name Drugs, Stress & Breast Cancer Survival

11-30-2008:   A Possible Cure for Down’s Syndrome?; Smoking & Cognitive Decline; Calcium & Vitamin D & Breast Cancer Risk

11-23-2008:  Breast Cancer & Fish Oil; Lymphedema after Breast Cancer Treatment; Vasectomy & Prostate Cancer Risk

11-16-2008:  Vitamin E & Vitamin C: No Impact on Cardiovascular Disease Risk; Does Lack of Sleep Increase Stroke & Heart Attack Risk in Hypertensive Patients?

11-9-2008:  Statins Cut Heart Attack Risk Even with Normal Cholesterol Levels; Statins & PSA Level

11-2-2008:  Radiation Treatment of Prostate Cancer & Second Cancers; Sexual Content on TV & Teen Pregnancy Risk

10-26-2008:  Smoking & Quality of Life

10-19-2008:  Agent Orange & Prostate Cancer

10-12-2008:  Pomegranate Juice & Prostate Cancer

10-5-2008:  Central Obesity & Dementia; Diet, Vitamin D, Calcium, & Colon Cancer

9-28-2008:  Publication & Citation Bias in Favor of Industry-Funded Research?

9-21-2008:  Does Tylenol® (Acetaminophen) Cause Asthma?

9-14-208:   Arthroscopic Knee Surgery- No Better than Placebo?; A Healthy Lifestyle Prevents Stroke

8-23-2008:  Alcohol Abuse Before & After Military Deployment; Running & Age; Running & Your Testicles

8-12-2008:  Green Tea & Diabetes; Breastfeeding & Adult Cholesterol Levels; Fish Oil & Senile Macular Degeneration

8-3-2008:   Exercise & Weight Loss; Green Tea, Folic Acid & Breast Cancer Risk; Foreign Language Interpreters & ICU Patients

7-26-2008:  Viagra & Sexual Function in Women; Patient-Reported Adverse Hospital Events; Curcumin & Pancreatic Cancer

7-13-2008:  Erectile Dysfunction & Frequency of Sex; Muscle Strength & Mortality in Men; Cryoablation for Prostate Cancer

7-6-2008:  Sleep, Melatonin & Breast Cancer Risk; Mediterranean Diet & Cancer Risk; New Treatment for Varicose Veins

6-29-2008:  Bone Marrow Stem Cells & Liver Failure; Vitamin D & Colorectal Cancer Survival; Green Tea & Colorectal Cancer

6-22-2008:  Obesity, Lifestyle & Heart Disease; Effects of Lifestyle & Nutrition on Prostate Cancer; Ginkgo Biloba, Ulcerative Colitis & Colorectal Cancer

6-15-2008:  Preventable Deaths after Coronary Artery Bypass Graft (CABG) Surgery; Green Tea & Colorectal Cancer; Attention-Deficit/Hyperactivity Disorder (ADHD) & St. John’s Wort

6-8-2008:  Vitamin D & Prostate Cancer Risk; Radiofrequency Ablation (RFA) of Kidney (Renal) Cancer; Antisense Telomerase & Cancer

6-2-2008:  Acute Coronary Syndrome- Do You Know the Symptoms?; Green Tea & Lung Cancer; Episiotomy & Subsequent Deliveries- An Unkind Cut

5-25-2008:  Early Childhood Screening Predicts Later Behavioral Problems; Psychiatric Disorders Among Parents of Autistic Children; Social & Psychiatric Profiles of Young Adults Born Prematurely

5-18-2008:  Can Statins Reverse Coronary Artery Disease?; Does Breast Ultrasound Improve Breast Cancer Detection?; Preventive Care Services at Veterans Administration (VA) Medical Centers

5-11-2008:  Smoking Cessation & Risk of Death; Childhood Traumas & Adult Suicide Risk; “White Coat Hypertension” & Risk of Cardiovascular Disease

5-4-2008:  Super-Size Me: Fast Food’s Effects on Your Liver; Exercise, Weight & Coronary Artery Disease; Contamination of Surgical Instruments in the Operating Room

4-27-2008:  Stents vs. Bypass Surgery for Coronary Artery Disease; The “DASH” Hypertension Diet & Cardiovascular Disease Prevention; Testosterone Therapy for Women with Decreased Sexual Desire & Function

4-20-2008:  BRCA Breast Cancer Mutations & MRI Scans; Bladder Cancer Prevention with Broccoli?; Diabetes: Risk of Death Due to Heart Attack & Stroke

4-13-2008:  Breast Cancer Recurrence & Hormone Replacement Therapy (HRT); Carotid Artery Disease: Surgery vs. Stents?; Statin Drugs & Cancer Prevention

4-6-2008:  Human Papilloma Virus (HPV), Pap Smear Results & Cervical Cancer; Human Papilloma Virus (HPV) Infection & Oral Cancer; Hormone Replacement Therapy (HRT) & the Risk of Gastroesophageal Reflux Disorder (GERD)

3-30-2008:  Abdominal Obesity & the Risk of Death in Women; Folic Acid Pretreatment & Heart Attacks; Pancreatic Cancer Regression after Injections of Bacteria

3-23-2008:  Age of Transfused Blood & Risk of Complications after Surgery; Obesity, Blood Pressure & Heart Size in Children

3-16-2008:  Benefits of a Full Drug Coverage Plan for Medicare Patients?; Parent-Teen Conversations about Sex; Soy (Genistein) & Prostate Cancer

3-9-2008:  Flat Colorectal Adenomas & Cancer; Health Risks after Stopping Hormone Replacement Therapy (HRT); Television, Children & Obesity 

3-2-2008:  Medication & Risk of Death After Heart Attack; Hormone Replacement Therapy (HRT) & Mammogram Results; Selenium: Cancer, Heart Disease & Death

2-23-2008:  Universal Healthcare Insurance Study; Glucosamine & Arthritis

2-17-2008:  Exceptional Longevity in Men; Testosterone & Risk of Prostate Cancer; Smoking & Pre-malignant Colorectal Polyps

2-10-2008:  Thrombus Aspiration from Coronary Arteries; Intensive Management of Diabetes & Death; Possible Cure for  Down's Syndrome?

2-3-2008:  Vitamin D & Cardiovascular Health; Vitamin D & Breast Cancer; Green Tea & Colorectal Cancer

1-27-2008:  Colorectal Cancer, Esophageal Cancer & Pancreatic Cancer: Update from the 2008 American Society of Clinical Oncology's Gastrointestinal Cancers Symposium

1-20-2008:  Testosterone Levels & Risk of Fractures in Elderly Men; Air Pollution & DNA Damage in Sperm; Statins & Trauma Survival in the Elderly

1-12-2008:  Statins, Diabetes & Stroke and Obesity; GERD & Esophageal Cancer

1-7-2008:  Testosterone Supplements in Elderly Men; Colorectal Cancer-- Reasons for Poor Compliance with Screening Recommendations

12-31-2007:  Minority Women, Hormone Replacement Therapy & Breast Cancer; Does Health Insurance Improve Health?

12-23-2007:  Is Coffee Safe After a Heart Attack?; Impact of Divorce on the Environment; Hypertension & the Risk of Dementia; Emotional Vitality & the Risk of Heart Disease

12-16-2007:   Honey vs. Dextromethorphan vs. No Treatment for Kids with Night-Time Cough, Acupuncture & Hot Flashes in Women with Breast Cancer, Physical Activity & the Risk of Death, Mediterranean Diet & Mortality 

12-11-2007:  Bias in Medical Research; Carbon Nanotubes & Radiofrequency: A New Weapon Against Cancer?; Childhood Obesity & Risk of Adult Heart Disease

12-2-2007:  Obesity & Risk of Cancer; Testosterone Level & Risk of Death; Drug Company Funding of Research & Results; Smoking & the Risk of Colon & Rectal Cancer 


Dr. Wascher's Home Page


Email ItEmail It | Print ItPrint It | CommentsComments (0) | TrackbacksTrackbacks (0) | Flag as offensiveFlag as Offensive

Depression, Stress, Anger & Heart Disease

 

Health Report:


Depression, Stress, Anger & Heart Disease

 



"A critical weekly review of important new research findings for health-conscious readers..."

 

By, Robert A. Wascher, MD, FACS

Updated:  03/15/2009


The information in this column is intended for informational purposes only, and does not constitute medical advice or recommendations by the author.  Please consult with your physician before making any lifestyle or medication changes, or if you have any other concerns regarding your health.


 

DEPRESSION, STRESS, ANGER & HEART DISEASE

 

According to recent surveys, about 75 percent of Americans are worried, depressed or angry about the economy. All of us, it seems, know someone who has lost their job recently, and many of us worry that we might be next. Sleep is hard to come by for many of us during these turbulent and uncertain times, and as I have discussed in recent articles on this website, chronic sleep deprivation, itself, has previously been linked to higher mortality rates in some clinical studies.

A number of illnesses have previously been linked to periods of prolonged stress, and particularly those situations that leave people feeling “helpless and hopeless” with respect to the events that are causing them to feel stressed. Prolonged periods of severe stress tend to disrupt the normal function of critical systems in our bodies, including the brain, the GI tract, the immune system, the reproductive system, and the cardiovascular system. Two important and timely news studies, just published in the Journal of the American College of Cardiology, further add to our understanding of the potentially adverse impact of chronic stress on our health.

In the first study, from Harvard University, more than 63,000 women participating in the enormous prospective Nurses’ Health Study were evaluated. All of these women underwent extensive psychological and physical evaluations in 1992, 1996, and again in 2000. None of these women had any clinical history of coronary artery disease or stroke at the time that they underwent their initial evaluation in 1992. The incidence of sudden cardiac death, heart attack, or death due to heart attack was then assessed in this huge cohort of adult women during the 8-year monitoring period. Additionally, the incidence of clinical depression (as measured by standardized mental health questionnaires and the use of antidepressant medications) was evaluated and analyzed in these patient volunteers.

The presence of clinical depression was found to significantly correlate with the risk of cardiac events in this study, even after controlling for other preexisting coronary artery disease risk factors in these 63,469 women. The presence of clinical depression was associated with a 49 percent increase in the risk of fatal heart attack (myocardial infarction) due to coronary artery disease. Sudden cardiac death was also much more common among the depressed women in this gigantic clinical study, and especially among the women who were taking antidepressant medications. In fact, the women who were taking antidepressant medications experienced more than twice the risk of sudden cardiac death (2.33-fold increased risk) when compared to the women without any history of depression or antidepressant use!

Therefore, clinical indicators of depression, including depression confirmed by standardized mental health screening questionnaires or the use of antidepressant medications, were associated with a strikingly increased risk of coronary artery disease, heart attack, fatal heart attack, and sudden cardiac death. If you believe that you are depressed (or if family or friends believe that you may be depressed), please see your physician or a mental health expert, as chronic depression can, indeed, be a matter of life or death.

The second, and related, research study that I would like to discuss today focuses more on the role of anger and hostility in coronary artery disease risk. In the 1970s and 1980s, a great deal of “pop psychology” was given over to classifying personalities into various general types. Highly driven people, who tend to be impatient, easily-angered, and prone to hostile responses, were categorized as having “Type A” personalities, while their calmer and less driven counterparts were considered to have “Type B” personalities. Type A people, it was said, are more likely to engage in risky behaviors that increased the likelihood of premature death due to accidents and cardiovascular disease. Some older research has even suggested that having a Type A personality might be directly associated with a higher risk of cardiovascular disease as a result of chronic anger and hostility, rather than indirectly from engaging in lifestyle behaviors known to increase the risk of heart disease.

In this second clinical study, researchers in London comprehensively reviewed 25 previously published clinical studies of coronary artery disease risk in healthy populations, as well as another 19 studies of patient volunteers with existing coronary artery disease. All of these studies included assessments of personality profiles among the patient volunteers who participated in these clinical research trials. 

Among the studies of previously healthy volunteers, those patients who scored highly on psychological assessment tools in terms of anger and hostility were nearly 20 percent more likely to develop evidence of new coronary artery disease (including heart attack) when compared to the patients who had very low hostility and anger scores. Among the patients who were known to already have coronary artery disease at the time that they enrolled in these studies, there was a 24 percent greater likelihood of serious complications associated with coronary artery disease among the angry and hostile patients, including death due to heart attack, than was observed among the heart disease patients who were not predisposed to anger and hostility. Interestingly, as has been observed in previous research studies, the incidence of coronary artery disease events, including heart attack and death due to heart attack, appeared to be significantly higher among angry and hostile men than was observed among angry and hostile women, particularly among the study volunteers who had no prior history of coronary artery disease at the time that they enrolled in these studies. 

In summary, this comprehensive review of previously published data appears to confirm the findings of earlier studies that chronic anger and hostility appear to be associated with an increased risk of coronary artery disease and heart attacks, even when other preexisting coronary artery disease risk factors are controlled for. Furthermore, this analysis suggests that having an angry and hostile predisposition is probably more dangerous for men than for women, although both genders probably experience an increased risk of heart disease if they are chronically angry or hostile. Finally, angry and hostile people who develop coronary heart disease appear to have a worse prognosis when compared with mellower folks who also have the equivalent extent of heart disease. 

As with the link between chronic depression and heart disease, chronic feelings of anger and hostility appear to increase one’s risk of developing heart disease too. If you believe that you are susceptible to depression, or to regular or frequent feelings of anger and hostility towards others (or towards yourself, for that matter), then you owe it to yourself, and to those who care about you, to seek help. These mental health and personality difficulties are often extremely difficult to resolve by yourself, no matter how much insight and motivation you might already have. If you struggle with any of these issues, or if other people who know you and care about you have suggested that you have problems in these areas, then please seek help now.



Disclaimer:  As always, my advice to readers is to seek the advice of your physician
before making any significant changes in medications, diet, or level of physical activity


 

Dr. Wascher is an oncologic surgeon, a professor of surgery, a widely published author, and a Surgical Oncologist at the Kaiser Permanente healthcare system in Orange County, California



Send your feedback to Dr. Wascher at:
 rwascher@doctorwascher.net


Dr. Wascher's Biography


Links to Other Health & Wellness Sites


http://doctorwascher.com


 

Copyright 2009

Robert A. Wascher, MD, FACS

All rights reserved


Dr. Wascher's Archives:

3-8-2009: Coronary Artery Disease: CABG vs. Stents?; Swimming Lessons & Drowning Risk in Children

3-1-2009: Aspirin & Colorectal Cancer Prevention; Fish Oil & Respiratory Infections in Children

2-22-2009: Health Differences Between Americans & Europeans; Lycopene & Prostate Cancer

2-15-2009: Statin Drugs & Death Rates; Physical Activity, Breast Cancer & Sex Hormones

2-8-2009: Hormone Replacement Therapy (HRT) & Breast Cancer; Stool DNA Testing & Cancer of the Colon & Rectum

2-1-2009:   Obesity and the Complications of Diverticulosis (Diverticulitis & Bleeding); Obesity, Weight Loss & Urinary Incontinence

1-25-2009: Prostate Cancer, Fatigue & Exercise; Does your Surgeon “Warm-up” Before Surgery?

1-18-2009: Cancer and Vitamins; Teenagers, MySpace and Risky Behaviors

1-11-2009: Exercise Reverses Some Effects of Fatty Meals; Vitamin C and Blood Pressure

1-4-2009: Secondhand Smoke & Heart Attack Risk; Poor Physical Fitness During Childhood & Heart Disease Risk During Adulthood

12-28-2008: Stress & Your Risk of Heart Attack; Vitamin D & the Prevention of Colon & Rectal Polyps

12-21-2008: Breast Cancer Incidence & Hormone Replacement Therapy; Circumcision & the Risk of HPV & HIV Infection

12-14-2008: Vitamin E, Vitamin C and Selenium Do Not Prevent Cancer; Postscript: A Possible Cure for Down’s Syndrome

12-7-2008: Generic vs. Brand-Name Drugs, Stress & Breast Cancer Survival

11-30-2008:   A Possible Cure for Down’s Syndrome?; Smoking & Cognitive Decline; Calcium & Vitamin D & Breast Cancer Risk

11-23-2008:  Breast Cancer & Fish Oil; Lymphedema after Breast Cancer Treatment; Vasectomy & Prostate Cancer Risk

11-16-2008:  Vitamin E & Vitamin C: No Impact on Cardiovascular Disease Risk; Does Lack of Sleep Increase Stroke & Heart Attack Risk in Hypertensive Patients?

11-9-2008:  Statins Cut Heart Attack Risk Even with Normal Cholesterol Levels; Statins & PSA Level

11-2-2008:  Radiation Treatment of Prostate Cancer & Second Cancers; Sexual Content on TV & Teen Pregnancy Risk

10-26-2008:  Smoking & Quality of Life

10-19-2008:  Agent Orange & Prostate Cancer

10-12-2008:  Pomegranate Juice & Prostate Cancer

10-5-2008:  Central Obesity & Dementia; Diet, Vitamin D, Calcium, & Colon Cancer

9-28-2008:  Publication & Citation Bias in Favor of Industry-Funded Research?

9-21-2008:  Does Tylenol® (Acetaminophen) Cause Asthma?

9-14-208:   Arthroscopic Knee Surgery- No Better than Placebo?; A Healthy Lifestyle Prevents Stroke

8-23-2008:  Alcohol Abuse Before & After Military Deployment; Running & Age; Running & Your Testicles

8-12-2008:  Green Tea & Diabetes; Breastfeeding & Adult Cholesterol Levels; Fish Oil & Senile Macular Degeneration

8-3-2008:   Exercise & Weight Loss; Green Tea, Folic Acid & Breast Cancer Risk; Foreign Language Interpreters & ICU Patients

7-26-2008:  Viagra & Sexual Function in Women; Patient-Reported Adverse Hospital Events; Curcumin & Pancreatic Cancer

7-13-2008:  Erectile Dysfunction & Frequency of Sex; Muscle Strength & Mortality in Men; Cryoablation for Prostate Cancer

7-6-2008:  Sleep, Melatonin & Breast Cancer Risk; Mediterranean Diet & Cancer Risk; New Treatment for Varicose Veins

6-29-2008:  Bone Marrow Stem Cells & Liver Failure; Vitamin D & Colorectal Cancer Survival; Green Tea & Colorectal Cancer

6-22-2008:  Obesity, Lifestyle & Heart Disease; Effects of Lifestyle & Nutrition on Prostate Cancer; Ginkgo Biloba, Ulcerative Colitis & Colorectal Cancer

6-15-2008:  Preventable Deaths after Coronary Artery Bypass Graft (CABG) Surgery; Green Tea & Colorectal Cancer; Attention-Deficit/Hyperactivity Disorder (ADHD) & St. John’s Wort

6-8-2008:  Vitamin D & Prostate Cancer Risk; Radiofrequency Ablation (RFA) of Kidney (Renal) Cancer; Antisense Telomerase & Cancer

6-2-2008:  Acute Coronary Syndrome- Do You Know the Symptoms?; Green Tea & Lung Cancer; Episiotomy & Subsequent Deliveries- An Unkind Cut

5-25-2008:  Early Childhood Screening Predicts Later Behavioral Problems; Psychiatric Disorders Among Parents of Autistic Children; Social & Psychiatric Profiles of Young Adults Born Prematurely

5-18-2008:  Can Statins Reverse Coronary Artery Disease?; Does Breast Ultrasound Improve Breast Cancer Detection?; Preventive Care Services at Veterans Administration (VA) Medical Centers

5-11-2008:  Smoking Cessation & Risk of Death; Childhood Traumas & Adult Suicide Risk; “White Coat Hypertension” & Risk of Cardiovascular Disease

5-4-2008:  Super-Size Me: Fast Food’s Effects on Your Liver; Exercise, Weight & Coronary Artery Disease; Contamination of Surgical Instruments in the Operating Room

4-27-2008:  Stents vs. Bypass Surgery for Coronary Artery Disease; The “DASH” Hypertension Diet & Cardiovascular Disease Prevention; Testosterone Therapy for Women with Decreased Sexual Desire & Function

4-20-2008:  BRCA Breast Cancer Mutations & MRI Scans; Bladder Cancer Prevention with Broccoli?; Diabetes: Risk of Death Due to Heart Attack & Stroke

4-13-2008:  Breast Cancer Recurrence & Hormone Replacement Therapy (HRT); Carotid Artery Disease: Surgery vs. Stents?; Statin Drugs & Cancer Prevention

4-6-2008:  Human Papilloma Virus (HPV), Pap Smear Results & Cervical Cancer; Human Papilloma Virus (HPV) Infection & Oral Cancer; Hormone Replacement Therapy (HRT) & the Risk of Gastroesophageal Reflux Disorder (GERD)

3-30-2008:  Abdominal Obesity & the Risk of Death in Women; Folic Acid Pretreatment & Heart Attacks; Pancreatic Cancer Regression after Injections of Bacteria

3-23-2008:  Age of Transfused Blood & Risk of Complications after Surgery; Obesity, Blood Pressure & Heart Size in Children

3-16-2008:  Benefits of a Full Drug Coverage Plan for Medicare Patients?; Parent-Teen Conversations about Sex; Soy (Genistein) & Prostate Cancer

3-9-2008:  Flat Colorectal Adenomas & Cancer; Health Risks after Stopping Hormone Replacement Therapy (HRT); Television, Children & Obesity 

3-2-2008:  Medication & Risk of Death After Heart Attack; Hormone Replacement Therapy (HRT) & Mammogram Results; Selenium: Cancer, Heart Disease & Death

2-23-2008:  Universal Healthcare Insurance Study; Glucosamine & Arthritis

2-17-2008:  Exceptional Longevity in Men; Testosterone & Risk of Prostate Cancer; Smoking & Pre-malignant Colorectal Polyps

2-10-2008:  Thrombus Aspiration from Coronary Arteries; Intensive Management of Diabetes & Death; Possible Cure for  Down's Syndrome?

2-3-2008:  Vitamin D & Cardiovascular Health; Vitamin D & Breast Cancer; Green Tea & Colorectal Cancer

1-27-2008:  Colorectal Cancer, Esophageal Cancer & Pancreatic Cancer: Update from the 2008 American Society of Clinical Oncology's Gastrointestinal Cancers Symposium

1-20-2008:  Testosterone Levels & Risk of Fractures in Elderly Men; Air Pollution & DNA Damage in Sperm; Statins & Trauma Survival in the Elderly

1-12-2008:  Statins, Diabetes & Stroke and Obesity; GERD & Esophageal Cancer

1-7-2008:  Testosterone Supplements in Elderly Men; Colorectal Cancer-- Reasons for Poor Compliance with Screening Recommendations

12-31-2007:  Minority Women, Hormone Replacement Therapy & Breast Cancer; Does Health Insurance Improve Health?

12-23-2007:  Is Coffee Safe After a Heart Attack?; Impact of Divorce on the Environment; Hypertension & the Risk of Dementia; Emotional Vitality & the Risk of Heart Disease

12-16-2007:   Honey vs. Dextromethorphan vs. No Treatment for Kids with Night-Time Cough, Acupuncture & Hot Flashes in Women with Breast Cancer, Physical Activity & the Risk of Death, Mediterranean Diet & Mortality 

12-11-2007:  Bias in Medical Research; Carbon Nanotubes & Radiofrequency: A New Weapon Against Cancer?; Childhood Obesity & Risk of Adult Heart Disease

12-2-2007:  Obesity & Risk of Cancer; Testosterone Level & Risk of Death; Drug Company Funding of Research & Results; Smoking & the Risk of Colon & Rectal Cancer 


Email ItEmail It | Print ItPrint It | CommentsComments (0) | TrackbacksTrackbacks (0) | Flag as offensiveFlag as Offensive

Coronary Artery Disease: CABG vs. Stents?; Swimming Lessons & Drowning Risk in Children

 

 

Health Report:


Coronary Artery Disease: CABG vs. Stents?

 

Swimming Lessons & Drowning Risk in Children

 



"A critical weekly review of important new research findings for health-conscious readers..."

 

By, Robert A. Wascher, MD, FACS

 

Updated:  03/8/2009


The information in this column is intended for informational purposes only, and does not constitute medical advice or recommendations by the author.  Please consult with your physician before making any lifestyle or medication changes, or if you have any other concerns regarding your health.


CORONARY ARTERY DISEASE: CABG vs. STENTS?

The debate over the optimal treatment of coronary artery diseases continues, even among top heart disease experts.  Much of the clinical research thus far has suggested that coronary artery stents work about as well as the far more invasive coronary artery bypass grafting (CABG) surgery does, at least in the short term, but that the benefits of CABG surgery tend to last longer than coronary artery stents.  Of course, the risks associated with CABG surgery, especially in the early period after surgery, tend to be higher than for stent placement (although patients undergoing CABG surgery also tend to have more advanced coronary artery disease than patients who are typically selected for less invasive coronary artery stent placement procedures).

A new prospective, randomized clinical research trial, just published in the New England Journal of Medicine, further clarifies important differences in outcomes among patients undergoing coronary artery stent placement versus CABG surgery.  In this impressive interventional study, 1,800 patients with coronary artery disease involving either all 3 major coronary arteries or the dominant “left main” coronary artery were randomized to undergo either CABG surgery or coronary artery stent placement (also known as percutaneous coronary intervention, or PCI).  Historically, patients with these patterns of advanced coronary artery disease have been advised to undergo CABG surgery instead of PCI, due to the improved durability of CABG, over time, when compared to PCI.  However, given the minimally invasive nature of coronary artery stent placement, when compared to CABG surgery, both cardiologists and patients have a strong interest in learning whether or not more advanced cases of coronary artery disease can be effectively treat with PCI instead of CABG surgery.

Following CABG or PCI, the 1,800 patient volunteers were observed for an average period of one year, and the incidence of death (from any cause), heart attack, stroke, or the need for additional coronary artery disease interventions, was tracked in both patient groups.

The results of this study largely confirmed earlier clinical studies that have favored CABG surgery over PCI in patients with diseased left main coronary arteries, and in patients with 3-vessel coronary artery disease.  The incidence of major acute coronary artery events was significantly higher in the PCI group when compared to the CABG surgery group (18 percent in the PCI group versus 12 percent in the CABG surgery group).   Much of this observed difference in recurrent coronary artery events between the two patient groups appeared to derive from the two-fold increase in the need for repeat coronary artery interventions in the PCI patient group when compared to the CABG surgery patients.  Nearly 14 percent of the PCI patients required a repeat coronary artery intervention within 12 months of their initial PCI procedure, while only 6 percent of the CABG surgery patients required another coronary artery intervention within a year of their initial surgery.  At the same time, it is important to note that, at 12 months following initial coronary artery intervention, the death rate and the heart attack (myocardial infarction) rate was essentially equivalent between the two patient groups, and the stroke rate was actually higher in the CABG surgery group (2 percent in the CABG surgery group versus 0.6 percent in the PCI group). 

The authors of this study concluded that, after one year of follow-up, CABG surgery was superior to coronary artery stent placement (PCI), as the patients who underwent PCI were twice as likely to require subsequent coronary artery interventions when compared to the patients who had undergone CABG surgery.  However, in my view, the results of this study, as published are somewhat more equivocal, especially from a patient’s perspective.  Although the duration of follow-up in this study (one year) was very brief, this study revealed that the overall death rate was essentially equivalent with either intervention, and many patients in the PCI group were spared the need for major open-heart surgery (and its attendant higher risk of stroke).  Ultimately, it will require longer follow-up of this cohort of patients, in my view, to prove the claimed superiority of CABG surgery over PCI for 3-vessel or left main coronary artery disease.  Based upon previous research studies, one would anticipate that, over a period of 10 to 15 years, the patients who underwent CABG surgery in this study are likely to experience fewer adverse cardiovascular events than the patients who underwent PCI.  As other recent clinical studies have shown, though, the differences in important clinical outcomes during the first few years following either CABG surgery or PCI may be far less than what older studies have suggested, and this narrowing of differences in early outcomes may reflect recent advances in PCI.  For now, in my view, the debate regarding the inherent superiority of CABG over PCI for certain groups of patients with coronary artery disease has not yet been fully resolved by this important new study, and only long-term follow-up of this study’s patient volunteers is likely to definitively decide this ongoing debate.

 

SWIMMING LESSONS & DROWNING RISK IN CHILDREN

My wife, it can be revealed, never learned to swim, despite spending most of her life living in beach communities.  As a form of parental compensation for my wife’s lack of comfort in an aquatic environment, our two young children have been charged with learning to swim from a very early age.  Of course, this makes perfect sense to me as well, given that we continue to live near the beach.  However, due to the not very infrequent tragic stories of young children drowning in family pools, I have sometimes worried that increasing our young children’s comfort levels in the water could expose them to an increased risk of a pool-related accidents, due to overconfidence on their part.  I was, therefore, quite relieved to find a newly published research study on this very topic, which appears in the current volume of the Archives of Pediatric and Adolescent Medicine. 

In this retrospective case-control study, the authors reviewed cases of drowning deaths occurring in children and adolescents between the ages of 1 and 19 years in the states of Maryland, North Carolina, Florida, California, Texas, and New York.  The researchers then interviewed a sample of 88 families of children and teens, from these same states, who had died in drowning accidents.  A control group of 213 families who had not experienced the tragic loss of a child was also interviewed.  The results and conclusions of this innovative clinical study were rather striking (and personally reassuring to me).

Of the 61 families who lost a child between the ages of 1 and 4 years to drowning, only 3 percent had enrolled their lost child in swimming lessons, while 26 percent of the control group families with children in this same age range had enrolled their toddlers in formal swimming lessons.  Among the 27 families that had lost children between the ages of 5 and 19 years to drowning accidents, 27 percent had enrolled their deceased children in formal swimming lessons, compared with 53 percent of the same-aged children in the 79 control group families.  (While these results suggest that formal swimming instruction in children aged 5 years or older decreases the risk of accidental drowning, the results in this age group were not statistically significant, unlike the results observed for the younger children.)  At the same time, when the researchers looked at unstructured or otherwise informal swimming instruction as a risk factor for accidental drowning, they found absolutely no association between informal instruction and drowning rates in children and adolescents.

The results of this retrospective case-control study identified a whopping 88 percent reduction in the risk of accidental drowning among 1 to 4 year-old children who had undergone formal swimming instruction, when compared to same-age toddlers who had either never undergone formal instruction or who had undergone only informal, unstructured swimming instruction.  While the retrospective case-control methodology used for this study is not as powerful as would be observed in a prospective clinical research trial, this study’s findings do reassure me that there is most likely some significant benefit associated with formal swimming lessons in younger children.  Selection biases, as well as other potential sources of bias, are difficult to eliminate in these types of clinical studies, and so the absolute benefit of swimming lessons is likely to be less than the 88 percent level reported by this retrospective study.  However, when one is considering even potentially modest reductions in the risk of losing one’s child to accidental drowning, there is no such thing as a trivial level of risk reduction, in my view.  So, our young children will definitely be continuing with their swimming lessons at our friendly neighborhood YMCA.

 



Disclaimer:  As always, my advice to readers is to seek the advice of your physician
before making any significant changes in medications, diet, or level of physical activity


Dr. Wascher is an oncologic surgeon, a professor of surgery, a widely published author, and a Surgical Oncologist at the Kaiser Permanente healthcare system in Orange County, California



Send your feedback to Dr. Wascher at:
 rwascher@doctorwascher.net


Dr. Wascher's Biography


Links to Other Health & Wellness Sites


http://doctorwascher.com


 

Copyright 2009

Robert A. Wascher, MD, FACS

All rights reserved

 


 

Dr. Wascher's Archives:

 

3-1-2009:  Aspirin & Colorectal Cancer Prevention; Fish Oil & Respiratory Infections in Children

2-22-2009:  Health Differences Between Americans & Europeans; Lycopene & Prostate Cancer

2-15-2009:  Statin Drugs & Death Rates; Physical Activity, Breast Cancer & Sex Hormones

2-8-2009:  Hormone Replacement Therapy (HRT) & Breast Cancer; Stool DNA Testing & Cancer of the Colon & Rectum

2-1-2009:   Obesity and the Complications of Diverticulosis (Diverticulitis & Bleeding); Obesity, Weight Loss & Urinary Incontinence

1-25-2009:  Prostate Cancer, Fatigue & Exercise; Does your Surgeon “Warm-up” Before Surgery?

1-18-2009:  Cancer and Vitamins; Teenagers, MySpace and Risky Behaviors

1-11-2009:  Exercise Reverses Some Effects of Fatty Meals; Vitamin C and Blood Pressure

1-4-2009:  Secondhand Smoke & Heart Attack Risk; Poor Physical Fitness During Childhood & Heart Disease Risk During Adulthood

12-28-2008:  Stress & Your Risk of Heart Attack; Vitamin D & the Prevention of Colon & Rectal Polyps

12-21-2008:  Breast Cancer Incidence & Hormone Replacement Therapy; Circumcision & the Risk of HPV & HIV Infection

12-14-2008:  Vitamin E, Vitamin C and Selenium Do Not Prevent Cancer;  Postscript: A Possible Cure for Down’s Syndrome

12-7-2008:  Generic vs. Brand-Name Drugs, Stress & Breast Cancer Survival

11-30-2008:    A Possible Cure for Down’s Syndrome?; Smoking & Cognitive Decline; Calcium & Vitamin D & Breast Cancer Risk

11-23-2008:  Breast Cancer & Fish Oil; Lymphedema after Breast Cancer Treatment; Vasectomy & Prostate Cancer Risk

11-16-2008:  Vitamin E & Vitamin C: No Impact on Cardiovascular Disease Risk; Does Lack of Sleep Increase Stroke & Heart Attack Risk in Hypertensive Patients?

11-9-2008:  Statins Cut Heart Attack Risk Even with Normal Cholesterol Levels; Statins & PSA Level

11-2-2008:  Radiation Treatment of Prostate Cancer & Second Cancers; Sexual Content on TV & Teen Pregnancy Risk

10-26-2008:  Smoking & Quality of Life

10-19-2008:  Agent Orange & Prostate Cancer

10-12-2008:  Pomegranate Juice & Prostate Cancer

10-5-2008:  Central Obesity & Dementia; Diet, Vitamin D, Calcium, & Colon Cancer

9-28-2008:  Publication & Citation Bias in Favor of Industry-Funded Research?

9-21-2008:  Does Tylenol® (Acetaminophen) Cause Asthma?

9-14-208:   Arthroscopic Knee Surgery- No Better than Placebo?; A Healthy Lifestyle Prevents Stroke

8-23-2008:  Alcohol Abuse Before & After Military Deployment; Running & Age; Running & Your Testicles

8-12-2008:  Green Tea & Diabetes; Breastfeeding & Adult Cholesterol Levels; Fish Oil & Senile Macular Degeneration

8-3-2008:   Exercise & Weight Loss; Green Tea, Folic Acid & Breast Cancer Risk; Foreign Language Interpreters & ICU Patients

7-26-2008:  Viagra & Sexual Function in Women; Patient-Reported Adverse Hospital Events; Curcumin & Pancreatic Cancer

7-13-2008:  Erectile Dysfunction & Frequency of Sex; Muscle Strength & Mortality in Men; Cryoablation for Prostate Cancer

7-6-2008:  Sleep, Melatonin & Breast Cancer Risk; Mediterranean Diet & Cancer Risk; New Treatment for Varicose Veins

6-29-2008:  Bone Marrow Stem Cells & Liver Failure; Vitamin D & Colorectal Cancer Survival; Green Tea & Colorectal Cancer

6-22-2008:  Obesity, Lifestyle & Heart Disease; Effects of Lifestyle & Nutrition on Prostate Cancer; Ginkgo Biloba, Ulcerative Colitis & Colorectal Cancer

6-15-2008:  Preventable Deaths after Coronary Artery Bypass Graft (CABG) Surgery; Green Tea & Colorectal Cancer; Attention-Deficit/Hyperactivity Disorder (ADHD) & St. John’s Wort

6-8-2008:  Vitamin D & Prostate Cancer Risk; Radiofrequency Ablation (RFA) of Kidney (Renal) Cancer; Antisense Telomerase & Cancer

6-2-2008:  Acute Coronary Syndrome- Do You Know the Symptoms?; Green Tea & Lung Cancer; Episiotomy & Subsequent Deliveries- An Unkind Cut

5-25-2008:  Early Childhood Screening Predicts Later Behavioral Problems; Psychiatric Disorders Among Parents of Autistic Children; Social & Psychiatric Profiles of Young Adults Born Prematurely

5-18-2008:  Can Statins Reverse Coronary Artery Disease?; Does Breast Ultrasound Improve Breast Cancer Detection?; Preventive Care Services at Veterans Administration (VA) Medical Centers

5-11-2008:  Smoking Cessation & Risk of Death; Childhood Traumas & Adult Suicide Risk; “White Coat Hypertension” & Risk of Cardiovascular Disease

5-4-2008:  Super-Size Me: Fast Food’s Effects on Your Liver; Exercise, Weight & Coronary Artery Disease; Contamination of Surgical Instruments in the Operating Room

4-27-2008:  Stents vs. Bypass Surgery for Coronary Artery Disease; The “DASH” Hypertension Diet & Cardiovascular Disease Prevention; Testosterone Therapy for Women with Decreased Sexual Desire & Function

4-20-2008:  BRCA Breast Cancer Mutations & MRI Scans; Bladder Cancer Prevention with Broccoli?; Diabetes: Risk of Death Due to Heart Attack & Stroke

4-13-2008:  Breast Cancer Recurrence & Hormone Replacement Therapy (HRT); Carotid Artery Disease: Surgery vs. Stents?; Statin Drugs & Cancer Prevention

4-6-2008:  Human Papilloma Virus (HPV), Pap Smear Results & Cervical Cancer; Human Papilloma Virus (HPV) Infection & Oral Cancer; Hormone Replacement Therapy (HRT) & the Risk of Gastroesophageal Reflux Disorder (GERD)

3-30-2008:  Abdominal Obesity & the Risk of Death in Women; Folic Acid Pretreatment & Heart Attacks; Pancreatic Cancer Regression after Injections of Bacteria

3-23-2008:  Age of Transfused Blood & Risk of Complications after Surgery; Obesity, Blood Pressure & Heart Size in Children

3-16-2008:  Benefits of a Full Drug Coverage Plan for Medicare Patients?; Parent-Teen Conversations about Sex; Soy (Genistein) & Prostate Cancer

3-9-2008:  Flat Colorectal Adenomas & Cancer; Health Risks after Stopping Hormone Replacement Therapy (HRT); Television, Children & Obesity 

3-2-2008:  Medication & Risk of Death After Heart Attack; Hormone Replacement Therapy (HRT) & Mammogram Results; Selenium: Cancer, Heart Disease & Death

2-23-2008:  Universal Healthcare Insurance Study; Glucosamine & Arthritis

2-17-2008:  Exceptional Longevity in Men; Testosterone & Risk of Prostate Cancer; Smoking & Pre-malignant Colorectal Polyps

2-10-2008:  Thrombus Aspiration from Coronary Arteries; Intensive Management of Diabetes & Death; Possible Cure for  Down's Syndrome?

2-3-2008:  Vitamin D & Cardiovascular Health; Vitamin D & Breast Cancer; Green Tea & Colorectal Cancer

1-27-2008:  Colorectal Cancer, Esophageal Cancer & Pancreatic Cancer: Update from the 2008 American Society of Clinical Oncology's Gastrointestinal Cancers Symposium

1-20-2008:  Testosterone Levels & Risk of Fractures in Elderly Men; Air Pollution & DNA Damage in Sperm; Statins & Trauma Survival in the Elderly

1-12-2008:  Statins, Diabetes & Stroke and Obesity; GERD & Esophageal Cancer

1-7-2008:  Testosterone Supplements in Elderly Men; Colorectal Cancer-- Reasons for Poor Compliance with Screening Recommendations

12-31-2007:  Minority Women, Hormone Replacement Therapy & Breast Cancer; Does Health Insurance Improve Health?

12-23-2007:  Is Coffee Safe After a Heart Attack?; Impact of Divorce on the Environment; Hypertension & the Risk of Dementia; Emotional Vitality & the Risk of Heart Disease

12-16-2007:   Honey vs. Dextromethorphan vs. No Treatment for Kids with Night-Time Cough, Acupuncture & Hot Flashes in Women with Breast Cancer, Physical Activity & the Risk of Death, Mediterranean Diet & Mortality 

12-11-2007:  Bias in Medical Research; Carbon Nanotubes & Radiofrequency: A New Weapon Against Cancer?; Childhood Obesity & Risk of Adult Heart Disease

12-2-2007:  Obesity & Risk of Cancer; Testosterone Level & Risk of Death; Drug Company Funding of Research & Results; Smoking & the Risk of Colon & Rectal Cancer 

 


Dr. Wascher's Home Page

Email ItEmail It | Print ItPrint It | CommentsComments (0) | TrackbacksTrackbacks (0) | Flag as offensiveFlag as Offensive

Statin Drugs & Death Rates; Physical Activity, Breast Cancer & Sex Hormones

 

Health Report:


Statin Drugs & Death Rates

 

 

Physical Activity, Breast Cancer & Sex Hormones

 



"A critical weekly review of important new research findings for health-conscious readers..."

 

By, Robert A. Wascher, MD, FACS


Last Updated:  02/15/2009


The information in this column is intended for informational purposes only, and does not constitute medical advice or recommendations by the author.  Please consult with your physician before making any lifestyle or medication changes, or if you have any other concerns regarding your health.


 

STATIN DRUGS AND DEATH RATES

As I’ve mentioned in previous columns, the statin class of cholesterol-lowering drugs have revolutionized the treatment of elevated cholesterol levels, and have been shown, by multiple clinical studies, to decrease the incidence of cardiovascular events, including fatal heart attacks (myocardial infarction), in susceptible patients. While their value in reducing non-cardiovascular disease events (such as cancer, for example) continues to be debated, there is no question but that statin drugs can significantly drive down the risk of coronary artery disease in patients with elevated cholesterol levels, as well as in patients with high-normal levels of  LDL (the “bad cholesterol”). 

A new clinical study assessing statin drugs and death rates has just been published in the Archives of Internal Medicine. Nearly 230,000 adult patients (average age was about 58 years) enrolled in an HMO were retrospectively assessed in this huge public health study, which was performed in Israel; and all of these patients were started on statin medications between 1998 and 2006. Two general groups of patients were included in this study. The first group included patients who were prescribed statin drugs to prevent coronary artery disease, and who had no clinical evidence of coronary artery disease at the time they started receiving statins. The second group consisted of patients who were prescribed statin drugs because they already had been diagnosed with coronary artery disease. In this study, the researchers were able to determine the level of compliance of each patient with their statin medications, based upon the HMO’s pharmacy refill data.

After an average follow-up of about 5 years, the death rates among the compliant and noncompliant patients were then compared. The patients who were at least 90 percent compliant with their statin prescriptions experienced a whopping 45 percent reduction in their risk of death, from any cause, when compared to the patients who were less than 10 percent compliant with their statin medications! Furthermore, this dramatic difference in survival was observed in both the prevention group and in the coronary artery disease group. 

The research data also revealed that the greatest reduction in the risk of death was observed in patients with very high baseline LDL levels, and in patients treated with more potent statin drugs. These latter two observations are especially important, because the retrospective nature of this study increases the risk that undetected biases might have influenced the researchers’ conclusions. (For example, patients who were noncompliant with their statin drugs may have also engaged in other risky health behaviors that, independent of not taking their statin drugs, might also have increased their risk of death.)      

The 45 percent reduction in all-cause mortality that was associated, in this study, with a greater than 90 percent patient compliance rate with statin prescriptions is significantly greater than has been observed in most prospective randomized clinical research studies, to date. Given the retrospective nature of this study, it is not clear if the much greater mortality benefit of statin drug compliance observed in this study is entirely valid or not, but the enormous population of HMO patients included in this study, and the moderately long duration of their follow-up (albeit retrospective in nature), suggests that this study’s conclusions are probably reasonable. 

If you have significant risk factors for coronary artery disease, or if you already have coronary artery disease, and your doctor has prescribed a statin drug for you, then the results of this study suggest that you can markedly reduce your risk of death by taking your medications as prescribed.


PHYSICAL ACTIVITY, BREAST CANCER & SEX HORMONES

There is considerable research evidence showing that regular exercise decreases the risk of several different types of cancer, including breast cancer. In the case of breast cancer, given that 85 to 90 percent of breast cancer cases appear to be linked in some way to exposure to estrogen and progesterone (the “female sex hormones”), most experts have assumed that increased levels of regular physical activity must somehow affect circulating sex ho